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ABSTRACT 
 
James Robertson Fuller: Characterization of the Francisella virulence factor RipA 
(Under the direction of Thomas Kawula) 
 
 Francisella tularensis is a highly virulent facultative intracellular pathogen; however, 
the mechanisms by which Francisella virulence factors mediate this virulence are not well 
defined.  We identified the Francisella tularensis LVS FTL_1914 locus in a transposon 
mutagenesis screen for genes required for intraepithelial replication.  Creation and 
characterization of a F. tularensis LVS ∆ripA strain revealed that the locus was necessary for 
intracellular replication and we termed the gene ripA (Required for Intracellular Propagation, 
Factor A).  We have studied the Francisella virulence factor RipA in an attempt to define its 
importance in pathogenesis.  RipA is required for Francisella virulence in a mouse model of 
tularemia.  A Francisella ∆ripA mutant fails to replicate after intracellular colonization.  The 
mutant invades at the same rate as wild type, escapes the phagosome, then fails to replicate in 
the cytoplasm.  RipA localizes to the cytoplasmic membrane of Francisella and interacts 
with the transcriptional regulator IclR.  How this interaction impacts virulence phenotypes 
and IclR transcriptional regulation are currently unknown.  RipA is repressed by the 
Francisella virulence regulator MglA and is suppressed during intracellular growth after 
replication in the cytosol.  MglA is upregulated after cell invasion.  Most other virulence 
factors regulated by MglA are positively impacted by MglA suggesting that other factors act 
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together with MglA to negatively influence gene expression.  We screened a transposon 
library to identify loci that can influence ripA gene expression as identified using a lacZ 
reporter system.  HU form B and NusA were identified as possible regulators that influence 
ripA expression.  RipA may be part of a programmed gene response of Francisella during 
different stages in its intracellular lifecycle.  MglA acting with other regulators may act to 
positively and negatively impact gene expression during different phases of intracellular 
growth and in the much more complex setting of in vivo pathogenesis.    
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Chapter 1 
INTRODUCTION 
 
Francisella tularensis is a small, gram negative, pleomorphic coccobacillus that is the 
etiologic agent of the disease tularemia.  Tularemia had mortality rates as high as 40% in the 
pre-antibiotic era (Stuart and Pullen 1945) and even with modern antibiotic therapy, 
tularemia is lethal in 2% of reported cases (Dennis, Inglesby et al. 2001).  This highly 
successful pathogen was developed as a biological weapon by both the United States and the 
Soviet Union during the cold war (Dennis, Inglesby et al. 2001) and recent concerns that 
Francisella tularensis could be used as a agent of bioterrorism have renewed interest in 
understanding F. tularensis pathogenesis (Oyston, Sjostedt et al. 2004).  As few as 1 to 10 
bacteria can initiate a lethal disease by the inhalational route of transmission (Saslaw, 
Eigelsbach et al. 1961; Saslaw, Eigelsbach et al. 1961).  This makes F. tularensis one of the 
most infectious bacteria known.  The mechanisms that make F. tularensis so infectious are 
unclear.  Insight into the strategies that make F. tularensis such a virulent pathogen may 
carry over into the pathogenesis of other virulent bacteria.  This would enable the coherent 
design of detection, prevention, and therapeutic protocols. 
 
In this era of worldwide travel, the potential for the emergence of virulent pandemics 
is staggering.   Historically pandemics used to traverse the globe over decades and years, 
now air travel has potentiated pandemics that can spread much more rapidly 
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(Colizza, Barrat et al. 2007).  Public health agencies are on the watch for known threats such 
as influenza and SARS; however, emerging pathogens may represent the biggest threat.  The 
rapidity with which emerging diseases may spread will limit the amount of time available to 
research their pathogenesis, properties, and to develop countermeasures.  To be prepared for 
emerging highly virulent pathogens we need to understand the mechanisms that make other 
pathogens, including F. tularensis, virulent.  The strategies used by highly virulent pathogens 
to evade, subvert, and resist the immune system will likely be conserved by other virulent 
organisms including emerging pathogens because of one fact, they work.  What has worked 
once will likely evolve again.   
 
History.  In 1910, George McCoy first recognized a plague-like disease in ground squirrels 
that infected a wide array of animal species in Tulare county, California (McCoy 1910).  He 
surmised that this disease could infect humans, and indeed in 1914 Wherry and Lamb 
reported two cases of human “Deer-fly fever” in Ohio (Wherry and Lamb 1914).  McCoy 
and Chapin first cultured the bacteria that caused “Deer-fly fever” on egg yolks and named it 
Bacterium tularense (McCoy and Chapin 1912).  Edward Francis studied Bacterium 
tularense for many years and as a consequence contracted Deer-fly fever on four different 
occasions (Francis 1936).  Bacterium tularense was later renamed Francisella tularensis in 
his honor.  “Deer-fly fever” and other diseases caused by F. tularensis were named tularemia 
on the recommendation of Edward Francis.  Tularemia was derived from the words Tulare 
and bacteremia based upon the location of the initial work and the clinical manifestations of 
the disease. 
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Clinical manifestations.  Tularemia is clinically categorized into ulceroglandular and 
typhoidal forms based on the involvement of the skin, mucous membranes, and the 
presentation of lymphadenopathy (Nigrovic and Wingerter 2008).  Approximately 75% of 
tularemia cases can be categorized as ulceroglandular tularemia based upon the development 
of a maculopapular lesion and the development of lymphadenopathy.  Typhoidal tularemia 
presents without skin involvement or lymphadenopathy.  Typhoidal tularemia patients have a 
high fever and hepatosplenomegaly.  Pneumonia develops in 30% of ulceroglandular and 
80% of typhoidal tularemia cases.  Tularemia in humans is a rare disease in most countries; 
however, occasional epidemic outbreaks of tularemia have helped to maintain clinical 
interest in F. tularensis detection and treatment.  More recently, interest in F. tularensis has 
been sparked because of its classification as a Category A Select agent by the United States 
based upon the potential for its use as an agent in bioterrorism (Dennis, Inglesby et al. 2001).    
 
Epidemiology.  Extensive epidemiological data has been gathered about tularemia, but the 
details of the F. tularensis lifecycle are still unclear.  F. tularensis is endemic in the Northern 
hemisphere, but is a rare disease in most countries (Johansson, Farlow et al. 2004).  The 
frequency of the disease does not correlate with the persistence of F. tularensis in the 
environment (Sjostedt 2007).  Tularemia occurs mainly in localized epidemic outbreaks 
(Berdal, Mehl et al. 1996; Feldman, Enscore et al. 2001; Eliasson, Lindback et al. 2002; 
Reintjes, Dedushaj et al. 2002; Hofstetter, Eckert et al. 2006; Wik 2006).  Based on current 
surveys, the most likely reservoirs of F. tularensis  are rodents and lagomorphs (Centers for 
Disease Control and Prevention (CDC) 2005), although F. tularensis  has been found to be 
infectious in all animals that have been tested, from amoeba to humans (Lavender, Stagg et 
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al. 1956; Abd, Johansson et al. 2003).  Transmission is most commonly linked to insect 
vectors such as ticks (Centers for Disease Control and Prevention (CDC) 2005) and 
mosquitoes (Eliasson, Lindback et al. 2002; Eliasson and Back 2007).  Other routes of 
transmission include physical contact with infected animal tissues (Centers for Disease 
Control and Prevention (CDC) 2005), contaminated water (Reintjes, Dedushaj et al. 2002; 
Celebi, Baruonu et al. 2006), and inhalation of aerosolized organisms (Feldman, Enscore et 
al. 2001).    Aerosol transmission of F. tularensis results in pneumonic tularemia.  
Pneumonic tularemia is a case of typhoidal tularemia known to be acquired by inhalation.  
Pneumonic tularemia is the most aggressive and lethal form of the disease (Stuart and Pullen 
1945; Matyas, Nieder et al. 2007; Nigrovic and Wingerter 2008).  Outbreaks of pneumonic 
tularemia are rare but are a significant public health threat when they occur (Feldman, 
Enscore et al. 2001; Matyas, Nieder et al. 2007).     
F. tularensis has been divided into the following subspecies and the virulent forms 
into two subtypes: Francisella tularensis (Type I F. tularensis), Francisella holoarctica 
(Type II F. tularensis), Francisella novicida, and Francisella mediasiaticia (Keim, 
Johansson et al. 2007).  Type I and Type II F. tularensis are the only clinically relevant 
subspecies (Sjostedt 2007) that cause disease in humans.  Type II F. tularensis has a wider 
geographic distribution being found throughout the Northern hemisphere and usually results 
in a milder, self limiting disease (Johansson, Farlow et al. 2004).  Type II F. tularensis was 
used by the Soviet Union to produce a Live Vaccine Strain (LVS) (Tigertt 1962).  This strain 
is attenuated in humans, but retains virulence in mice.  LVS is used a model system for 
virulent F. tularensis infection (Rick Lyons and Wu 2007).  Type I F. tularensis is typically 
localized to North America and results in aggressive, virulent, and highly infectious cases of 
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tularemia (Centers for Disease Control and Prevention (CDC) 2002; Farlow, Wagner et al. 
2005).  The routes of transmission and initial disease presentation are similar in the two 
forms with differences being noted in the severity of the disease and associated mortality rate 
(Eliasson, Broman et al. 2006).  F. tularensis is most infectious by the inhalational route of 
transmission. Less than 10 bacteria can result in an aggressive, lethal case of pneumonic 
tularemia (McCrumb 1961; Conlan, Chen et al. 2003; Sjostedt 2003).  As a comparison, 
pneumonic transmission of plague and anthrax spores have 50% lethal dose as low as 16 
bacteria (Heckly and Blank 1980) and 1000 bacteria (Lyons, Lovchik et al. 2004) 
respectively. 
 
Pathogenesis.  F. tularensis pathogenesis is complex and poorly understood.  F. tularensis is 
a facultative intracellular pathogen that replicates in macrophages (Thorpe and Marcus 1964; 
Thorpe and Marcus 1965; Nutter and Myrvik 1966).  Intracellular replication has so far 
correlated well with virulence in animal models of tularemia, but this property does not fully 
explain the remarkable infectivity and virulence of the bacterium.  Other pathogenic bacteria, 
such as Mycobacterium tuberculosis (Pieters 2008) and Legionella pneumophila (Cianciotto 
2001), replicate in macrophages yet are less virulent in an acute infection.  F. tularensis is 
taken up by phagocytosis into macrophages (Clemens, Lee et al. 2005; Balagopal, 
MacFarlane et al. 2006; Clemens and Horwitz 2007), blocks phagosome maturation, and 
quickly escapes to the cytosol where it replicates to high density (Clemens, Lee et al. 2004; 
Santic, Molmeret et al. 2005).  Recent advances have demonstrated that F. tularensis reenters 
autophagosomal vacuoles in a process that is dependent on F. tularensis  replication 
(Checroun, Wehrly et al. 2006).  The vacuoles are double membrane bound and are positive 
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for the autophagosomal marker LC3, and the late endosomal marker LAMP-1.  However, the 
mechanisms by which F. tularensis disseminates from one host cell to another are not 
understood. 
Intracellular replication clearly is not the only mechanism of F. tularensis 
pathogenesis.  The host immune system is modulated during both infection in a mouse model 
of tularemia and during intracellular replication in vitro.  F. tularensis actively inhibits the 
ability of macrophages to produces pro-inflammatory cytokines when stimulated post 
invasion (Telepnev, Golovliov et al. 2003; Telepnev, Golovliov et al. 2005; Cole, Santiago et 
al. 2008).  F. tularensis also stimulates the secretion of prostaglandin E2 which promotes a 
Th2 response and blocks T cell proliferation (Woolard, Wilson et al. 2007). However, the 
molecular mechanisms of F. tularensis immune system modulation have not been described.  
 
Francisella virulence determinants.  Work on identifying and characterizing F. tularensis 
virulence factors has revealed that a set of genes on a putative pathogenicity island and their 
regulator, MglA, are essential for intracellular replication (Baron and Nano 1998; Lauriano, 
Barker et al. 2004). A number of F. tularensis strains with insertional mutations in 
pathogenicity island genes are attenuated in animal models of tularemia and deficient for 
intra-macrophage replication.  The F. tularensis pathogenicity island is an approximately 30 
kb chromosomal genomic island that is present in one copy in F. novicida and duplicated in 
Type I and Type II F. tularensis.  The pathogenicity island has been linked to virulence by 
transposon mutagenesis of F. novicida.  Transposon mutants in the F. novicida pathogenicity 
island do not replicate after macrophage invasion and fail to escape the phagosome in 
mutants where intracellular trafficking has been studied (Nano, Zhang et al. 2004).  No 
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transposon insertions in the pathogenicity islands of the Type I and Type II F. tularensis have 
been linked to virulence, presumably because of the island duplication in these strains.  The 
island contains from 16 to 19 open reading frames that do not have significant similarity to 
any proteins of known function.  Gene regulation of many of the pathogenicity island genes 
has been linked to the transcriptional regulator MglA (Lauriano, Barker et al. 2004). 
 MglA is a positive transcriptional regulator that is homologous to stringent starvation 
protein A or SspA (Baron and Nano 1998).  Both sspA and mglA are present in F. tularensis  
species and have been found to be necessary for intracellular replication and virulence in 
mouse models of tularemia (Lauriano, Barker et al. 2004).  MglA and SspA cooperatively 
interact with RNA polymerase.  Microarray analysis of gene expression in ∆mglA and ∆sspA 
strains demonstrate that the mglA and sspA regulons almost totally overlap (Charity, 
Costante-Hamm et al. 2007).  MglA and SsspA act as positive regulators of gene expression 
in the F. tularensis  pathogenicity island (Lauriano, Barker et al. 2004). Many MglA 
regulated genes play roles in stress responses and some are required for intracellular 
replication, including the genes of the F. tularensis pathogenicity island (Guina, Radulovic et 
al. 2007).  The four genes of the iglABCD operon were among the first loci identified as 
being required for intracellular replication (Golovliov, Ericsson et al. 1997; Gray, Cowley et 
al. 2002).  The iglABCD operon is located in the F. tularensis  pathogenicity island (Titball 
and Petrosino 2007).  This operon is MglA regulated and is upregulated after macrophage 
invasion by F. tularensis (Baron and Nano 1999; Kovarova, Halada et al. 2002; de Bruin, 
Ludu et al. 2007).  F. tularensis iglA and iglC mutants fail to escape the phagosome and do 
not replicate in the intracellular niche (Lindgren, Golovliov et al. 2004; de Bruin, Ludu et al. 
2007).  Although, some of the predicted proteins in the F. tularensis  pathogenicity island 
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show distant similarity to some of the loci of described Type VI secretion systems (Nano and 
Schmerk 2007),  the mechanisms by which IglC and IglA act remain a mystery.  These 
predictions of a Type VI secretion system in F. tularensis have not been validated and no 
secreted proteins in Type I or Type II F. tularensis have been identified to date. 
 Seven secreted proteins have been identified in F. novicida.  The secreted proteins 
were identified as the proteinase (PepO), two chitinases (ChiA and ChiB), a chitin binding 
protein (CbpA), beta glucosidase (BglX), and two proteins of unknown function. PepO, 
ChiA, and BglX were found to be regulated by MglA (Hager, Bolton et al. 2006; Forsberg 
and Guina 2007).  The secretion of these factors in F. novicida was found to be dependent on 
a functional pilA gene in culture (Forsberg and Guina 2007).  Mutation of the pilA gene 
abrogated secretion and resulted in increased virulence in a mouse model of tularemia.  Type 
I and Type II F. tularensis have sequence differences or mutations that result in a pilA 
pseudogene.  Protein secretion has not been demonstrated in those strains; however, pili have 
been observed in electron micrographs (Forsberg and Guina 2007).  The role of Type IV pili 
in F. tularensis secretion or attachment is not well characterized.  
  
Pneumonic Type I Francisella tularensis infections are the most virulent cases of 
tularemia.  What makes Type I strains more virulent than other F. tularensis  species is 
unknown even though the genome of a F. tularensis Schu S4, a Type I strain, has been 
sequenced (Larsson, Oyston et al. 2005; Rohmer, Fong et al. 2007).   The pathogenicity 
island is common to all sequenced Francisella species (Titball and Petrosino 2007).  Another 
gap in the F. tularensis knowledge base is why aerosol transmission is more infectious and 
results in more aggressive infections.  Mortality in tularemia is generally surmised to be due 
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to multiple organ failure with large bacterial burdens and not specifically linked to infection 
of the lungs (Conlan, Chen et al. 2003).  So why does pneumonic tularemia have increased 
mortality rates? 
 
F. tularensis can infect and replicate in alveolar macrophages (Nutter and Myrvik 
1966), which is generally considered to be an important factor in the pathogenesis of F. 
tularensis.  However, the ultrastructure of the alveolus consists of much more than alveolar 
macrophages.  The alveolar epithelium consists of Type I and Type II epithelial cells which 
produce surfactant and enable gas exchange.  The alveolar epithelium must be breached or 
bypassed to enable the dissemination seen during the course of a pneumonic F. tularensis 
infection.  These alveolar epithelial cells have largely been ignored as potential sites of 
infection and replication, even though they comprise the majority of alveolar surface area.  
We hypothesize that F. tularensis comes in to contact with and infects alveolar epithelial 
cells and that a subset of F. tularensis genes are necessary for intraepithelial replication.  In 
this work we have characterized a gene we have termed ripA.  The ripA gene encodes a 
protein required for intracellular replication and virulence in a mouse model of tularemia. 
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ABSTRACT 
 
Francisella tularensis replicates in macrophages and dendritic cells, but interactions with 
other cell types have not been well described.  F. tularensis LVS invaded and replicated 
within alveolar epithelial cell lines.  Following intranasal inoculation of C57BL/6 mice, 
Francisella localized to the alveolus and replicated within alveolar type II epithelial cells.  
 
INTRODUCTION 
Francisella tularensis, the etiological agent of tularemia, is a zoonotic pathogen with 
a broad host range spanning from protists to humans.  The organism is transmitted to humans 
through handling of contaminated material, insect bites, or inhalation (1, 10).  It has been 
determined that contact with 25 or fewer bacteria is sufficient to cause disease  (16, 17).  
Following contact, the bacteria disseminate to liver, spleen and lungs regardless of initial 
transmission route (7, 10). The low infectious dose, myriad of transmission routes, broad host 
range, and severity of disease caused by F. tularensis led a number of nations to develop and 
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stockpile this organism as a biological weapon (9), yet little is known about the basis of its 
pathogenesis or virulence.  It has been reported that macrophages and potentially dendritic 
cells serve as the primary host cells for Francisella growth in humans and other animals (6, 
18).  This conclusion is supported by the observation that F. tularensis and other closely 
related Francisella species survive and replicate in human and rodent macrophages (2, 5), 
and that many of the identified attenuating mutations impair intra-macrophage growth (3, 11, 
12, 14, 15). 
Clearly intra-macrophage survival is an important Francisella virulence property.  
However, apart from one report of hepatocyte association in infected liver (8), the potential 
contribution of other host cell interactions to F. tularensis virulence and pathogenesis 
remains untested. Given the severity of inhalation-acquired tularemia, we sought to address 
this possibility by using in vitro and in vivo models to examine whether Francisella invades 
and replicates within epithelial cells of the lung. 
 
RESULTS 
Francisella tularensis LVS invades and replicates within lung epithelial cells in vitro.  
To determine if Francisella could invade and replicate within lung epithelial cells, in 
vitro invasion and replication assays were performed using a human alveolar type II (ATII) 
epithelial-derived cell line A549 (ATCC), a mouse ATII-derived cell line MLE-12 (ATCC), 
and a mouse lung epithelial-derived cell line Tc-1 (ATCC).  For comparison, the mouse 
macrophage-like cell line, J774A.1 (ATCC) was also used.  Intracellular bacteria were 
enumerated using a gentamicin protection assay.  The cell lines were grown to confluency in 
24-well plates and inoculated with F. tularensis LVS at a multiplicity of infection (MOI) of 
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100:1.  Four hours following inoculation, the cells were washed with PBS and media 
containing gentamicin (25 µg/mL) was added to kill extracellular bacteria.   
Intracellular organisms were recovered from all cell lines 6 and 24 hours post-
inoculation (Figure 2.1A).  The number of intracellular organisms recovered 6 hours post-
inoculation as well as the percentage of infected cells varied among the lung epithelial cell 
lines with the fewest intracellular Francisella recovered from the human ATII cell line, 
A549.  The percentage of infected epithelial cells ranged from 0.2% infected A549 cells 
infected to 17% infected Tc-1 cells (Figure 2.1A).  The number of intracellular bacteria 
recovered from each lung epithelial cell line at 6 hours was less than the recovery from 
J774A.1 cells as was the percentage of infected cells, indicating that entry into epithelial cells 
may be a less efficient process than uptake by macrophages.   
The number of intracellular bacteria increased by an average of 100 fold during the 
following 18 hours in each cell line representing an intracellular doubling time of roughly 3 
hours (Figure 2.1A).  Intracellular localization and proliferation was confirmed using 
fluorescence microscopy and digital image deconvolution (Figure 2.1B-E).  From 6 to 24 
hours post-inoculation, the relative increase of intracellular bacteria within lung epithelial 
cells was similar to that observed within J774A.1 cells, indicating that F. tularensis LVS 
replicated to the same degree within lung epithelial cells as in macrophages.   
There are many reports of Francisella replicating within macrophages in vitro and 
here we report Francisella’s ability to replicate within cultured lung epithelial cells.  
Whereas some work has been done to examine Francisella localization in the liver (8), little 
is known about the localization of inhaled Francisella in the lung.  Bosio et al recently 
reported that Francisella was associated primarily with dendritic cells isolated from 
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bronchioalveolar lavage fluid of mice one hour following inhalation (6).  However, the 
localization of bacteria in lung tissue throughout the course of infection has not been 
addressed.  
Following inhalation, Francisella localizes to the alveolus.   
To determine the localization of Francisella in the airway following inhalation, 
anesthetized 6-8 week old female C57BL/6 mice were inoculated intranasally with 105 CFU 
of F. tularensis LVS expressing GFP suspended in 50 µl of PBS (All mouse work was 
performed under IACUC-approved protocol.).  Immunofluorescence analysis was performed 
on formalin fixed and paraffin embedded tissue sections obtained from nasal turbinates, 
trachea, and lungs harvested 1, 3 and 7 days post-inoculation.  No bacteria were observed in 
turbinates or trachea.  In the lung, few bacteria associated with the apical surface of bronchial 
epithelial cells while the majority localized with alveolar cells (Figure 2.2).  Fluorescence 
imaging of sequential vertical planes revealed that most infected alveolar cells contained 
multiple bacteria throughout the cytoplasm, indicative of intracellular replication (data not 
shown).  Bacterial replication within ciliated or non-ciliated (Clara) bronchial epithelial cells 
was not observed.  The absolute number of bacteria (Figure 2.2D) and the number of infected 
alveolar cells increased by day 3 (Figure 2.2B).  By day 7, F. tularensis within the lung was 
widespread but remained exclusively in the alveolus (Figure 2.2C).  Throughout the course 
of infection, the amount of extracellular space observed in the network of alveolar cells 
decreased leading to the alveolar cells appearing more condensed (Figure 2.2).   
Inhaled Francisella co-localizes to and replicates within ATII cells in vivo.   
Given that Francisella invaded and replicated within ATII-derived cell lines in vitro, 
we probed infected lung tissue sections with antibodies to non-secreted surfactant protein 
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precursors proSP-B and proSB-C (Chemicon) to determine if Francisella localized to and 
replicated within ATII cells in vivo following inhalation.  proSP-B is produced by ATII cells 
and non-ciliated bronchiolar Clara cells (13) whereas proSP-C is produced by ATII cells 
exclusively (4).  Three days following inoculation, the majority of alveolar cells associated 
with F. tularensis also bound antibodies to non-secreted surfactant protein precursors, proSP-
B and proSB-C (Figure 2.3A-D).  Some cells associated with bacteria were not positive for 
proSP-B or proSP-C indicating that Francisella interacts with other cell types in the lung 
following inhalation.   
In addition to the co-localization with proSP proteins, microscopy of sequential 
vertical planes confirmed that bacteria were inside infected ATII cells (data not shown).  
Rabbit antibody specific for β-tubulin (Abcam) did not co-localize with F. tularensis (Figure 
2.3E) indicating that the co-localization of Francisella with rabbit proSP antibodies was not 
due to bacteria non-specifically binding rabbit antibodies, nor did the proSP antibodies cross-
react with cultured Francisella (data not shown).  These collective data demonstrate that F. 
tularensis replicates within ATII cells following inhalation, and the proportion of ATII cells 
harboring bacteria increases during the course of pneumonic tularemia.   
Bacteria were also observed in probed sections that did not co-localize with proSP-B 
and proSP-C (Figure 2.3) indicating that ATII cells are not the only alveolar cell type 
harboring replicating Francisella.  Macrophages and dendritic cells have been reported as 
potential host cells for replicating Francisella (2, 5, 6).  Due to difficulties in staining for 
surface macrophage and dendritic cell markers in embedded lung sections, we utilized 
dispase digestion of infected mouse lungs to stain for surface markers and also to assess our 
results from the embedded tissue staining.   
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Three days following inoculation with LVS expressing GFP, lungs were infused and 
incubated with the neutral protease, dispase (BD Biosciences).  Digested tissue was washed 
in PBS and subsequently filtered through 40 µm and 20 µm mesh.  Staining with 
fluorescently-labeled antibody specific for the surface markers F4/80 (eBioscience) and 
CD11c (eBioscience) was performed prior to fixation with 4% paraformaldehyde.  Staining 
for the intracellular markers proSP-B and proSP-C occurred following fixation and required 
the use of Cytoperm (BD Biosciences) to permeabilize the cells.  F. tularensis LVS was 
observed within cells expressing F4/80, CD11c, proSP-B, and proSP-C (Figure 2.4) 
indicating that following inhalation, bacteria survive and replicate within macrophages, 
dendritic cells, and ATII cells.   
Here we report that in addition to replicating within macrophages and dendritic cells, 
F. tularensis also invades and replicates within alveolar type II epithelial cells, indicating that 
interaction with these cells following inhalation may be an important component of 
pneumonic tularemia.  Future work will analyze the proportion of various cell types that are 
infected in the lung as well as attempt to identify the contribution of ATII cell invasion and 
replication to the disease progression of pneumonic tularemia.    
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FIGURES 
 
Figure 2.1.  F. tularensis LVS invades and replicates within ATII cell lines in vitro.  (A) 
Intracellular bacteria recovered from A549, MLE-12, Tc-1, and J774A.1 cells 6 and 24 hours 
post inoculation.  Percentages above bars represent percentage of infected cells.  (B) 
Fluorescence imaging of A549s inoculated with GFP-expressing LVS 6 and (C) 24 hours 
following inoculation.  Cell borders were visualized by rhodamine-phalloidin (Molecular 
Probes) staining (red) and nuclei visualized with DAPI (blue). (D) Fluorescence imaging of 
J774A.1 cells inoculated with GFP-expressing LVS (green) 6 and (E) 24 hours post-
inoculation.  Cell borders were visualized using biotinylated lectin from Lens culinaris and 
streptavidin-conjugated Alexa Fluor 647 (Molecular Probes) (red) and nuclei were stained 
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with DAPI (blue).  Intracellular replication experiments were carried out in triplicate with 
error bars representing standard deviations of the means.   
 
Figure 2.2.  Following inhalation F. tularensis localizes to the alveolus.  Mice were 
intranasally inoculated with 105 CFU of F. tularensis LVS expressing GFP.  One, three, and 
seven days post-inoculation, lungs were harvested and prepared for immunofluorescence 
analysis.  Bacterial localization was determined by probing lung sections with a 
fluorescently-labeled antibody to GFP (green).  Nuclei were stained with DAPI (blue) to 
visualize lung cells.  Representative images of the alveolus of infected mice (A) 1, (B) 3, and 
(C) 7 days post-inoculation. (D) Bacterial recovery from lungs 1, 3, and 7 days following 
intranasal inoculation with 105 CFU LVS.  Each bar represents mean recovery from 3 mice 
with error bars representing standard deviations of the means. 
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Figure 2.3.  Following inhalation, F. tularensis LVS expressing GFP co-localized with 
proSP-B and proSP-C; proteins produced by ATII epithelial cells.  Bacterial localization 
was determined with a fluorescently-labeled antibody to GFP (green).  Nuclei were stained 
with DAPI (blue).  Sections were probed with fluorescently-labeled antibody to (A-B) 
proSP-B (red), (C-D) proSP-C (red) to identify ATII cells and (E) β-tubulin (red).  
Representative images are from lung sections 3 days post-inoculation. 
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Figure 2.4. F. tularensis LVS expressing GFP co-localized with cells expressing the 
macrophage marker F4/80, the dendritic cell marker CD11c, and the ATII cell markers 
proSP-B and proSP-C.  Nuclei were stained with DAPI (blue).  Mouse lung cells were 
probed with fluorescently-labeled antibody to (A-B) F4/80 (red), (C-D) CD11c (red), and (E) 
proSP-B (red).  Representative images are from lung cells 3 days post-inoculation. 
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ABSTRACT 
 
Francisella tularensis, a gram-negative facultative intracellular bacterial pathogen, 
causes disseminating infections in humans and other mammalian hosts. Macrophages and 
other monocytes have long been considered the primary site of F. tularensis replication in 
infected animals. However, recently it was reported that F. tularensis also invades and 
replicates within alveolar epithelial cells following inhalation in a mouse model of tularemia. 
TC-1 cells, a mouse lung epithelial cell line, were used to study the process of F. tularensis 
invasion and intracellular trafficking within nonphagocytic cells. Live and paraformaldehyde 
fixed F. tularensis live vaccine strain (LVS) associated with, and were internalized by, TC-1 
cells at a similar frequency and with indistinguishable differences in kinetics. Inhibitors of 
microfilament and microtubule activity resulted in significantly decreased F. tularensis 
invasion, as did inhibitors of PI3 kinase and tyrosine kinase activity. Collectively these 
results suggest that F. tularensis epithelial cell invasion is mediated by a preformed ligand on 
the bacterial surface and driven entirely by host cell processes. Once internalized, F. 
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tularensis containing endosomes associated with EEA1 followed by LAMP-1 with peak co-
association frequencies occurring at 30 and 120 minutes post-inoculation, respectively. By 2 
hours post-inoculation 70.0% (±5.5%) of intracellular bacteria were accessible to antibody 
delivered to the cytoplasm indicating vacuolar breakdown and escape into the cytoplasm. 
 
INTRODUCTION 
Francisella tularensis, the causative agent of the disease tularemia, infects a wide 
range of animal hosts. Humans can be infected by a variety of routes, including physical 
contact with infected animals, insect bites, ingestion of contaminated food or water, and 
inhalation of organisms (13, 52). Disease severity is affected by both the route of inoculation 
and bacterial subtype (13, 48, 52). F. tularensis strains are subdivided into two groups, A and 
B; the more severe form of tularemia in humans is caused by type A strains (13, 48, 52). The 
type A strain F. tularensis subspecies tularensis is found almost exclusively in North 
America, whereas the type B strain F. tularensis subspecies holarctica is found throughout 
Europe, as well as in North America (35). There is a 5% to 15% mortality rate associated 
with untreated human tularemia caused by type A strains, however that rate reaches 30% to 
60% for untreated pneumonic and typhoid forms of the disease (11). The live vaccine strain 
(LVS) is an attenuated type B strain that causes a tularemia-like disease in mice, and is used 
as a model organism to study F. tularensis pathogenesis. There has been heightened interest 
in the study of this organism in recent years due to its history of weaponization and potential 
for use as an agent of biological warfare. F. tularensis is a category A select agent on the 
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CDC's bioterrorism agent list, which includes organisms with the potential to cause high 
numbers of casualties if disseminated in an aerosol form (26). 
Much of the Francisella pathogenesis research has focused on survival and 
replication of F. tularensis in macrophages and dendritic cells, and many of the genes 
identified to date that are required for full virulence contribute to survival or replication in 
the macrophage (1, 6, 17, 20, 27, 30, 32, 37, 42). We recently demonstrated that F. tularensis 
also invades and replicates in alveolar type II (ATII) epithelial cells of infected mice (21). 
ATII cells have a number of biological functions, including the production, secretion and 
recycling of surfactant, proliferation to produce additional type II cells as well as 
transdifferentiation into type I cells, maintenance of alveolar fluid balance, and production of 
antimicrobial and anti-inflammatory substances(29). Due to the close proximity between the 
blood and alveolar epithelial cells required for gas exchange and fluid balance, these cells are 
ideally located to provide a portal through which bacteria could disseminate to distal organs. 
F. tularensis attaches to and invades nonphagocytic cells, including the ATII cell 
lines A549 and MLE 12 and the lung epithelial cell line TC-1 (21, 28).  Melillo et al. also 
reported that E. coli expressing the F. tularensis surface protein FsaP bind to A549 cells (31), 
identifying a surface protein that may play a role in ATII cell association. 
A primary function of monocytes is to engulf bacterial cells and other foreign 
particles (24, 44). However, invasion of epithelial and other nonphagocytic host tissue cells 
requires bacterially mediated exploitation of host cell functions to gain entry (10, 15, 16). 
Alveolar epithelial cells provide a site where F. tularensis can replicate in the infected host 
(21), and as such it is important to understand how bacterial interaction with these cells may 
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differ from interaction with macrophages. Herein we describe our efforts to understand how 
F. tularensis invades lung epithelial cells. 
 
MATERIALS AND METHODS 
Bacterial strains 
Francisella tularensis LVS was obtained from the Centers for Disease Control and 
Prevention, Atlanta, Ga. LVSgfp was constructed using the pKK214GFP plasmid (a gift of 
Mats Forsman). F. tularensis LVS and LVSgfp were propagated on chocolate agar 
supplemented with 1% IsoVitaleX (Becton-Dickinson). Listeria monocytogenes EGD1/2a, 
Salmonella enterica serovar Typhimurium, Yersinia pseudotuberculosis, and Campylobacter 
jejuni strain 81-176 were gifts from Paul Orndorff, Craig Altier, Ralph Isberg, and Deborah 
Threadgill, respectively. All bacterial strains were grown on LB agar, with the exception of 
C. jejuni, which was grown on Mueller-Hinton agar with 5% CO2, and F. tularensis LVS, 
which was grown on chocolate agar as described above. All bacterial strains were grown at 
37°C. Salmonella enterica was grown overnight in LB broth under static conditions for 
invasion assays. 
 
Cell culture 
TC-1 (ATCC CRL-2785) is a tumor cell line derived from primary lung epithelial 
cells of C57BL/6 mice. The cells were immortalized with HPV-16 E6 and E7 and 
transformed with the c-H-ras oncogene. These cells were grown in RPMI 1640 
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supplemented with 2 mM L-glutamine, 1.5 g/L sodium bicarbonate, 10 mM HEPES, 1.0 mM 
sodium pyruvate, 0.1 mM non-essential amino acids and 10% FBS. Cell cultures were 
maintained at 37°C and 5% CO2. 
 
Attachment, Invasion and Vacuolar Escape Assay 
To evaluate the percentage of TC-1 cells with associated bacteria synchronized 
infections were carried out by adding F. tularensis LVS expressing GFP (LVSgfp) at a 
multiplicity of infection (MOI) of 100 to TC-1 cells chilled to 4°C. Bacterial suspensions 
were made in tissue culture media from bacteria grown as described above. Bacterial 
concentration of suspensions was determined using a Klett meter.  Dilutions of suspensions 
were plated to verify MOI. Plates were centrifuged at 300 x g for 5 minutes at 4°C, and then 
rapidly warmed by placing in a 37°C water bath for 2 minutes before transferring to a 37°C, 
5% CO2 incubator. For experiments using killed LVS, organisms were treated with 4% 
paraformaldehyde (PFA) for 10 minutes. There was no growth from a PFA treated bacterial 
aliquot that was plated on chocolate agar, demonstrating that PFA treatment killed all 
organisms. At 10 minutes post-inoculation samples were washed with PBS to remove 
unattached bacteria and pre-warmed media was added to monolayers. Cells were collected by 
trypsinization at 10, 20, 30 and 60 minutes post-inoculation and samples were processed at 
4°C. Cells to be analyzed for bacteria association were fixed in 4% PFA for 10 minutes, and 
analyzed by flow cytometry. 
Parallel wells were analyzed for intracellular bacteria by collecting samples as 
described above. Extracellular bacteria were labeled using anti-F. tularensis LPS antibody 
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(USBiological) conjugated to Pacific Blue (Molecular Probes) 1:1000 for 30 minutes at 4°C. 
Cells were then lysed with water and centrifuged at 300 x g to removed eukaryotic cell 
debris. Supernatant containing bacteria was centrifuged at 16,000 x g, fixed with 4% PFA, 
and analyzed by flow cytometry to differentiate intracellular (GFP only) from extracellular 
(GFP and Pacific Blue) bacteria. 
To evaluate bacterial escape into the cytoplasm, synchronized inoculations of TC-1 
cells and staining of extracellular bacteria was done as described above. Cells were collected 
by trypsinization at 10, 20, 30, 60 and 120 minutes post-inoculation. TC-1 cells were treated 
with 50 µg/ml digitonin in KHM buffer (110 mM potassium acetate/20 mM Hepes/2 mM 
MgCl2, pH 7.3) for 1 minute, washed in KHM buffer, and incubated with anti-F. tularensis 
LPS antibody conjugated to Alexa Fluor 647 (Molecular Probes) 1:1000 for 30 minutes at 
4°C. Cells were then washed in KHM buffer, lysed with water and centrifuged at 300 x g to 
removed cellular debris. Supernatants were centrifuged at 16,000 x g and bacterial pellets 
were fixed in 4% PFA and analyzed by flow cytometry to differentiate extracellular (GFP, 
Pacific Blue and Alexa Fluor 647), cytoplasmic (GFP and Alexa Fluor 647) and vacuolar 
(GFP only) bacteria. 
Flow cytometry of whole cells and bacteria was performed using a CyAn ADP flow 
cytometer (Dako Cytomation). Data was analyzed using Summit Software (Dako), with 
gating for single events for whole cell samples and GFP positive single events for bacterial 
samples.  
 
Inhibitor Assays 
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Inhibitor assays were carried out with cytochalasin D, colchicine, wortmannin and 
genistein. Cytochalasin D, an actin polymerization inhibitor, was used at 0.5 and 1.0 µM 
concentrations. Colchicine, a microtubule polymerization inhibitor, was used at 0.1 and 0.25 
µM concentrations. Wortmannin, an inhibitor of PI3 kinase activity, was used at 100 and 200 
nM concentrations. Genistein, an inhibitor of tyrosine kinase activity, was used at 50 and 100 
µM concentrations. Monolayers were preincubated for one hour with escalating 
concentrations of inhibitor, and then bacteria suspended in media containing inhibitor were 
added at an MOI of 100 for LVS, or 25 to 50 for other bacteria. Samples without inhibitor 
included bacteria suspended in tissue culture media alone, or media containing the carrier in 
which the inhibitor was reconstituted where appropriate. After four hours, cells were washed 
with PBS to remove inhibitor. Extracellular bacteria were killed by adding media containing 
25 µg/ml of gentamicin and incubated 2 hours before monolayers were washed with PBS and 
scraped from the plate using sterile applicator sticks. Serial dilutions were plated on 
chocolate agar to quantify colony forming units (CFU) of intracellular bacteria. Inhibitors did 
not affect LVS viability as demonstrated by incubating bacteria in tissue culture media 
containing inhibitor for four hours, followed by plating onto chocolate agar to quantify CFU. 
Inhibitors did not affect eukaryotic cell viability at the concentrations used as determined by 
Trypan Blue exclusion. The effect of inhibitors on bacterial attachment to cells was 
determined as described above for invasion, except that gentamicin was not added, allowing 
bacteria attached to cells but not internalized to be included in the CFU recovered. Inhibitors 
had no effect on LVS attachment to TC-1 cells. Results are expressed as the percentage of 
LVS or control organism that survived gentamicin treatment, relative to the sample without 
inhibitor inoculated with the same organism. Invasion without inhibitor is defined as 100% 
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invasion. Data presented are the results of assays done in triplicate, and are representative of 
multiple repetitions of each experiment. Data were analyzed for statistical significance by 
paired two-tailed t test, and considered significantly different from the untreated control 
when P<0.01. 
 
Fluorescence microscopy 
Cells were grown on poly-L-lysine coated coverslips in 24-well cell culture plates to 
~90% confluency.  LVSgfp was added at an MOI of 100 to pre-chilled TC-1 plates, and 
centrifuged at 300 x g for three minutes to synchronize infection as described above. At 10, 
20, 30, 60, 120 and 180 minutes post-inoculation monolayers were washed with PBS to 
remove unattached bacteria and fixed using 4% PFA. Samples were blocked with PBS/Fc 
block/5% donkey serum, incubated with anti-F. tularensis LPS diluted 1:1000 for 30 minutes 
at 4°C followed by donkey anti-mouse AMCA (7-amino-4-methylcoumarin-3-acetic acid, 
Jackson ImmuoResearch) diluted 1:100, 30 minutes, 4°C to label extracellular bacteria. For 
early endosome antigen 1 (EEA1) or lysosome associated membrane protein 1 (LAMP-1) 
staining samples were blocked using PBS/0.1% saponin/5% serum of host species of 
secondary antibody followed by goat polyclonal anti-EEA1 (N-19; Santa Cruz 
Biotechnologies) diluted 1:200 in blocking solution, or rat monoclonal anti-mouse LAMP-1 
(1D4B, developed by J. T. August, obtained from the Developmental Studies Hybridoma 
Bank developed under the auspices of the NICHD and maintained by The University of 
Iowa, Department of Biological Sciences, Iowa City, IA 52242) diluted 1:200 in blocking 
solution. Secondary antibodies used were donkey anti-goat Cy5 (Jackson ImmunoResearch) 
or goat anti-rat Alexa Fluor 647 (Molecular Probes), diluted 1:500 in PBS/0.1% saponin. 
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Samples were examined using a Zeiss Axioplan 2 epifluorescence microscope and SlideBook 
digital deconvolution software (Intelligent Imaging Innovations). 100 intracellular bacteria 
were counted for each time point and condition. Images of sequential vertical planes were 
acquired to determine the location of bacteria within EEA1 or LAMP-1 containing vacuoles. 
Data presented are the results of three independent experiments.  
 
Electron microscopy 
Cell monolayers grown on polystyrene plates were rinsed with PBS or serum-free 
medium and fixed in 3% glutaraldehyde/0.15M sodium phosphate, pH 7.4. Following three 
rinses with sodium phosphate buffer, the monolayers were post-fixed for 1 hour in 1% 
osmium tetroxide/1.25% potassium ferrocyanide/0.15M sodium phosphate buffer,  rinsed in 
deionized water, dehydrated using increasing concentrations of ethanol (30%, 50%, 75%, 
100%, 100%, 10 minutes each) and embedded in Polybed 812 epoxy resin (Polysciences, 
Inc.,Warrington, PA).   The embedded samples were sectioned parallel and perpendicular to 
the substrate at 70nm using a diamond knife.  Ultrathin sections were collected on 200 mesh 
copper grids and stained with 4% aqueous uranyl acetate for 15 minutes, followed by 
Reynolds’ lead citrate for 7 minutes.  Sections were observed using a LEO EM910 
transmission electron microscope at 80kV (LEO Electron Microscopy, Thornwood, NY) and 
photographed using a Gatan Bioscan Digital Camera (Gatan, Inc., Pleasanton, CA). 
 
RESULTS 
Kinetics of F. tularensis epithelial cell attachment and invasion 
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Francisella tularensis LVS invades and replicates within TC-1, MLE 12 and A549 
lung epithelial cell lines (21). While the intracellular replication rates within these lines are 
indistinguishable, TC-1 cells support the highest initial invasion frequency (21).  In addition, 
TC-1 cells are a mouse cell line, and LVS infection causes a tularemia-like disease in mice 
similar to that seen with virulent strains in humans. We therefore used TC-1 cells to examine 
the initial stages of F. tularensis invasion. 
To determine kinetics of lung cell attachment and invasion by F. tularensis we 
synchronized infection of TC-1 cells at an MOI of 100 with LVSgfp. At 10, 20, 30 and 60 
minutes post-inoculation, cells were washed to remove nonadherent bacteria and collected to 
quantify TC-1 cells associated with GFP expressing bacteria by flow cytometry (Figure 
3.1A). At these same time points, in parallel samples, extracellular bacteria were stained 
using a Pacific Blue labeled antibody to F. tularensis LPS and TC-1 cells were lysed to 
recover cell-associated bacteria. GFP positive bacteria recovered from cells were analyzed by 
flow cytometry to determine intracellular (GFP alone) versus extracellular (GFP and Pacific 
Blue) localization (Figure 3.1B). At 10 minutes 1.7% (±0.4%) of TC-1 cells had associated 
bacteria, of which 1.4% (±0.1%) of TC-1 cell-associated bacteria were intracellular. At 20 
minutes post-inoculation 1.1% (±0.2%) of TC-1 cells had cell-associated bacteria, of which 
7.0% (±0.6%) were internal. At 30 minutes post-inoculation 1.0% (±0.2%) of TC-1 cells had 
cell-associated bacteria, of which 21.3% (±6.3%) were internal. At 60 minutes post-
inoculation 1.4% (±0.1%) of TC-1 cells had cell-associated bacteria, of which 23.6% 
(±5.8%) were intracellular.  
To determine if LVS entry into lung epithelial cells required viable bacteria, we 
repeated the above experiments using killed LVSgfp. At 10 minutes 0.9% (±0.2%) of TC-1 
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cells had dead bacteria associated with them, of which 1.2% (±0.4%) of TC-1 cell-associated 
bacteria were intracellular. At 20 minutes post-inoculation 1.1% (±0.7%) of TC-1cells had 
cell-associated dead bacteria, of which 5.7% (±0.6%) were internal. At 30 minutes post-
inoculation 0.6% (±0.2%) of TC-1 cells had cell-associated dead bacteria, of which 17.3% 
(±3.5%) were internal. At 60 minutes post-inoculation 0.4% (±0.1%) of cells had dead 
bacteria associated with them, of which 25.7% (±1.6%) were intracellular. These results 
indicated that both live and dead LVS attached to and invaded lung epithelial cells. Further, 
invasion frequency and kinetics were not significantly different between live and dead 
bacteria (P<0.01), except cell association at 60 minutes (Figure 3.1). The ability of nonviable 
F. tularensis to invade lung epithelial cells suggested that a preformed ligand on the bacterial 
surface may interact with the host cell. 
 
Effects of cytoskeleton and signaling pathway inhibitors on F. tularensis invasion of 
epithelial cells. 
Inhibitors of eukaryotic cell function were used to determine the contribution of host 
cell signaling and cytoskeleton rearrangement to LVS invasion of lung epithelial cells. 
Bacterial entry into host cells generally requires rearrangement of cytoskeletal structures; 
either microfilaments alone, as is the case with Salmonella, Shigella, Listeria and Yersinia 
spp. (12), or both microfilaments and microtubules, as is the case with Neisseria 
gonorrhoeae and Campylobacter jejuni (4, 43). 
To determine the contribution of actin polymerization to LVS invasion we incubated 
TC-1 lung epithelial cells with cytochalasin D, an actin polymerization inhibitor that disrupts 
microfilaments, and measured bacterial internalization by gentamicin protection assay. 
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Treatment of TC-1 cells with 0.5 and 1.0 µM cytochalasin D decreased LVS invasion more 
than 99% (±0.1%) (Figure 3.2A), whereas Salmonella enterica invasion, which is known to 
be actin dependent (36), decreased by 84.6% (±2.3%) and 88.1% (±2.5%) at the same 
inhibitor concentrations, respectively. TC-1 cell invasion by Campylobacter jejuni strain 81-
176, a strain which does not require actin for invasion of intestinal epithelial cells (34), was 
not decreased by actin inhibition.  
Microtubules are responsible for the cytoplasmic organization of eukaryotic cells, 
control of organelle transport, and are a primary component of cilia and flagella (55). 
Microtubule polymerization has been shown to contribute to the epithelial cell invasion of 
Neisseria gonorrhoeae and Campylobacter jejuni (4, 43). To determine the contribution of 
microtubules to LVS invasion we treated lung epithelial cells with colchicine, which binds 
tubulin and inhibits microtubule polymerization, and determined invasion by gentamicin 
protection assay. Treatment of TC-1 cells with colchicine decreased LVS invasion by 55.2% 
(±18.3%) and 94.2% (±2.4%) at 0.1 and 0.25 µM concentrations, respectively (Figure 3.2B). 
TC-1 cell invasion by Campylobacter jejuni strain 81-176, a strain for which invasion is 
blocked by microtubule depolymerization in intestinal epithelial cells (34), was decreased 
significantly at the higher colchicine concentration.  Salmonella enterica invasion, which is 
not considered microtubule dependent (4), did not demonstrate a statistically significant 
decrease in invasion at these concentrations.  
Signaling pathways are frequently manipulated by bacteria to cause the cytoskeletal 
rearrangement necessary to gain entry into nonphagocytic cells (10, 15, 16). PI3 kinase and 
tyrosine kinase signaling are exploited by other pathogens for invasion (25, 45). These 
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pathways were examined for their contribution to Francisella tularensis entry into lung 
epithelial cells.  
PI3 kinases phosphorylate inositol phospholipids, forming lipid products that are in 
turn involved in cellular functions such as cell growth, actin rearrangement and vesicular 
trafficking (51). To determine the importance of PI3 kinase signaling to F. tularensis 
invasion, lung epithelial cells were treated with wortmannin, an inhibitor of PI3 kinase 
activity, and invasion was assessed by gentamicin protection assay. Wortmannin decreased 
LVS invasion of TC-1 cells by 69.4% (±4.6%) and 84.1% (±1.8%) when cells were exposed 
to 100 and 200 nM concentrations, respectively (Figure 3.3A). Invasion by Listeria 
monocytogenes, which is PI3 kinase dependent (25), was significantly decreased. Salmonella 
enterica invasion, which is not PI3 kinase dependent (49), was not significantly decreased at 
these concentrations in TC-1 cells. 
Cells monitor and respond to their external environment via receptors that lead to 
intracellular signaling events (53). Activation of receptor tyrosine kinases can lead to 
receptor internalization, as well as initiation of a cascade of downstream signaling events 
(53). Some organisms, such as Yersinia pseudotuberculosis, exploit signaling through host 
cell receptors to gain entry into cells, and this entry can be blocked by tyrosine kinase 
inhibitors (45). To determine the contribution of tyrosine kinase signaling to LVS invasion, 
the inhibitor genistein was added to lung epithelial cells and the number of intracellular 
organisms measured by gentamicin protection assay. Genistein decreased LVS invasion of 
TC-1 cells by 68.1% (±1.1%) and 77.1% (±1.1%) at 50 and 100 µM concentrations, 
respectively (Figure 3.3B). Invasion by Yersinia pseudotuberculosis was significantly 
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reduced at these concentrations, while Salmonella enterica invasion, which is tyrosine kinase 
independent (45), was not significantly decreased in TC-1 cells. 
Collectively, these results indicate that actin and microtubule rearrangement both 
contribute to the entry of F. tularensis into lung epithelial cells. PI3 kinase and tyrosine 
kinase, proteins which regulate cytoskeletal rearrangement, both impact F. tularensis 
invasion of lung epithelial cells. 
 
LVS traffics along the endocytic pathway in lung epithelial cells 
To characterize the trafficking of F. tularensis LVS along the endocytic pathway in 
lung epithelial cells, we synchronized the addition of LVSgfp to TC-1 cells and evaluated 
these cells microscopically for the presence of bacteria inside vacuoles containing the early 
endosomal marker EEA1 or the late endosomal/lysosomal marker LAMP-1 (Figure 3.4A and 
4.4B). LVS association with EEA1 containing phagosomes increased from 1.4% (±2.4%) at 
10 minutes to 40.4% (±5.3%) at 30 minutes, before decreasing (Figure 3.4C). LVS 
association with LAMP-1 containing vacuoles peaked two hours post-inoculation at 49.3% 
(±3.5%) (Figure 3.4C). These results indicate that LVS traffics along the endocytic pathway 
in lung epithelial cells, associating first with early endosomes before progressing to late 
endosomes/lysosomes. 
 
LVS escapes the phagosome and replicates in the cytoplasm of lung epithelial cells 
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Once inside host cells invasive bacteria either replicate within the endosome or 
escape the vacuole and replicate in the cytoplasm. To determine the intracellular location of 
bacteria, TC-1 cells were inoculated with LVS at an MOI of 100 and examined at one and 24 
hours by transmission electron microscopy. At 1 hour post-inoculation LVS were TC-1 cells 
in a membrane-bound vacuole (Figure 3.5A). The membrane was easily visualized, and in 
some cases was beginning to degrade (Figure 3.5A). By 24 hours all observed intracellular 
bacteria were no longer contained within a visible membrane, and appeared to be free in the 
cytoplasm (Figure 3.5B), though they were surrounded by an electron lucent zone that has 
been noted by other researchers (8, 19). 
To determine the kinetics of LVS escape from the endocytic pathway into the 
cytoplasm of lung epithelial cells, we differentially labeled extracellular, cytoplasmic and 
vacuolar LVSgfp and analyzed recovered bacteria by flow cytometry (modified from 
Checroun et al.).We first labeled bacteria that were extracellular and attached to TC-1 cells 
using Pacific Blue conjugated anti-F. tularensis LPS. We then permeabilized the cytoplasic 
membrane of TC-1 cells using digitonin, allowing Alexa Fluor 647 conjugated anti-F. 
tularensis LPS to access cytoplasmic bacteria, but not those enclosed in intact vacuoles, 
which are digitonin impermeable. TC-1 cells were lysed and cell-associated bacteria 
recovered and analyzed by flow cytometry, gating on GFP to differentiate bacteria from 
residual TC-1 debris. The resulting three populations of bacteria were analyzed: extracellular 
(Pacific Blue, Alexa Fluor 647 and GFP), cytoplasmic (Alexa Fluor 647 and GFP), and 
vacuolar (GFP only) (Figure 3.6A and 3.6B). At 10 minutes post-inoculation 19.3% (±8.1%) 
of intracellular bacteria were accessible to antibody delivered to the cytoplasm, and therefore 
considered cytoplasmic (Figure 3.6C). This number increased to 70.0% (±5.5%) at 2 hours 
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post-inoculation, indicating that the majority of intracellular bacteria were no longer 
contained within intact endocytic vacuoles. It should be noted that once the vacuolar 
membrane begins to degrade bacteria are accessible to antibody. As a result, bacteria that 
were associated with LAMP-1 staining vacuoles at 2 hours post-inoculation (Figure 3.4C) 
would be identified as cytoplasmic by this assay if the vacuolar membrane was no longer 
intact. When TC-1 cells were treated with saponin, which permeabilizes both vacuolar and 
cytoplasmic membranes, greater than 99% of bacteria were accessible to antibody labeling 
(data not shown), demonstrating that a population of bacteria were protected from staining 
when only the cytoplasmic membrane was permeabilized. Microscopic examination of 
saponin treated TC-1 cells revealed that anti-F. tularensis antibody was able to access 
bacteria in EEA1 containing vacuoles, while antibody was excluded from these vacuoles in 
digitonin treated cells (data not shown). When TC-1 cells were inoculated with PFA killed 
bacteria >90% of organisms were vacuolar at 60 minutes post-inoculation, indicating that 
killed bacteria did not escape into the cytoplasm (data not shown). Thus, bacterial viability 
was required for escape from the epithelial cell endosome.  
 
DISCUSSION 
The ability of many facultative intracellular bacterial pathogens to cause disease is 
dependent upon their ability to invade and replicate within various host cells (14, 22, 41). F. 
tularensis survival and replication within macrophages and dendritic cells has been well 
described (1, 5, 6, 8, 33). We previously demonstrated that F. tularensis LVS also localizes 
to and replicates within alveolar type II epithelial cells following inhalation of organisms in a 
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mouse model of infection (21), prompting us to investigate lung epithelial cell invasion by 
this organism. 
Alveolar type II cells account for about 12% of the total cells, and 2% of the surface 
area, of the alveolar region in mice (50). Approximately 98% of the surface area, and 10% of 
the total cell number, is comprised of type I cells, which provide structure and are the site of 
gas exchange (50). Type II cells have a number of biological functions, including the 
production, secretion and recycling of surfactant, proliferation to produce additional type II 
cells as well as transdifferentiation into type I cells, maintenance of alveolar fluid balance, 
and production of antimicrobial and anti-inflammatory substances (29). Due to the close 
proximity between the blood and alveolar epithelial cells required for gas exchange and fluid 
balance, these cells are ideally located to provide a portal through which bacteria could 
disseminate to distal organs.  
To characterize the interactions of F. tularensis with lung epithelial cells we 
investigated the initial interactions of LVS with the lung epithelial cell line TC-1. We 
determined that bacteria associated with and were internalized by lung epithelial cells within 
10 minutes of inoculation, and that viable bacteria were not necessary for gaining entry into 
these cells. We previously found that the frequency with which F. tularensis invaded lung 
epithelial cell lines was low (21). The low invasion frequency may be due to the inherent 
inability of a transformed cell line grown in a non-polarized fashion to recapitulate the 
complex environment within the host lung. These cells may also intermittently express a 
relevant receptor or other process that facilitates F. tularensis invasion in vivo. A system 
using primary cells grown in a polarized manner may more realistically reproduce the 
environment in the lung (18). Given the quantity of cells required for studies, cell culture 
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lines provide a reasonable place to begin the investigation of the interaction of bacteria with 
epithelial cells, and have been described as a model for such interactions (28). 
Pathogens have developed numerous means of exploiting host cell functions to gain 
entry into nonphagocytic cells (10, 15). These invasion strategies are typically classified as 
either a zipper mechanism, which is utilized by pathogens such as Yersinia 
pseudotuberculosis and Listeria monocytogenes or a trigger mechanism, which is utilized by 
organisms such as Salmonella typhimurium and Shigella flexneri. The zipper mechanism is 
characterized by bacterial surface proteins binding to host cell receptors leading to 
internalization. The trigger mechanism is characterized by the injection of bacterial effector 
proteins into the host cell via a type III secretion system resulting in bacterial engulfment via 
induced macropinocytosis. Entry by either of these mechanisms requires the manipulation of 
host cell cytoskeletal components and signaling pathways. A number of host cell receptors 
play a role in F. tularensis entry into macrophages, including Fcγ, CR3,  MR and SRA 
receptors (3, 38, 47). However, very little is known about how this organism is able to access 
cells that are not considered to be professional phagocytes.  
To better understand the process of F. tularensis entry into lung epithelial cells we 
investigated cytoskeletal components and signaling pathways that are involved in epithelial 
invasion by other bacterial pathogens for their contribution to internalization of LVS by a 
lung epithelial cell line. Lindemann et al. previously demonstrated that actin and 
microtubules are necessary for F. tularensis invasion the human epithelial cell line HEp-2 
(28). We determined that both actin and microtubules contribute to F. tularensis invasion of 
lung epithelial cells, as do PI3 kinases and tyrosine kinases, both of which can control 
signaling events leading to cytoskeletal rearrangement. We showed that F. tularensis 
47 
 
internalization by lung epithelial cells is dependent upon a variety of host cell mechanisms, 
and that interruption of any of these mechanisms interferes with bacterial invasion.  
We were unable to identify the characteristic membrane ruffling that is seen with 
Salmonella invasion either by phalloidin staining or Field Emission Scanning Electron 
Microscopy (FESEM) under conditions where we were able to clearly identify membrane 
ruffling with Salmonella (data not shown). While this points toward F.tularensis not causing 
massive actin reorganization at the site of entry it is possible that membrane ruffling occurs 
but was not detected by us. Listeria monocytogenes, another organism that is able to invade 
epithelial cells, also requires PI3 kinase and tyrosine kinase function for invasion, in a cell 
type dependent manner (39, 40). This organism has two invasion proteins, InlA and InlB, 
which interact with different host receptors, leading to different signaling events. It is 
possible that F. tularensis also uses multiple receptors for entry into lung epithelial cells, and 
that interruption of various signaling pathways could decrease uptake via various receptors. 
Toll-like receptors (TLRs) may play a role in modulation of the immune response to F. 
tularensis (9, 23, 54), and functional TLRs are present on ATII cells (2). However, TLRs 
have not been implicated among macrophage receptors for F. tularensis internalization 
identified to date, which include Fcγ, CR3,  MR and SRA receptors (3, 38, 47). Melillo et al. 
have reported that E. coli expressing the F. tularensis surface protein FsaP were able to bind 
A549 cells (31). We have also demonstrated that killed F. tularensis was taken up by lung 
epithelial cells. This information, taken together with the absence of genes predicted to 
encode a type III secretion system, point toward the presence of a preformed ligand receptor 
interaction as with the zipper mechanism of uptake, rather than injection into the host cell of 
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effector proteins as with organisms that gain entry via the trigger mechanism. Further studies 
are needed to identify receptors necessary for uptake of F. tularensis by nonphagocytic cells. 
 
To investigate F. tularensis trafficking along the endocytic pathway in lung epithelial 
cells we examined association of LVS with EEA1 and LAMP-1 containing vacuoles, as well 
as escape into the cytoplasm. F. tularensis traffics along the endocytic pathway in 
macrophages before escaping to the cytoplasm where replication occurs. The timing of this 
escape seems to be dependent upon the Francisella species and host cell type tested. F. 
tularensis subsp.novicida begins to disrupt the phagosomal membrane of quiescent human 
macrophages at 4 hours and is free in the cytoplasm by 12 hours post-infection (46). LVS 
and clinical isolates of  F. tularensis associate with EEA1 then LAMP-1 containing vacuoles 
in mouse bone marrow derived macrophages, human macrophages, and mouse and human 
macrophage-like cell lines before degrading the phagosomal membrane and beginning  to 
escape into the cytoplasm between one and two hours post-inoculation (7, 8, 19).  We 
determined that LVS was initially associated with EEA1 containing vacuoles, then LAMP-1 
containing vacuoles, before being found free in the cytoplasm of lung epithelial cells, in a 
manner and kinetic consistent with that seen in macrophages. 
F. tularensis LVS is found in ATII cells in the lungs of C57BL/6 mice 1, 3 and 7 days 
post-intranasal inoculation, replicates in these cells as disease progresses, and by day 7 
organisms are widespread in the alveolar epithelium (21).  These observations demonstrate 
that that ATII cell invasion and replication is a part of the F. tularensis disease process. 
Understanding how this bacterium gains access to these cells, and just as importantly, how 
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they replicate and establish a stronghold in the lung epithelium, is necessary to understanding 
the progression of respiratory tularemia, as well as potentially providing insight into methods 
that may be used to block bacterial uptake or replication, and thus prevent disease. 
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Figure 3.1. F. tularensis LVS association with and internalization by TC-1 lung epithelial 
cells. (A) Percent of TC-1 cells with associated live (♦) or PFA-fixed (■) LVS at designated 
times post-inoculation. * Data are significantly different from untreated control, P<0.01 by 
paired two-tailed t test. (B) Percent of TC-1 cell-associated live (♦) or PFA-fixed (■) LVS 
that are intracellular at designated times post-inoculation. 
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Figure 3.2. The effect of actin and microtubule polymerization on F. tularensis LVS 
invasion of lung epithelial cells. TC-1 cells were treated with designated concentrations of 
(A) cytochalasin D or (B) colchicine. Results are expressed as the percentage of LVS, 
Salmonella or Campylobacter that survived gentamicin treatment, relative to the sample 
without inhibitor inoculated with the same organism (defined as 100% invasion). * Data are 
significantly different from untreated control, P<0.01 by paired two-tailed t test. 
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Figure 3.3. The effect of PI3 kinase and tyrosine kinase activity on LVS invasion of lung 
epithelial cells. (A) Wortmannin or (B) genistein were added to TC-1 cells at the indicated 
concentrations. Results are expressed as the percentage of LVS or control organism that 
survived gentamicin treatment, relative to the sample without inhibitor inoculated with the 
same organism(defined as 100% invasion). * Data are significantly different from untreated 
control, P<0.01 by paired two-tailed t test 
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Figure 3.4. Representative fluorescence microscopy images demonstrating LVSgfp 
localization within EEA1 or LAMP-1containing endosomes in TC-1 cells. Images depict (A) 
TC-1 cells stained for EEA1 30 minutes post-inoculation with LVSgfp or (B) 2 hours post-
inoculation stained for LAMP-1. Single color images: LVSgfp images depict bacteria alone, 
EEA1 and LAMP-1 images depict staining for EEA1 or LAMP-1 only, and extracellular 
images depict staining of extracellular bacteria (no extracellular bacteria were present in B). 
The merged color images depict LVSgfp (green), vacuoles labeled with anti-EEA1 antibody 
(N19)(red) or anti-LAMP-1 (1D4B) (red), or extracellular LVS labeled with anti-F. 
tularensis LPS antibody conjugated to Pacific Blue (blue). Extracellular LVSgfp (arrow with 
round end), intracellular but not EEA1 associated LVSgfp (small arrow), and LVS associated 
with EEA1 containing vacuoles (large arrowhead). (C)Trafficking of LVSgfp in TC-1 cells. 
100 intracellular bacteria were counted for each condition and scored for association with 
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EEA1 (♦) or LAMP-1 (▪) containing vacuoles. Three replicates were examined for each time 
point and condition. 
 
A B
 
Figure 3.5. Transmission electron micrographs of TC-1 infected with F. tularensis LVS. (A) 
One hour post-inoculation TC-1 cells showing LVS in a membrane bound vacuole that in 
some cases appeared to be degrading (arrow). (B) 24 hours post-inoculation LVS were free 
in the cytoplasm. 
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Figure 3.6. LVSgfp was analyzed by flow cytometry for escape from vacuoles into the 
cytoplasm of TC-1 cells. Extracellular bacteria were labeled with anti-F. tularensis LPS 
antibody conjugated to Pacific Blue (region R8). Cytoplasmic bacteria were identified by 
labeling with anti-F. tularensis LPS conjugated to  Alexa Fluor 647 after digitonin 
permeabilization of the cytoplasmic membrane (region R10). Vacuolar bacteria were 
inaccessible to antibody, and therefore GFP positive only (region R9). Representative flow 
cytometry data of bacteria recovered (A) 10 minutes or (B) 60 minutes post-inoculation. The 
value shown in region R10 represents the percent of intracellular bacteria that are 
cytoplasmic. (C) Percent of intracellular bacteria present in the cytoplasm at designated times 
post-inoculation 
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ABSTRACT 
Francisella tularensis is a highly virulent zoonotic bacterial pathogen capable of infecting 
numerous different mammalian species, including humans. Elucidation of the pathogenic 
mechanisms of F. tularensis has been hampered by a lack of tools to genetically manipulate 
this organism. Herein we describe the use of transposome complexes to create insertion 
mutations in the chromosome of the F. tularensis live vaccine strain (LVS). A Tn5-derived 
transposon encoding kanamycin resistance and lacking a transposase gene was complexed 
with transposase enzyme and transformed directly into F. tularensis LVS by electroporation. 
An insertion frequency of 2.6 x 10–8 ± 0.87 x 10–8 per cell was consistently achieved using 
this method. There are 178 described Tn5 consensus target sites distributed throughout the F. 
tularensis genome. Twenty-two of 26 transposon insertions analyzed were within known or 
predicted open reading frames, but none of these insertions was associated with the Tn5 
target site. Analysis of the insertions of sequentially passed strains indicated that the 
transposons were maintained stably at the initial insertion site after more than 270 
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generations. Therefore, transformation by electroporation of Tn5-based transposon-
transposase complexes provided an efficient mechanism for generating random, stable 
chromosomal insertion mutations in F. tularensis.  
INTRODUCTION 
Francisella tularensis is a gram-negative bacterial pathogen and is the etiologic agent 
of tularemia. The manifestations of tularemia depend on the initial route of inoculation, but 
all modes of contact can result in sepsis and disseminated disease, with organisms found in 
the liver, spleen, lymph nodes, kidney, and lungs (6, 20, 24, 25). Skin contact results in ulcer 
formation at the site of inoculation, where the organisms multiply and spread to the draining 
lymph nodes. Inhalation of F. tularensis leads to bronchial hemorrhaging, mediastinal 
lymphadenopathy (27), and pneumonia without a corresponding productive cough. Ingestion 
of the organisms can result in oropharyngeal tularemia, where patients typically develop 
exudative ulcerative pharyngitis and pharyngeal lymphadenopathy (1, 4).  
F. tularensis strains are divided into two groups, A and B, which are distinguished by 
acid production from glycerol and by citrulline ureidase activity. The two groups of 
organisms exhibit similar pathogenesis; however, group A strains are considered to be highly 
virulent for humans and other animals, whereas group B strains typically cause milder 
disease (28). A live attenuated vaccine strain (LVS) derived from a group B F. tularensis 
strain has been developed and used to vaccinate laboratory workers (7). This vaccine 
provides significant protection against the highly virulent strains initiated by skin contact (21) 
and inhalation (13, 22). However, the basis for attenuation of this strain in humans is not 
known, and it has not been licensed for general public use in the United States.  
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F. tularensis can survive within macrophages, a feature that is thought to be important 
in the pathogenesis of this organism (5, 12, 17, 26). F. tularensis subsp. novicida, a related 
organism historically referred to as Francisella novicida, also survives within macrophages, 
but it is an animal pathogen that does not infect humans. Two different genetic loci, termed 
mglAB for macrophage growth locus (2) and iglABCD for intracellular growth locus (11), 
have been identified in F. tularensis subsp. novicida that contribute to its survival in 
macrophages. The function of the igl gene products in promoting this survival has not been 
determined. MglA of F. tularensis subsp. novicida has recently been shown to function as a 
positive regulator for at least seven different genes (16) that are normally induced in 
macrophages, including iglC. An F. tularensis subsp. novicida mutant lacking mglA is unable 
to survive in cultured macrophages and is attenuated in mice (16). Homologues of these 
genes are present in both group A and B F. tularensis strains, and they presumably serve 
similar functions in these organisms.  
Apart from the described macrophage survival phenotype and the identification of a 
limited number of genetic loci that contribute to intracellular survival (11), very little is 
known about the molecular mechanisms that support F. tularensis pathogenesis and 
virulence. The lack of tools for the genetic manipulation of F. tularensis has made it difficult 
to identify and dissect the bacterial products and processes that contribute to this organism's 
extraordinary virulence and pathogenesis. Mechanisms of transformation and allelic 
exchange have only recently been described (3, 8, 15), and most of these procedures have 
been developed in F. tularensis subsp. novicida. Lauriano et al. (15) recently described the 
use of allelic exchange to generate targeted insertion mutations in F. tularensis LVS. They 
also reported that Tn10- and Tn1721-based transposon insertions were unstable in F. 
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tularensis and that bacterial gene-encoded transposase-complementing activity may function 
to promote the movement of these transposons.Herein we describe a procedure that uses a 
Tn5 derivative to create insertion mutations in F. tularensis LVS which, unlike Tn10 and 
Tn1721, were stably maintained at the initial insertion site.  
 
MATERIALS AND METHODS 
F. tularensis LVS was obtained from the Centers for Disease Control and Prevention, 
Atlanta, Ga., and were propagated at 37°C on chocolate medium supplemented with 1% 
IsoVitalex (BBL). Multiple colonies from an overnight culture of LVS grown on chocolate 
agar were picked and swabbed onto fresh plates to achieve confluent growth, and they were 
then incubated for 16 h. Cells from one plate of freshly confluent LVS were suspended in 6 
ml of wash buffer, consisting of 0.5 M sucrose and 10% glycerol, and then were centrifuged 
at 16,000 x g for 3 min. The pellet was suspended in wash buffer and centrifuged again for a 
total of four washes. The pellet resulting from the final centrifugation was suspended in wash 
buffer to a total volume of 100 µl.  
A procedure initially described by Goryshin et al. (9) to create mutations in 
Salmonella, Proteus, and Escherichia species was used to produce similar transposon 
insertion mutations in F. tularensis LVS. One microliter of EZ::TN <kan-2> transposome 
complex (Epicentre) containing 0.1 pmol of transposon and 1 U of transposase was added to 
100 µl of the washed cell suspension, consisting of 109 to 1010 cells in 0.5 M sucrose and 
10% glycerol. The contents were then mixed and transferred to a 0.1-cm-gap electroporation 
cuvette.  
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The EZ::TN <kan-2> transposome contains a derivative of Tn5 that lacks a 
transposase gene and has the transposase enzyme bound to the inverted repeat ends of the 
transposon. The transposase is stably associated with the transposon but is inactive in the 
absence of Mg2+. Magnesium ions present inside the bacterium activate the transposase 
following transformation, facilitating transposition into the Francisella chromosome. Thus, 
transposition is dependent simply upon activation of the enzyme and not the expression of a 
foreign transposase gene.  
The transposome was introduced into F. tularensis LVS by electroporation using a 
Bio-Rad Gene Pulsar set at 2.5 kV, 25 µF, and 200 . Immediately following electroporation 
the cells were suspended in 1 ml of brain heart infusion broth (BBL) supplemented with 50 
µg of hemin/ml, incubated for 1 h at 37°C, and then plated on chocolate agar containing 10 
µg of kanamycin/ml.  
 
RESULTS 
We consistently achieved an insertion frequency of 2.6 x 10–8 ± 0.87 x 10–8 (Table 
4.1), as determined by the number of antibiotic-resistant colonies divided by the total number 
of potential recipient organisms. The insertion frequency was not appreciably affected by the 
number of bacteria, nor was it improved by increasing the concentration of transposome 
complexes. Recovering the organisms with cold or prewarmed media following 
electroporation as described for other organisms (23) also did not alter the frequency with 
which we isolated antibiotic-resistant organisms.  
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Ideally a transposon will insert randomly throughout a genome in order to be a useful 
tool for creating insertion mutation libraries. The transposon insertion sites were mapped by 
directly sequencing the transposon-chromosome junctions by using oligonucleotide primers 
that hybridize within the transposon. Primers Kan-2 FP-1 
(ACCTACAACAAAGCTCTCATCAACC) and JF119 (GGATCAGATCACGCATCTTC) 
hybridize 70 and 150 bp, respectively, from the end of the transposon adjacent to the 3' end 
of the Kan resistance gene, and primer KAN RP-1 
(GCAATGTAACATCAGAGATTTTGAG) hybridizes 43 bp from the other end of the 
transposon. Individual kanamycin-resistant colonies were picked and restreaked on selective 
media. Chromosomal DNA was prepared from strains by using the MasterPure DNA 
purification kit according to the manufacturer's instructions (Epicentre).  
The precise transposon-chromosome junction sites were determined in a total of 26 
kanamycin-resistant colonies from each of three different transformations. One microgram of 
chromosomal DNA was mixed with 100 pM primer, and DNA sequence was generated by 
the University of North Carolina Genome Analysis Center. The transposon insertion site was 
determined by aligning the sequence to the F. tularensis LVS strain genome database 
produced by the Biology and Biotechnology Research Program Sequencing Group at 
Lawrence Livermore National Laboratory (http://bbrp.llnl.gov/bbrp/html/microbe.html).  
Tn5, the transposon upon which EZ::TN is based, has a reported insertion bias for the 
sequence A-GNTYWRANC-T (where W is A or T, R is A or G, Y is C or T, and N is any 
base) (10). The F. tularensis 1.8-Mbp LVS genome has 178 of these insertion bias sequences, 
but none of the 26 insertions that we analyzed occurred within one of these sites. Of the 26 
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junction sites sequenced, 21 were within potential open reading frames and 1 was in the 
transcription termination sequence of an open reading frame, which is consistent with the 
observation that, apart from the Tn5 insertion bias site, this transposon has a propensity for 
inserting into actively transcribed DNA and regions of high superhelical density (18, 19). 
One insertion, B5, was in a gene encoding the RNA polymerase ß subunit; this is an essential 
gene. The insertion is located 12 bases from the 3' end of the gene. F. tularensis LVS does 
not possess a second copy of this gene; thus, it is likely that the B5 mutant still produces a 
functional RNA polymerase ß subunit. Ironically, one of the insertions (strain A10; Table 4.2 
and Fig. 4.1) was within a gene reported to encode a Francisella transposase (14). The 
insertions did not appear to cluster within a specific chromosomal segment (Fig. 4.1). 
Insertions in potential reading frames were examined further by translating the 
sequence and blasting the protein database to tentatively identify the products of interrupted 
genes. The majority, but not all, of these mutations occurred in genes that encoded proteins 
with significant homology to proteins with known functions or conserved hypothetical 
proteins (Table 2).  
Lauriano et al. reported that insertion mutations created by derivatives of the Tn10 
and Tn1721 transposons in the closely related organism F. tularensis subsp. novicida were 
unstable and subject to movement to other chromosomal locations, possibly through the 
activity of a host-encoded transposase (15). We picked five transposon insertion mutation 
strains representing insertions within and outside of potential reading frames, including the 
strain with the insertion in the reported Francisella transposase gene. These strains were 
passed daily for 10 days on kanamycin-containing media, and chromosomal DNA was 
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prepared from cells on passages 0, 5, and 10. Southern blots were performed by digesting 5 
µg of chromosomal DNA with EcoRI, which does not cleave the transposon. Digested DNA 
segments were separated by agarose gel electrophoresis, transferred to nylon, and probed 
with digoxigenin-labeled Tn5 probe. The Tn5 probe hybridized to identically sized fragments 
in each of the DNA samples prepared from different passages of the same insertion strain 
(Fig. 4.2). Given that a single colony is composed of at least 108 organisms, a single passage 
equates to at least 27 generations of growth. Thus, after 10 passages the analyzed insertions 
were stable for a minimum of 270 generations.  
Electroporation of a Tn5-derived transposon-transposase enzyme complex into F. 
tularensis LVS resulted in the creation of random insertion mutant strains at a frequency that 
is sufficient to generate mutant libraries of this organism. These insertions are genetically 
stable and are apparently unaffected by the activities of any potential chromosomally 
encoded transposases. Thus, this scheme will facilitate the use of genetic approaches to study 
the mechanisms of F. tularensis physiology and pathogenesis.  
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TABLES AND FIGURES 
 
Table 4.1. Transposon insertion frequencies 
 
Input (CFU) No. of mutants Mutants/CFU 
 
2.8 x 1010 344 1.0 x 10–8 
4.9 x 109 62 1.2 x 10–8 
1.1 x 109 50 4.5 x 10–8 
2.6 x 109 207 7.0 x 10–8 
5.7 x 1010 1,097 1.9 x 10–8 
2.3 x 1010 550 1.0 x 10–8 
1.4 x 1010 210 1.5 x 10–8 
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Table 4.2. Identified transposon insertion sites 
Strain designation Predicted insertion 
 
A1 Extragenic 
A2 Deacyclase 
A3 Guanosine polyphosphate pyrophosphohydrolases 
A4 Hydrolase of HD superfamily 
A5 Metal-dependent hydrolase 
A6 Extragenic 
A8 Hypothetical protein gi34496297 
A9 Extragenic 
A10 Francisella transposase (14) 
B1 ATPase 
B2 Extragenic 
B4 Eflux pump protein 
B5 RNA polymerase ß subunit 
B6 Transcription terminator 
B7 Predicted membrane protein of unknown function, pfam03956 
B8 Phosphate acetyltransferase 
B9 Adenylosuccinate synthase 
B10 UsoAp of Emericella nidulans 
C1 Pyruvate phosphate dikinase 
C2 Methyltransferase 
C3 Isocitrate dehydrogenase 
C4 Chloride channel protein EriC 
C6 Anthranilate synthase 
C7 Tryptophan synthase alpha chain 
C8 Multidrug resistance protein 
C10 Integral membrane protein 
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Figure 4.1. Graphic representation of the chromosomal positions of the 27 identified 
insertion sites. The insertions assessed for stability and depicted in Fig. 4.2 are labeled. 
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Figure 4.2. Southern blot of five insertion mutants (A6, A10, B1, B2, B5, and C10) and 
wild-type F. tularensis LVS probed with labeled Tn5. Chromosomal DNA was prepared 
from mutants after 0, 5, and 10 passages, digested with EcoRI, and probed. All insertions 
analyzed in this manner retained the transposon at the initial insertion site. 
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ABSTRACT 
Francisella tularensis is a highly virulent bacterial pathogen that invades and 
replicates within numerous host cell types including macrophages and epithelial cells. In an 
effort to better understand this process we screened a transposon insertion library of F. 
tularensis LVS for mutant strains that invaded but failed to replicate within alveolar 
epithelial cell lines.  One such strain isolated from this screen contained an insertion in the 
gene FTL_1914, which is conserved among all sequenced Francisella species, yet lacks 
significant homology to any gene with known function.   A deletion strain lacking FTL_1914 
was constructed.  This strain did not replicate in either epithelial or macrophage – like cells, 
and intracellular replication was restored by the wild type allele in trans.  Based on the 
deletion mutant phenotype FTL_1914 was termed ripA (Required for Intracellular 
Proliferation, Factor A).  Following uptake by J774.A1 cells, F. tularensis LVS ∆ripA co-
localized with LAMP-1 then escaped the phagosome at the same rate and frequency as wild 
type infected cells.  Electron micrographs of F. tularenisis LVS ∆ripA demonstrated reentry 
of the mutant bacteria into double membrane vacuoles characteristic of autophagosomes in a 
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process that was not dependent on replication.  F. tularensis LVS ∆ripA was significantly 
impaired in its ability to persist in the lung and in its capacity to disseminate and colonize the 
liver and spleen in a mouse model of pulmonary tularemia.  The RipA protein was expressed 
during growth in laboratory media, and localized to the cytoplasmic membrane.  Thus, RipA 
is a cytoplasmic membrane protein conserved among Francisella species that is required for 
intracellular replication within the host cell cytoplasm, as well as disease progression, 
dissemination and virulence. 
 
INTRODUCTION 
Francisella tularensis is a highly virulent zoonotic pathogen that is the etiologic agent 
of the disease tularemia.  Francisella species have been isolated from over 250 animal 
species including mice, rabbits, and squirrels (5).  Transmission to humans from infected 
animals occurs through arthropod bites (41), physical contact with infected animal tissues 
(10), consumption of contaminated water (9, 50), or inhalation of aerosolized organisms (19).  
Transmission by inhalation results in the most aggressive form of tularemia where as few as 
10 colony forming units (CFU) can lead to a disease (55) that can rapidly progress (62) and 
result in mortality rates as high as 60% if untreated (17).  Individual cases of tularemia occur 
throughout the Northern hemisphere (35) with clusters of outbreaks occurring in Scandinavia 
(63), Europe (28, 33), and the American Midwest (56).  Reported cases of tularemia peaked 
in the United States during the 1930’s and 1940’s, but have since declined with only 1368 
cases between 1990 and 2000 (11). 
F. tularensis strains infectious for humans are subdivided into two groups, Type A 
(Francisella tularensis tularensis) and Type B (Francisella tularensis holoarctica).  Type A 
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is characterized by high virulence for humans and geographic localization to North America; 
although recently Type A was isolated in Europe as well (29).  Type B is distributed 
throughout the Northern hemisphere and infections with this strain are associated lower 
mortality than Type A.    A Type B F. tularensis strain was used to create an attenuated live 
vaccine strain (LVS) for use in the Soviet Union (59); however, this vaccine is not 
universally protective nor is it licensed for use in the United States.  F. tularensis LVS is 
attenuated in humans, but remains pathogenic for mice and other rodents, making it an 
excellent model for laboratory studies on Francisella pathogenesis (21). 
F. tularensis is a facultative intracellular pathogen.  The ability to replicate in various 
cell types such as alveolar macrophages (3, 45, 48, 58), dendritic cells (8), and lung alveolar 
Type II epithelial cells (22, 31) are all considered to be important in the pathogenesis of 
Francisella. Virulence factors such as mglA (4), iglA (16), iglC (38, 39, 54), tolC (24), clpB 
(42), Type IV pili (20, 23, 30), and a recently identified 58 kDa protein (60) have all been 
characterized using macrophage and mouse models of infection.  Yet the actual function of 
many of these proteins remains to be determined.  We screened a transposon insertion library 
to identify additional genes that contribute to the intracellular growth of F. tularensis. Herein 
we describe one such gene that is required for intracellular growth and virulence in a mouse 
model of tularemia. 
 
MATERIALS AND METHODS 
Bacterial strains and Cell culture.  Escherichia coli TOP10 and M15 strains were used for 
cloning and expression of 6HIS fusion proteins, respectively.   E. coli cultures were 
propagated in Luria’s broth supplemented with ampicillin at 100µg/ml or kanamycin at 
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20µg/ml as necessary for maintaining antibiotic selection. Francisella tularensis Live 
Vaccine Strain (LVS) was obtained from the Centers for Disease Control and Prevention, 
Atlanta, Ga. F. tularensis LVS was propagated on chocolate agar (25g/l BHI, 50µg/ml 
hemoglobin, 15g/l agarose) supplemented with 1% IsoVitaleX (Becton-Dickson), complete 
BHI broth (35g/l BHI, 50µg/ml hemin, 1% IsoVitalex), or Chamberlains Defined Media 
(12).  All bacterial strains cultured on chocolate agar were grown at 37°C.  Broth cultures 
were incubated in a shaking water bath at 37 ºC. 
TC-1 (ATCC CRL-2785) is a tumor cell line derived from mouse primary lung 
epithelial cells that was cultured in RPMI 1640 supplemented with 2mM L-glutamine, 
1.5g/liter sodium bicarbonate, 10mM HEPES, 1.0mM sodium pyruvate, 0.1mM nonessential 
amino acids, and 10% fetal bovine serum.  J774A.1 (ATCC TIB-67) is a reticulum cell 
sarcoma mouse macrophage-like cell line that was cultured in D-MEM with 4.5g/l glucose, 
2mM L-glutamine, and 10% fetal bovine serum.  Cell lines were cultured at 37 ºC and 5% 
CO2 atmosphere. 
 
Plasmids and Molecular Techniques.  Cloning of F. tularensis LVS DNA was conducted 
by PCR amplification of genomic DNA using Pfu turbo DNA polymerase (Stratagene) and 
cloned into pCR Blunt-II TOPO vector (Invitrogen) using the manufacturer’s protocols.  
Plasmids for complementation experiments were created by ligating cloned regions of the F. 
tularensis LVS genome into pKK MCS, a pKK214 GFP (1) derivative where a gfp tetR 
fragment was removed and replaced with a fragment containing a multiple cloning site 
(MCS) and a kanR allele.  Kanamycin selection was maintained at 20 µg/ml for E. coli 
TOP10, and 10 µg/ml for F. tularensis LVS.  The kanamycin resistance gene was a F. 
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tularensis codon optimized version of aphA1 synthesized by Blue Heron Biotechnology that 
was expressed from a modified F. tularensis groEL promoter (18).  
  
Gentamicin Protection Assay.  To determine the rate of intracellular invasion and 
replication, F. tularensis LVS strains were cultured to mid-exponential phase in 
Chamberlains Defined Media and then added to J774A.1 or TC-1 monolayers at a 
multiplicity of infection (MOI) of 100 in 200µl prewarmed tissue culture media.  Gentamicin 
protection assays were then conducted as described previously (31). Assays were done in 
triplicate and statistical significance was determined using unpaired t tests with unequal 
variance on the log transforms of recovered CFU to compare mutant strains to the wild type. 
 
Mutagenesis and Allelic Exchange.  A ripA deletion construct was made by Splice Overlap 
Extension (SOE) PCR (34) using primers designed to delete the ripA locus and while 
maintaining 1kb flanking regions.  All ripA sequence between the start and stop codons was 
deleted while leaving the start and stop codons intact.  The construct was sequenced to 
confirm the deletion was in frame and to ensure the integrity of the flanking DNA sequence.  
A BamHI-NotI fragment containing the deleted allele was ligated into pMP590 kanRsacB for 
allelic exchange (40).  Kanamycin (10µg/ml) was used to select for plasmid integration and 
10% sucrose to counterselect for resolution as described by LoVullo et el. (40). 
 
Invasion and Vacuolar Escape Assay.  Intracellular bacteria accessible to cytoplasmically 
delivered antibodies were enumerated by the methods described previously (15).  F. 
tularensis LVS ∆ripA accessibility to the cytoplasm was compared to wild type at 20 
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minutes, 60 minutes, and 180 minutes post invasion in J774A.1 cells in triplicate assays per 
time point.  Bacteria accessible to the cytoplasm were described as cytoplasmic and bacteria 
inaccessible to the cytoplasm as vacuolar. 
 
Fluorescence microscopy.  J774A.1 cells were cultured in 8 well chamber slides (Nunc).  F. 
tularensis LVS pKK214 gfp and F. tularensis LVS ∆ripA pKK214 gfp were prepared for 
inoculation as done for Gentamicin protection assays.  Invasion assay synchronization, 
epifluorescent microscopy, and LAMP1 co-localization quantitation was done as in Craven 
et. el. (15) at the described times post inoculation in J774A.1 mouse macrophage-like cells.  
Three independent assays were conducted for quantitation with multiple captures at each 
time point examined.  LVS GFP positive objects at 24 hours contained multiple bacteria and 
were scored as a group.  Three independent counts of over 100 GFP positive objects were 
scored as positive or negative for LAMP-1 co-localization.  The mean percent co-localization 
± the standard deviations were recorded and mutant values compared to wild type with an 
unpaired two-tailed t test. 
 
Electron microscopy.  Cell monolayers grown on polystyrene plates were rinsed with PBS 
and fixed in 3% glutaraldehyde/0.15M sodium phosphate, pH 7.4. Following three rinses 
with sodium phosphate buffer, the monolayers were post-fixed for 1 hour in 1% osmium 
tetroxide/1.25% potassium ferrocyanide/0.15M sodium phosphate buffer,  rinsed in deionized 
water, dehydrated using increasing concentrations of ethanol (30%, 50%, 75%, 100%, 100%, 
10 minutes each) and embedded in Polybed 812 epoxy resin (Polysciences, Inc.,Warrington, 
PA).   The embedded samples were sectioned parallel and perpendicular to the substrate at 
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70nm using a diamond knife.  Ultrathin sections were collected on 200 mesh copper grids 
and stained with 4% aqueous uranyl acetate for 15 minutes, followed by Reynolds’ lead 
citrate for 7 minutes.  Sections were observed using a LEO EM910 transmission electron 
microscope at 80kV (LEO Electron Microscopy, Thornwood, NY) and photographed using a 
Gatan Bioscan Digital Camera (Gatan, Inc., Pleasanton, CA). 
 
Mouse Model of Pulmonary Infection.  Francisella strains were prepared for intranasal 
inoculation by culturing in Chamberlains Defined Media to mid-exponential phase prior to 
suspension in PBS.  Anesthetized 6- to 8-week-old female C57BL/6 mice were inoculated 
intranasally with 105 CFU of F. tularensis LVS suspended in 50 µl of PBS.  Inoculations 
were conducted in groups of four mice per strain for each time point.  Organ burdens were 
evaluated by homogenization and serial dilution before plating on Chocolate agar to 
determine recovered CFU per organ.  Statistical analysis was conducted on log transforms of 
organ burdens using independent unpaired t-tests to compare mutant strains to wild type.  
 
Membrane Fractionation.  F. tularensis LVS was cultured to mid-exponential phase in 
Chamberlains Defined Media, pelleted by centrifugation, and resuspended in lysis buffer 
(10mM Tris pH 7.5, 150mM NaCl).  Lysozyme was added to 0.1mg/ml and the bacterial 
suspension incubated on ice for 30 minutes. A 1:1 cell suspension with 0.1mm silica beads 
was beaten for 20 minutes in a Disruptor Genie (Scientific Industries).  Cell lysates were 
collected after the beads settled and the beads were washed 3 times with lysis buffer.  Cell 
lysates were clarified by centrifugation at 12,000 x g for 4 minutes.  Crude membrane 
fractions were collected by ultracentrifugation at 100,000 x g for 90 minutes, and the 
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supernatants were saved as the cytosolic fractions.  Crude membrane fractions were washed 
one time by re-suspension in lysis buffer and ultracentrifugation.  Cytoplasmic membrane 
fractions were solubilized with lysis buffer and extracted with 10% sarkosyl (Sigma) added 
to a 0.2% final concentration.  Outer membrane fractions were then pelleted by 
ultracentrifugation at 100,000 x g for 60 minutes (16, 44). 
 
Recombinant RipA and anti-RipA Antiserum Production.  The F. tularensis LVS ripA 
gene was cloned and sequenced to confirm the integrity of the DNA sequence.  The ripA 
allele was ligated into a pQE30 (Qiagen) vector to construct an N terminal 6x His tag fusion.  
The ripA::6His allele was induced using 0.1mM IPTG for 4 hours and cells were harvested 
by centrifugation.  The cell pellet was resuspended (40 mM Tris-HCl pH 8.0, 1 mM EDTA, 
0.1M NaCl) and lysozyme treated at 1 mg/ml for 30 minutes before sonication.  The lysate 
was clarified by centrifugation. The crude membrane fraction was pelleted by 
ultracentrifugation at 115,000 x g for 60 minutes.  RipA::6His was purified from the crude 
membrane fraction using a Qiagen native purification protocol with buffers containing 1% 
Triton X-100 and 10mM β-mercaptoethanol.  The purified RipA::6His was analyzed for 
purity by SDS-PAGE and Coomassie staining.  The purified protein was methanol 
chloroform precipitated (61) and resuspended in PBS.  Purified RipA::6His was sent to 
Proteintech Group, Inc for the production of Rabbit antiserum by the standard Proteintech 
long protocol.  Preimmune bleeds were collected from each rabbit used in the protocol.  
Antiserum was screened for reactivity and specificity by Western blotting of the purified 
protein. 
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SDS-PAGE and Western Analysis.  SDS-PAGE was conducted by the methods of 
Laemmli et al (36) utilizing a denaturing discontinuous 12.5% acrylamide gel.  Total protein 
loaded in each sample was equivalent as determined by a BCA assay (Pierce).  Proteins were 
transferred to nitrocellulose and blocked in 5% BSA blocking buffer (0.05% Tween 20, PBS) 
overnight.  Antibody incubations were conducted in 0.5% BSA Wash buffer (0.05% Tween 
20, PBS). Membranes were washed in 0.05% Tween 20 PBS.  Primary incubations and 
secondary antibody incubations were for 60 minutes.  Rabbit anti-RipA serum was used at 
1:1000, Chicken anti-AtpB IgY at 1:5000 (AgriSera), Mouse anti-GFP IgG (Abcam) at 
1:1000, Goat anti-rabbit IgG-HRP at 1:10,000 (Sigma), and Goat anti-Chicken IgG HRP at 
1:10,000 (Sigma).  Development was conducted using Pierce SuperSignal Pico substrate as 
the manufacturer’s protocols and exposed to autoradiography film. 
 
RESULTS 
Identification of RipA.  To identify genes involved in Francisella intracellular growth, we 
created and screened a transposon mutant library of F. tularensis (LVS) for strains that 
entered but did not replicate within TC-1 cells, which are a transformed lung epithelial cell 
line.  We identified one mutant strain that invaded epithelial cells at the same frequency as F. 
tularensis LVS, but did not replicate following invasion (Fig. 5.1A).  At 6 hours post 
inoculation there was no significant difference between the number of CFU recovered from  
mutant or wild type infected-TC-1 cells.  However, by 24 hours post inoculation there were 
significantly fewer (P<0.001) mutant organisms (1.9x105 CFU) than wild type LVS (1.1x107 
CFU) recovered from the Tn5 mutant and wild type LVS -infected cells, respectively.   
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To compare the intracellular growth of the Tn5 mutant strain and wild type LVS in 
epithelial and macrophage – like cell lines, identical assays were performed using the 
J774A.1 mouse macrophage-like cell line (Fig. 5.1B).  As in the TC-1 epithelial cell line, the 
mutant and wild type strains entered J774A.1 cells at the same frequency.  At 24 hours post 
inoculation, 8.2x107 versus 8.7x106 CFU (P < 0.01) were recovered from LVS and Tn5 
mutant infected cells, respectively.  Thus, in contrast to the no growth phenotype observed in 
TC-1 cells, the Tn5 mutant replicated within J774A.1 cells, but to a lesser extent than wild 
type LVS.  Similar results were obtained in other lung epithelial cell lines (MLE-12, A549) 
and in bone marrow derived mouse macrophages (data not shown).  The monocyte and 
epithelial cell lines are propagated in modestly different media formulations, but swapping 
the media had no impact on the cell type specific growth defect of the mutant (data not 
shown).  
Analysis of the DNA sequence flanking the Tn5 insertion showed that the interrupted 
allele was FTL_1914 (Fig. 5.2A).  This allele was termed ripA (required for intracellular 
proliferation, factor A).  The ripA locus is predicted to encode a 178 amino acid membrane 
protein conserved in all sequenced Francisella strains.  There is only one copy of the locus in 
each sequenced genome.  pBLAST (25) was used to identify similar non-F. tularensis 
proteins (E < 1).  These were hypothetical membrane proteins of unknown function in 
Streptomyces coelicolor A3(2) (E = 1x10-10), Beggiatoa sp. PS (E = 2x10-10), Moritella sp. 
PE36 (E = 1x10-9), Sulfitobacter sp. NAS-14.1 (E = 0.006), Clostridium perfringens C strain 
JGS1495 (E = 0.044), a predicted membrane protein linked to a retron element in an 
Escherichia coli clinical isolate (E = 0.36), and a nitric oxide reductase (NorW) in 
Aeromonas salmonicida (E = 0.60).  NorW plays a role in nitric oxide detoxification through 
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interactions with NorR and NorV; however, there are no NorR or NorV homologs encoded in 
the Francisella genome and the amino acid similarity is to a NorW fragment not part of the 
functional oxidoreductase.  Thus, at this time protein homology analyses did not reveal any 
obvious clues to RipA function 
 
Creation and initial characterization of ripA deletion mutant. Intracellular growth of the 
LVS Tn5::ripA mutant was not restored by in trans complementation with wild type ripA.  
Thus, to circumvent potential complications caused by the transposon insertion a, F. 
tularensis LVS ∆ripA strain lacking all but the start and stop codons was created for use in 
subsequent phenotypic assays.  The deletion allele was generated by splice overlap extension 
(SOE) PCR (Fig. 5.2B), cloned into the allelic exchange vector pMP590 (40) and introduced 
into LVS as described (27, 40).  Following sucrose selection to isolate resolved plasmid 
integrants, strains lacking wild type ripA and possessing the ripA deletion locus were 
identified by PCR.  Integrity of the ∆ripA locus and flanking DNA was confirmed by 
sequencing.  Growth of the mutant strain in Chamberlains Defined Media was not 
significantly different than that of wild type LVS.   After 24 hours of growth in Chamberlains 
Defined Media, the mutant and wild type strains reached equivalent maximum densities (data 
not shown). 
 
Francisella intracellular growth requires ripA.  Mutant and wild type strains were 
subjected to gentamicin protection assays conducted in J774A.1 (Fig. 5.3B) and TC-1 cell 
lines (Fig. 5.3A) to determine the contribution of ripA on intracellular growth.  Invasion 
frequencies of the deletion mutant were not significantly different from wild type (P 
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values>0.4) in either cell line.  However, in contrast to wild type, the number of recovered 
intracellular mutant CFU decreased after 24 hours in both cell types indicating that the ∆ripA 
mutant had an intracellular survival defect.  Mean recovery for LVS and LVS ∆ripA was 
1.23 x 107 versus 2.60 x 102 CFU (P<0.001), respectively, at 24 hours in TC-1 lung epithelial 
cells.  Mean recovery for LVS and LVS ∆ripA was 1.04 x 108 versus 1.07 x 105 CFU 
(P<0.001), respectively, at 24 hours in J774A.1 cells. The intracellular growth defect of LVS 
∆ripA was not due to increased sensitivity to gentamicin (data not shown).  Intracellular 
replication of LVS ∆ripA was restored by in trans complementation with ripA demonstrating 
a direct cause and effect relationship between ripA expression and intracellular growth.   
 
F. tularensis ∆ripA is unaffected in its ability to escape the phagosome.  Following uptake 
by host cells, wild type F. tularensis escape the phagosome and replicate within the 
cytoplasm (13, 26).   With the notable exception of F. novicida ∆iglD (53), F. tularensis LVS 
∆purMCD (47),  and F. tularensis LVS clpB (42), most intracellular growth defective 
mutants strains of Francisella fail to escape the phagosome (39, 54).  To determine the 
contribution of ripA to this property, we compared the phagosome escape frequencies and 
rates of wild type and ∆ripA in J774A.1 cells.  Briefly, monolayers were inoculated with 
GFP-expressing strains at an MOI of 100.  Invasion was synchronized as described (13).   
Infected cells were treated with digitonin to selectively permeablize the cytoplasmic, but not 
phagosomal, membrane 20, 60, and 180 minutes post invasion and probed with Alexa 647 
conjugated anti-F. tularensis antibody.  Extracellular and cytoplasmic bacteria were antibody 
accessible, but not bacteria contained by an intact phagosomal membrane.  Antibody bound 
and unbound organisms were quantified via FACS, and the contribution of extracellular 
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bacteria was accounted for in corresponding samples not treated with digitonin.   At each 
time point, the percentage of antibody accessible mutant and wild type bacteria were 
statistically identical (Fig. 5.4A).  Thus, the ∆ripA strain accessed the cytoplasm at the same 
rate as wild type F. tularensis LVS, demonstrating that ripA is not required for phagosome 
escape and that failure to escape the phagosome does not account for the intracellular growth 
defect conferred by the ∆ripA allele. 
 
Francisella ripA mutant colocalizes with LAMP-1.  Francisella containing phagosomes 
associate with early and late maturation antigens EEA-1 and LAMP-1 before membrane 
integrity is compromised and the bacteria are released to the cytoplasm.  There is evidence to 
suggest that early phagosome maturation steps are required for Francisella survival and 
subsequent intracellular replication (17,62).  We compared mutant and wild type co-
localization with LAMP-1 in infected cells to determine if the lack of ripA affected 
phagosome trafficking.   J774A.1 cells were inoculated with GFP-expressing wild type and 
∆ripA strains as described above, permeablized and probed with Alexa 647 conjugated 
LAMP-1 antibody. Co-localization of LAMP-1 with bacterial cells was evaluated by epi-
fluorescence.      Consistent with what has been reported by other groups (13,27), at 20 and 
180 minutes post inoculation 50% and 22% respectively, of intracellular LVS co-localized 
with LAMP-1 (Fig. 5.4B).  The number of wild type organisms co-localizing with LAMP-1 
reached a minimum of 1.5 % at 12 hrs post inoculation, which was followed by an increase 
to 26% at 24 hrs (Fig. 5.4B).  This reacquisition of LAMP-1 co-localization has been 
described previously as the replication dependent formation of Francisella containing 
vacuoles (13).  The co-localization of LVS ∆ripA with LAMP-1 was not statistically different 
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from wild type at any point tested (P>0.05, unpaired two tailed t test) save for 24 hrs post 
inoculation where 40% of the mutant organisms co-localized with LAMP-1.  It should be 
noted that LVS ∆ripA infected cells contained only 1 – 3 bacterial per cell, whereas wild type 
infected cells had what appeared to be hundreds of bacteria 24 hours post inoculation.  Thus, 
the concentration of wild type bacteria in these cells may impact the LAMP-1 co-localization 
calculations.  More important than the difference in proportion of mutant and wild type 
organisms that co-localized with LAMP-1 in 24 hr infected cells is the observation that 
LAMP-1 colocalization with LVS ∆ripA increased between 12 and 24 hours.  This process of 
re-association with LAMP-1 positive vacuoles was previously thought to require bacterial 
replication.  These results demonstrate that replication per se is not required for this process, 
and that failure to re-associate with LAMP-1 positive vacuoles does not account for the 
intracellular growth deficiency of ∆ripA.   
 Francisella ripA mutant reenters a membrane bound vacuole after escape to the 
cytoplasm.  Francisella escapes from the phagosome quickly after cell invasion before 
replicating in the cytosol.  Francisella then reenters a vacuole with autosomal characteristics 
in a replication dependent process (13)   We compared mutant and wild type subcellular 
localization by electron microscopy to determine if the mutant bacteria were associated with 
Francisella containing vacuoles (FCV).  J774A.1 cells were inoculated with wild type and 
∆ripA strains as described above. 
 Mutant and wild type bacteria were found in membrane bound vacuoles at 15 minutes 
post inoculation and were free in the cytoplasm at 3 hours post inoculation (Fig. 5.5).  No 
difference in the subcellular localization was evident when the wild type and mutant bacteria 
were compared.  By 24 hours post inoculation, evidence of bacteria in membrane bound 
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vacuoles was present.  Wild type bacteria were present at high density in most cells and 
could be located in either the cytosol or membrane bound vacuoles.  Mutant bacteria were 
present in small clusters of 1 to 3 bacteria that could be found in either the cytosol or 
membrane bound vacuoles.  Some bacteria containing vacuoles demonstrated the double 
membranes characteristic of autophagosomes (Fig. 5.5).  The reentry of F. tularensis LVS 
∆ripA into Francisella containing vacuoles did not appear to be dependent on replication, 
differentiating it from the wild type phenotype. 
RipA is Required for Virulence in a Mouse Model of Infection.  We used a mouse model 
of pulmonary tularemia to assess the role of ripA in F. tularensis virulence and pathogenesis.  
Anesthetized C57BL/6 mice were inoculated intranasally with 105 CFU of either LVS pKK 
MCS (wild type + vector), LVS ∆ripA pKK MCS (mutant + vector), or LVS ∆ripA pKK 
MCS ripA (mutant + plasmid complement).  Bacterial burdens were measured by serial 
dilution, and plating of homogenized organs.  Lung burdens were determined two hours post 
inoculation to monitor the delivery of each strain to the lung.  Lung, liver, and spleen organ 
burdens (Fig. 5.6) were determined 1, 3, 7, and 14 days post inoculation. 
 The CFU recovered from the lungs at 2 hours post inoculation, 2.48 x 104, 1.18 x 104, 
and 1.12 x 104 for LVS, LVS ∆ripA, and LVS ∆ripA pJRF146, respectively, were not 
statistically different (P > 0.2, independent two tailed t-test with unequal variance), thus 
equivalent numbers of each strains were delivered to the lung.  By day 1 the organ burdens of 
LVS ∆ripA infected animals were significantly lower than those of wild type and 
complemented mutant strains (P<0.001).  Within the first 24 hours post inoculation, the 
number of LVS ∆ripA organisms in the lung decreased, whereas the number of both wild 
type and complemented strains increased by at least one order of magnitude over the number 
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of organisms initially delivered. In contrast to the wild type and complemented mutant 
strains, LVS ∆ripA was not detected in the liver or spleen before day seven.   At day seven, 
all LVS ∆ripA-infected mice had detectable liver burdens but only 1 LVS ∆ripA –infected 
mouse had a detectable spleen burden (> 30 CFU).  In mice infected with LVS ∆ripA or LVS 
∆ripA pJRF146 ripA organ burdens were reduced at day 14  relative to day 7 (P<0.01). Mice 
infected with wild type LVS were euthanized at day 7 due to significant morbidity. 
Collectively, these data demonstrate the importance of ripA in establishing a Francisella 
infection. 
   
Characterization and localization of the RipA Protein.  Subcellular fractions of LVS, 
LVS ∆ripA, and LVS ∆ripA pJRF146 ripA were analyzed by Western blotting using anti-
RipA antiserum (Fig. 5.7A).  RipA migrated at a relative molecular weight of 17 kDa. RipA 
protein was not detected in LVS ∆ripA lysates.  Complementation with the native ripA allele 
in a multicopy plasmid resulted in increased RipA expression relative to the wild type strain. 
When the translated amino acid sequence was analyzed with TopPred (14), RipA was 
predicted to be localized to the cytoplasmic membrane with three transmembrane domains 
and the amino terminus in the cytoplasm.   Western analysis of cytoplasmic, cytoplasmic 
membrane, and outer membrane enriched protein fractions (16, 44) prepared from GFP-
expressing LVS revealed that RipA localized to the cytoplasmic membrane (Fig. 5.7B).  
RipA was differentiated from proteins that reacted non-specifically with the anti-serum by 
probing corresponding samples with preimmune serum.  Antibodies recognizing the F0F1 
ATP synthase β subunit (AtpB) (37) and GFP were used as markers for cytoplasmic 
membrane and cytoplasmic components, respectively. No GFP was detected in either 
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membrane fraction.  Low levels of AtpB and RipA were detected in the outer membrane 
fraction, indicating that the presence of low level contamination with cytoplasmic membrane 
proteins.  However, the relative band intensities demonstrate that the majority of RipA was 
present in the cytoplasmic membrane fraction of F. tularensis.  
  
DISCUSSION 
The highly virulent nature of F. tularensis was recognized even before it was isolated 
and identified in the 1920’s as the etiologic agent of a plague like disease in rodents.  It is 
evident that the ability to survive and replicate within diverse host cell types is fundamental 
to F. tularensis pathogenesis.  While the processes of host cell entry, phagosome escape, and 
intracellular replication have been described, the mechanisms used by F. tularensis to 
achieve these have not.  The recent creation and improvement of tools and procedures for the 
genetic manipulation of F. tularensis has led to the identification of a number of genes that 
are required for intracellular growth and/or virulence in animal models of tularemia. 
We screened a transposon insertion mutant library of F. tularensis LVS to identify 
previously unstudied genes required for proliferation within host cells.  One such mutant 
strain contained a transposon insertion in FTL_1914 (ripA), which is conserved among 
Francisella species.  The transposon insertion mutant possessed an unusual phenotype in that 
it failed to replicate within cell lines of epithelial origin, yet retained the ability to replicate 
within monocyte cell lines and bone marrow derived macrophages. We created a F. novicida 
U112 Tn5::ripA mutant strain by replacing the wild type gene with the LVS Tn5::ripA allele 
via homologous recombination, and this strain had the same intracellular growth phenotype 
as LVS Tn5::ripA (data not shown).  However, the F. tularensis LVS ∆ripA deletion mutant 
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strain failed to replicate in any cell type tested.  We cannot account for the differences in 
intracellular growth conferred by the transposon insertion and deletion mutant alleles.  Only 
the deletion mutant phenotype was complemented by wild type ripA in trans suggesting that 
the transposon insertion may have exerted cis-acting or polar effects, or possibly created 
selective pressure for secondary unlinked mutations that compensated for the growth defect 
in macrophages.  
Even though ripA has homology to a limited number of genes in other unrelated 
bacteria, this information does not provide significant insight into the ripA function.  Thus, 
we thoroughly characterized the expression and subcellular localization of RipA, as well as 
the ∆ripA mutant phenotypes to provide a basis for discerning the mechanism(s) by which 
this protein contributes to intracellular growth.   
Intracellular pathogens must overcome the host innate immune response to 
successfully colonize the intracellular niche.  The primary host defense is centered on the 
antimicrobial properties of the phagosome.  Most successful intracellular pathogens either 
escape the phagosome or divert phagosome maturation to their own ends.  Francisella 
quickly escapes the phagosome into the cytoplasmic environment where it replicates (13, 26, 
39).  Since the recovery of LVS ∆ripA from infected epithelial cells or macrophages 
decreased dramatically after the initial invasion, we wanted to assess if the decreased survival 
was due to altered intracellular trafficking of LVS ∆ripA.  LVS ∆ripA became accessible to 
the cytoplasm at the same rate as wild type LVS.  The mutant also co-localized with the late 
endosomal/lysosomal marker LAMP-1 with the same frequency as wild type.  Thus, the 
intracellular survival defect was not due to failure to escape from and subsequent killing in 
the phagolysosome.   
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  Autophagy is another important means by which host cells clear pathogens from the 
host cytoplasm (43, 51).  Most cytoplasmic pathogens studied to date either evade or hijack 
autophagic mechanisms.  For example, Shigella flexneri and Listeria monocytogenes evade 
autophagy in a process requiring de novo protein synthesis (46, 51).  While Legionella 
pneumophila, Salmonella enterica, and Coxiella burnetti exploit the autophagic machinery 
(6, 7, 32, 52, 57).   Francisella is different from other intracellular pathogens that have been 
examined because evasion of autophagy is not dependent on de novo protein synthesis (13).  
Francisella reenters autophagosome like, LAMP-1 positive, vacuoles after replication in the 
cytoplasm.  LVS ∆ripA also localizes with LAMP-1 after escape to the cytoplasm.  Electron 
micrographs showed F. tularensis LVS ∆ripA present in vacuoles with double membranes 
characteristic of autophagosomes by 24 hours post inoculation.  Reentry of the mutant 
bacteria into Francisella containing vacuoles was not dependent on replication differentiating 
the phenomenon from the wild type process.  We hypothesize that autophagy of intracellular 
F. tularensis LVS ∆ripA occurs in the cytoplasm although this may or may not have a direct 
bacteriocidal effect on the bacteria.  Further work needs to be done to determine if LVS 
∆ripA requires de novo protein synthesis to stimulate compartmentalization during the 
cytoplasmic phase of its lifecyle and what effect compartmentalization of LVS ∆ripA has on 
intracellular bacterial survival.           
The survival defect of LVS ∆ripA in the cytoplasm is likely due to increased 
sensitivity to host anti-microbial factors, its inability to acquire a necessary nutrient, or 
failure to adapt to the cytoplasmic environment.    Nutritional deprivation or auxotrophy 
would have a bacteriostatic effect on the bacteria (2).  For example, F. tularensis ∆purF, a 
purine auxotroph, fails to replicate in host cell cytoplasm, but persists for an extended period 
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before declining gradually (49).   This is not the phenotype demonstrated by F. tularensis 
∆ripA, which declines dramatically between 6 hours and 24 hours in the intracellular niche.  
Though not conclusive, this rapid loss of intracellular viability coupled with the fact that the 
∆ripA strain replicates at the same rate and extent as wild type LVS in chemically defined 
minimal Chamberlains media suggests that F. tularensis ∆ripA is not an auxotroph.  We are 
currently working to determine if the ∆ripA strain is affected in its ability respond and adapt 
to the host cell cytoplasmic environment and are identifying RipA interacting proteins with 
the aim of inferring its function based on the properties of interacting proteins. 
 
ACKNOWLEDGEMENTS 
We gratefully acknowledge Victoria Madden of the Microscopy Services Laboratory 
and Larry Arnold of the Flow Cytometry Facility at UNC-CH for his expertise.  
This work was supported by a Southeast Regional Center of Excellence in Biodefense 
and Emerging Infections grant (NIH/NIAID U54-AI057157) and by the National Institutes of 
Health (R21-AI053399). 
ATTRIBUTIONS 
I performed all work in this chapter with the following exceptions. Josh Hall isolated 
and characterized the original transposon mutant and assisted in mouse experiments.  Robin 
Craven performed flow cytometric analyses for cytoplasmic accessibility.  Todd Kijek and 
Sharon Taft-Benz assisted in animal experiments.  This work has been previously published, 
97 
Copyright © American Society for Microbiology, Infection and Immunity epublished ahead 
of print September, 2008. Permission has been granted to reprint this material. 
FIGURES 
 
Fig. 5.1.  Gentamicin protection assays with LVS ripA::tn5. (A) TC-1 lung epithelial cells or 
(B) J774A.1 mouse macrophage-like cells were infected with either LVS or LVS ripA::tn5 at 
an MOI of 100.  Mean CFU (N=3) at 6 hours and 24 hours post inoculation with error bars ± 
one standard deviation.  Student’s t-tests were conducted comparing LVS to LVS ripA::tn5 
at each time point (P<0.01 demarcated by **). 
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Fig. 5.2.  (A) Graphical representation of the genomic organization of the LVS ripA locus. 
Loci in close proximity to ripA (FTL_1914) on the chromosome are FTL_1912 (30S 
ribosomal protein S1), FTL_1913 (Sua5/YciO/YrdC family protein), and FTL 1915 
(Acetyltransferase).  Primers utilized for SOE PCR are marked by arrows.  (B)  DNA 
sequence of the ripA deletion marked with the forward and reverse overlapping internal 
primers used in the SOE PCR.  The predicted ribosome binding site (RBS) and the remaining 
ripA codons (M and *) are marked. 
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Fig. 5.3.  Gentamicin protection assays with ∆ripA. (A) TC-1 lung epithelial cells or (B) 
J774A.1 mouse macrophage-like cells were infected at an MOI of 100.  Mean CFU (N=3) at 
6 hours and 24 hours post inoculation with error bars ± one standard deviation.  Student’s t-
tests were conducted comparing strains to wild type LVS at each time point (P<0.05 
demarcated by * and P<0.01 demarcated by **).  
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Fig. 5.4.  Intracellular trafficking of LVS ∆ripA.  (A) Cytoplasmic accessibility of LVS gfp 
and LVS ∆ripA gfp in J774A.1 macrophage-like cells at 20 minutes, 1 hr, and 3 hrs post 
inoculation (PI).  Vacuolar bacteria were defined as bacteria inaccessible to the 
cytoplasmically delivered α-Francisella LPS antibodies.  Mean % vacuolar (N=3) values 
plotted and error bars are representative of ± 1 standard deviation.  Percent accessibility with 
saponin permeabilization marked with a broken line.  (B) Co-localization of LVS gfp and 
LVS ∆ripA gfp with LAMP-1 in J774A.1 macrophage-like cells.  Percent LAMP-1 co-
localization was determined from 3 independent experiments and recorded as mean % 
LAMP-1 positive with error bars representative of ±1 standard deviation.  At 24 hours PI, 
LAMP-1 co-localization done on a per cells basis.  Individual bacteria were not 
distinguishable in wild type images.  (C) Representative epiflourescent images of LVS gfp 
and LVS ∆ripA gfp at 20 minutes, 3 hrs, and 24 hrs PI in J774A.1 macrophage-like cells.  
The 20 minute and 3 hour images demonstrate a similar staining pattern for LVS gfp and 
LVS ∆ripA gfp.  The 24 hours image demonstrates that LVS ∆ripA gfp may be visualized as 
individual bacteria co-localized with LAMP-1 at this time point.  Extracellular bacteria were 
stained with AMCA and colorized blue.  GFP captures demarked by LVS and colorized 
green in merged images.  LAMP-1 stained with Alexa 647 and colorized red.  Individual 
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channels for GFP and Alexa 647 captures marked LVS and LAMP-1 
respectively.
 
Fig. 5.5.  Francisella ripA reenters membrane bound vacuoles after phagosomal escape.  
J774A.1s were infected with LVS and LVS ∆ripA.  Samples were processed for TEM at 20 
min, 3 hrs, and 24 hrs post inoculation. TEM micrographs demonstrating individual bacteria 
enclosed  by membranes at 20 minutes and 24 hours post inoculation  (indicated by arrows).  
Arrows on 24 hrs post inoculation micrographs demonstrate double membrane regions 
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characteristic of autophagosomes.   The 3h post inoculation micrographs demonstate F. 
tularensis not enclosed by membranes. (Scale bars: 200 nm) 
 
Fig. 5.6. Bacterial organ burdens from infected mice (N=4) were quantified as CFU per 
organ and graphed as individual data points.  Mean organ burdens are demarcated by 
horizontal lines. Organ burdens in mice inoculated with LVS vector only (○), LVS ∆ripA 
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vector only (□), and LVS ∆ripA pJRF146 ripA (∆) strains.  Lung (A), liver (B), and spleen 
(C) burdens were determined at 2 hours (lung only), 1 day, 3 days, 7 days, and 14 days (LVS 
∆ripA vector only and   LVS ∆ripA pJRF146 ripA) post inoculation.  The limit of detection is 
marked as a broken line at ~10 CFU.  Burdens that were below the limit of detection are 
plotted at 10 CFU. 
 
Fig. 5.7.  (A) Western blot analysis of cytoplasmic membrane enriched fractions of LVS, 
LVS ∆ripA, and LVS ∆ripA pJRF146 ripA.  Rabbit anti-RipA (1:1000) antiserum was used 
as the primary antibody.  (B) Subcellular localization of RipA.  Western analysis of cytosolic 
(Cyt.), cytoplasmic membrane (CM), and outer membrane (OM) enriched fractions of LVS 
pKK214 gfp. Non specific bands were determined with preimmune serum from the mouse 
used to generate the mouse anti-RipA serum.  AtpB was used as a marker for the cytoplasmic 
membrane and GFP for the cytoplasm.  Specific bands (RipA, AtpB, and Gfp) are marked 
with black arrows.  Non-specific bands are marked with gray arrows.
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ABSTRACT 
Francisella tularensis is a highly virulent, facultative, intracellular pathogen that is 
the etiologic agent of the zoonotic disease tularemia.  We recently identified a cytoplasmic 
membrane protein, RipA, which is conserved among Francisella species and is required for 
intracellular growth.   Characterization of ripA expression by Northern analysis of total RNA 
determined that the ripA allele was predominantly expressed as a monocistronic message and 
not as part of an operon.  Multi- and single copy transcriptional and translational lacZ fusions 
were constructed to facilitate ripA expression analyses. Site directed mutagenesis of the 
predicted ripA promoter and ribosome binding sites significantly reduced Φ(ripA’-lacZ) 
expression.   LacZ activity produced by the ripA fusions accurately reflected changes in both 
ripA transcript and protein levels. The Φ(ripA’-lacZ) strains were used to quantify ripA 
expression in response to different environmental conditions and during different stages of 
intracellular growth. The expression of ripA was as much as two fold higher in laboratory 
cultures grown at pH 7.5 as compared to pH 5.5.  Further, ripA expression levels associated 
with different stages of intracellular growth mirrored that of the pathogenicity island gene 
iglA.  However, in contrast to iglA, the ripA gene is moderately repressed by the 
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transcriptional regulators MglA and SspA.  The expression of ripA was two-fold or more 
higher in ∆mglA or ∆sspA mutant backgrounds whereas iglA expression was significantly 
lower in these two strains.  Expression of ripA and iglA were returned to near wild type levels 
by complementation in the respective mutants with the native mglA and sspA alleles in trans.  
The activation and suppression of genes required for intracellular growth by mglA suggests a 
temporally compartmentalized expression profile of Francisella virulence factors related to 
the expression levels of mglA. 
 
INTRODUCTION 
Francisella tularensis is the etiologic agent of the highly virulent zoonotic disease 
tularemia. Routes of transmission include arthropod bites (Markowitz et al., 1985), physical 
contact with infected animal tissues (Centers for Disease Control and Prevention (CDC), 
2005), contaminated water (Celebi et al., 2006; Reintjes et al., 2002), and inhalation of 
aerosolized organisms (Feldman et al., 2001).  Pulmonary tularemia is the most lethal form 
of the disease with a mortality rate as high as 60% (Dennis et al., 2001).  This lethal disease 
rapidly progresses after colonization of the lungs by as few as 10 colony forming units or 
CFU (Saslaw et al., 1961; White et al., 1964).   
F. tularensis is a facultative intracellular pathogen that escapes the phagosome and 
replicates in the cytoplasm (Checroun et al., 2006; Clemens et al., 2004; Golovliov et al., 
2003).  Francisella mutations that result in the loss of intracellular replication have been 
linked to either a lack of replication in the cytoplasm (Fuller et al., 2008; Meibom et al., 
2008; Mohapatra et al., 2007; Pechous et al., 2006) or a failure to escape the phagosome 
(Lindgren et al., 2004; Santic et al., 2005).  Regulation of Francisella virulence factors 
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required for phagosomal escape and intracellular replication have been in many cases linked 
to the transcriptional regulator MglA (Brotcke et al., 2006; Charity et al., 2007; Lauriano et 
al., 2004; Santic et al., 2005).  Snapshots of Francisella intracellular protein expression have 
been taken using proteomics studies (Golovliov et al., 1997; Twine et al., 2006), but studies 
on how the expression of Francisella virulence factors change during the course of 
intracellular infection are limited. Existing studies include measurement of intracellular IglA 
by Western blotting (de Bruin et al., 2007) and mglA expression through the use of a mglA-
cat reporter (Baron & Nano, 1999).   Recent advances in the understanding of subcellular 
localization of Francisella during intracellular growth (Checroun et al., 2006; Clemens et al., 
2004; Lindgren et al., 2004) have enhanced the value of examining how intracellular gene 
expression changes during different phases of intracellular growth and subcellular 
localization.  
The ripA locus is dispensable for growth in chemically defined media, yet is essential 
for intracellular replication (Fuller et al., 2008).  Many loci necessary for intracellular 
replication are positively regulated by MglA (Charity et al., 2007; Lauriano et al., 2004); 
however, data on whether MglA regulates ripA expression is contradictory.  Microarray data 
on MglA regulated loci show ripA expression unchanged (Charity et al., 2007), while 
proteomics data demonstrate RipA to be repressed by MglA (Guina et al., 2007).  This 
repression is seemly in conflict with the upregulation of MglA after cell invasion and the 
necessity of ripA for intracellular replication.  To clarify this conflict, we used lacZ as a 
reporter gene to study F. tularensis LVS ripA extracellular and intracellular gene expression.  
Gene expression of bacteria in intracellular niches has been studied using lacZ reporter 
fusions in Listeria monocytogenes (Moors et al., 1999) and Salmonella typhimurium (Chen et 
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al., 1996).   In Francisella, lacZ has been used successfully as a reporter gene introduced by 
transposon mutagenesis and evaluated during extracellular growth (Buchan et al., 2008).    
This is the first use of a lacZ reporter system in Francisella to evaluate intracellular gene 
expression. 
 
METHODS 
Bacterial strains and Cell culture.  F. tularensis LVS (Table 6.1) was propagated on 
chocolate agar (25 g BHI l-1, 50 µg hemoglobin ml-1, 1.5 g agarose l-1) supplemented with 
1% (v/v) IsoVitaleX (Becton-Dickson), BHI broth (35 g BHI l-1, 1% (v/v) IsoVitalex), or 
Chamberlains defined media (Chamberlain, 1965) .  All bacterial strains cultured on 
chocolate agar were grown at 37 °C.  Broth cultures were incubated in a shaking water bath 
at 37 ºC.   J774A.1 (ATCC TIB-67) reticulum cell sarcoma mouse macrophage-like cells 
were cultured in DMEM plus 4 mM L-glutamine, 4500 mg glucose l-1, 1 mM sodium 
pyruvate, 1500 mg sodium bicarbonate l-1, and 10% (v/v) FBS at 37 ºC and 5% CO2 
atmosphere. 
 
Reverse Transcriptase PCR.  Total RNA was isolated from mid exponential phase cultures 
using a mirVana RNA isolation kit (Ambion).  DNA was removed by incubation with RQ1 
DNase (Promega) for 1 hour at 37 °C.  First strand cDNA was generated using SuperScript 
III Reverse transcriptase (Invitrogen) and random primers.  cDNA was quantified using a 
ND-1000 spectrophotometer (Nanodrop).  PCR analysis of ripA and tul4 expression was 
accomplished using 20 ng cDNA per 50 µl PCR reaction.  As a control for DNA 
contamination, a Reverse transcriptase reaction was conducted without the Reverse 
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transcriptase enzyme.  Ten percent of each reaction was analyzed by agarose gel 
electrophoresis, ethidium bromide staining, and densitometry using BioRad Quantity One 
software.  Trace intensity (Int mm) of ripA was normalized to the mean tul4 expression 
(Charity et al., 2007).  Mean normalized expression and standard deviation were calculated 
on four independent samples.  Significance was determined using an unpaired two tailed t 
test with unequal variance. 
 
Agarose Formaldehyde Electrophoresis and Northern Analysis.  Total RNA was 
harvested from mid exponential phase F. tularensis LVS grown in Chamberlains defined 
media using RNAeasy columns (Qiagen), concentrated using ethanol/sodium acetate 
precipitation and quantified with a ND-1000 spectrophotometer (Nanodrop).  RNA was 
separated using agarose-formaldehyde (2% agarose, 2.2 M Formaldehyde) electrophoresis 
followed by capillary transfer to nitrocellulose as described (Rueger et al., 1997).    
Additional lanes of the membrane containing duplicate samples were stained with methylene 
blue to assess rRNA bands for degradation and equality of loading.  Digoxigenin labeled 
RNA probes were generated using a Northern Starter Kit (Roche).  Probe generation, 
hybridization, washing, and detection were performed using the manufacturer’s (Roche) 
protocols. 
 
Plasmids and Molecular techniques.  Specific F. tularensis LVS DNA fragments were 
produced by PCR amplification of genomic DNA using Pfu turbo DNA polymerase 
(Stratagene).  Francisella translational lacZ fusions were generated by ligating a KpnI/EcoRV 
fragment containing a native RBS and translational start site into KpnI/SmaI digested pBSK 
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lacZ cat (Table 6.1). Francisella transcriptional lacZ fusions were generated by ligating a 
NotI/PacI fragment to NotI/PacI digested pBSK lacZ aphA1 (Table 6.1) containing the lacZ 
RBS and translational start site.  The pBSK lacZ fusion clones that lack a Francisella origin 
of replication were used as co-integration vectors to generate single copy expression strains 
of Francisella.  This allowed the subsequent use of Francisella shuttle vectors in these 
strains.  The cat and aphA1 alleles were expressed by a Francisella promoter derived from 
the groEL gene. Francisella multicopy lacZ vectors were created by transferring the fusion 
constructs to the Francisella shuttle vector pKK MCS (Table 6.1).  All Francisella 
transformations were performed as described (LoVullo et al., 2006). 
 
Intracellular β-galactosidase Assay.  To determine the activity of Francisella promoter 
lacZ fusions in the intracellular environment, intracellular invasion and replication assays 
were conducted by adding F. tularensis LVS strains cultured to mid exponential phase in 
BHI to J774A.1 monolayers at a multiplicity of infection (MOI) of 100 in 200 µl tissue 
culture media.  Assays were synchronized as described (Checroun et al., 2006; Craven et al., 
2008). At 15 minutes post inoculation, monolayers were washed 3 times with pre-warmed 
tissue culture media to remove extracellular bacteria.   At 1, 6, and 24 hours post inoculation 
samples were washed with PBS and scraped into 200 µl PBS.  CFU present in each sample 
were determined by serial dilutions and plating on Chocolate agar.  100 µl of each sample 
was lysed in 2x lysis buffer (1% NP40, 0.5 M Tris pH 7.4, 5 mM EDTA) and assayed for β-
galactosidase activity using the substrate Chlorophenol red-ß-D-galactopyranoside (CPRG).  
Twenty µl of each sample was mixed with 130 µl of CPRG buffer (2 mM CPRG, 25 mM 
MOPS pH 7.5, 100 mM NaCl, 10 mM MgCl2, 50 mM β -mercaptoethanol) and incubated at 
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37 ºC until visible color developed.  Enzymatic activity was stopped by adding 80 µl of 0.5 
M Sodium carbonate and measured by absorbance at OD580.  Background β-galactosidase 
activity was determined at each time point using duplicate samples of J774A.1 cells infected 
with wild type F. tularensis LVS.  Mean background activity was subtracted from each 
sample before calculating relative activity.  Relative β-galactosidase activity was calculated 
by normalizing OD580 readings with time of development, dilution of sample, and CFU 
recovered per sample.  Data are presented as activity per 1010 bacteria which results in an 
activity range similar to Miller units. All assays were performed using four wells of infected 
cells from a 24 well tissue culture plate per time point.  Inoculum activities were determined 
using the same techniques before addition to cell culture in replicates of four. 
Relative activity = 1010 * OD580 * (Dilution * ∆T * CFU) -1 
Statistical analysis was as applied to the mean activity and standard deviation of four 
independent samples.  Significance was calculated using an unpaired two tailed t test 
assuming unequal variance.  P values of less than 0.05 were considered significant.  
 
Mutagenesis and Allelic Exchange.  A Φ(ripA’-TC) fusion was made by Splice Overlap 
Extension (SOE) PCR (Horton et al., 1989) using primers designed to insert the tetracysteine 
(TC) tag sequence with a glycine linker between the last ripA codon and the stop codon (Fig. 
6.3b).  Deletion constructs were made by SOE PCR designed to keep the start and stop 
codons of mglA (fusion of first four and last two codons) and sspA (fusion of first four and 
last four codons) in frame with 0.8 kb of flanking sequence.  The constructs were cloned into 
pMP590 (Table 6.1) and sequenced to confirm the integrity of the flanking DNA sequence. 
Allelic exchange was achieved by transformation, selection for plasmid co-integrates, 
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counter selection on sucrose containing media and screening via PCR for replacement of the 
wild type allele with the deletion mutant allele as described (LoVullo et al., 2006).  Each 
mutation was confirmed by DNA sequencing.  Site directed mutagenesis was performed 
using the Stratagene QuickChange XL kit and the manufacturers protocols.  DNA 
sequencing was used to confirm all ripA promoter mutations.  
 
Extracellular β-galactosidase Assay.  Overnight cultures of lacZ reporter strains were 
diluted 1:10 in Chamberlains defined media and cultured until mid exponential phase (0.2-
0.8 OD600).   β-galactosidase activity was measured as OD420 using the substrate ONPG 
(Sigma) as described elsewhere (Miller, 1972).   Relative promoter activity was normalized 
using OD600 of culture, time of development, and cell to buffer ratio (CBR).   
Miller Units = 1000 * OD420 * (∆T * CBR * OD600) -1 
 Statistical analysis was performed to determine the mean Miller units and standard 
deviation of replicates of three independent samples and significance calculated using an 
unpaired two tailed t test with unequal variance. 
 
SDS-PAGE and FlAsH™ labeling.  Proteins were separated by SDS-PAGE.  Total protein 
loaded in each sample was equivalent as determined by a BCA assay (Pierce).  FlAsH™ 
labeling was accomplished using the manufactor’s protocols (Invitrogen).  In gel 
fluorescence of the arsenical fluoriscein and total protein stain was conducted on a Typhoon 
9200 laser scanner (488 nm laser/ 520 nm BP 40 filter and 633 nm laser/ 670 nm BP 30 
filter).  Densitometry was conducted using ImageQuant XL software and sample 
comparisons made using the same gel and scan.  Mean intensity and standard deviation of 
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four independent samples was calculated and significance determined using an unpaired two 
tailed t test with unequal variance. 
 
RESULTS 
Analysis of the ripA transcript.    The Francisella tularensis LVS ripA gene is required for 
intracellular replication and virulence in a mouse model of tularemia (Fuller et al., 2008).   
The ripA gene is preceded by two other genes, FTL_1912 and FTL_1913, that are predicted 
to be transcribed in the same orientation, and thus the ripA locus may be a part of a three 
gene operon. A Rho independent terminator is predicted to exist between FTL_1912 and 
FTL_1913, but not between FTL_1913 and ripA. Results from an analysis of this locus with 
the operon prediction tool FGENESB (www.softberry.com) were inconclusive.  Thus, we 
analyzed F. tularensis LVS ripA transcripts by RT PCR and Northern blot. 
  One set of primers was designed to amplify coding regions from each of the 3 genes, 
and another set was designed to amplify RNA that bridged adjacent genes (Fig. 6.1a).  20 ng 
of synthesized first strand cDNA was subjected to 25 or 30 cycles of amplification to 
synthesize intra-genic and potential gene bridging products, respectively. There was no 
detectible product following amplification with primers bridging FTL_1912 and FTL_1913 
(Fig. 6.1b), suggesting that the predicted Rho independent terminator is functional.  A faint 
amplicon was present in reactions using FTL_1913 – ripA bridging primers (Fig. 6.1b).  
However, the band intensity was significantly lower than that of the ripA intra-genic 
amplicon and was detectable only after the additional cycles of amplification.  This result 
suggests that FTL_1913 transcription terminates, albeit less efficiently than FTL_1912, and 
that ripA expression was initiated by a promoter independent of FTL_1913 expression.   
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Northern analysis of total RNA harvested from mid exponential phase F. tularensis 
LVS and F. tularensis LVS ripA::Tn5 (Table 6.1) was used to evaluate the size of ripA 
containing transcripts.  The ripA coding sequence is 537 nucleotides, and an approximately 
600 nucleotide RNA fragment hybridized to an anti-sense ripA probe confirming that the 
ripA gene was transcribed (Fig. 6.1c). No ripA message was detected in the F. tularensis 
LVS ripA::Tn5 RNA samples.   
 
Construction and characterization of Francisella Φ(ripA’-lacZ) transcriptional 
and translational fusions.  Transcriptional Φ(ripA’-lacZ)2 and translational Φ(ripA’-lacZ)1 
fusions were constructed to facilitate studies on ripA expression (Table 6.1).  The sequence 
5’ of ripA was analyzed using BPROM (www.softberry.com) to identify potential promoters.  
Φ(ripA’-lacZ)1 was by constructed by amplifying and cloning the ripA ATG start codon and 
1 kB of preceding sequence in frame with the Escherichia coli lacZ gene (AAA24053) in a 
pBSK lacZ cat vector.  Φ(ripA’-lacZ)2 lacks the ripA ATG and preceding 6 bp of 
untranslated sequence but includes the E. coli lacZ initiation codon and ribosome binding site 
in a pBSK lacZ aphA1 vector (Fig. 6.2a).  Each construct was sequenced to ensure that no 
mutations were introduced. The Φ(ripA’-lacZ)1 cat and Φ(ripA’-lacZ)2 aphA1 regions were 
cloned into the Francisella shuttle vector pKK MCS to produce multicopy reporter vectors. 
 The pBSK Φ(ripA’-lacZ) clones (Table 6.1), which cannot replicate in Francisella, 
were used to create single copy reporters by co-integration into the chromosome.  Use of 
integrated reporters facilitated the use of Francisella shuttle vectors in analyses.  Mid 
exponential phase cultures grown in Chamberlains defined media were assayed for β-
galactosidase activity (Miller, 1972).  Activity was recorded as mean Miller units ± standard 
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deviation of three replicates.  Background β-galactosidase activity in Francisella tularensis 
LVS was less than 1 Miller unit (Data not shown). 
  The LVS Φ(ripA’-lacZ)1 and LVS pKK Φ(ripA’-lacZ)1 reporter strains expressed 
17.4 ± 0.43 and 163.6 ± 3.91 Miller units, respectively, whereas the LVS Φ(ripA’-lacZ)2 and 
LVS pKK Φ(ripA’-lacZ)2 reporter strains expressed 2823 ± 75.9 and 7887 ± 43.0 Miller 
units, respectively (Fig. 6.2b).  To validate that lacZ expression accurately reflected ripA 
promoter activity we measured the impact of mutations in the predicted -10 promoter region, 
the RBS, and a frameshift mutation in pKK Φ(ripA’-lacZ)1 (Fig. 6.2a).  In the -10 box 
mutant the TAGCATTAT sequence was replaced by TAGCCTTAC (pKK Φ(ripA’-lacZ)1a).   
The predicted RBS AGGA was mutated to ACCA (pKK Φ(ripA’-lacZ)1b).   The frameshift 
mutation consisted of a one base deletion in the fourth codon in pKK Φ(ripA’-lacZ)1c.  β-
galactosidase assays were performed on strains containing these constructs in multi-copy.  
The ripA promoter mutations decreased β-galactosidase activity to 67.4% (-10 box), 12.7% 
(RBS), and 0.4% (frameshift) of the parent reporter (Fig. 6.2c).  Thus, the predicted ripA 
promoter and ripA RBS are responsible for lacZ expression in the reporter strains.  
 
Quantification of RipA protein. Attempts to quantify RipA protein concentrations in 
Francisella were complicated by the fact that antisera that we generated produced  high 
background in Western blots and ELISA (Fuller et al., 2008).  We therefore generated an 
expression construct Φ(ripA’-TC) fusing a tetracysteine (TC) tag to the C-terminal end of 
RipA to facilitate the use of FlAsH™ (Invitrogen) reagents to directly measure RipA protein 
concentrations. 
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 SOE PCR was used to fuse a TC tag with a glycine linker to the C terminus of RipA 
(GGCCPGCCGGG) while maintaining native Francisella flanking DNA sequence (Fig. 
6.3b).  The TC tag was codon optimized using F. tularensis codon usage tables 
(http://www.kazusa.or.jp/codon/cgi-bin/showcodon.cgi?species=119857).  Φ(ripA’-TC) was 
cloned into pMP590 for allelic exchange and pKK MCS for multi-copy expression in 
Francisella.  
  Whole cell lysates prepared from mid exponential phase bacteria growing in 
Chamberlains defined media were suspended in FlAsH™ loading buffer containing 
biarsenical fluorescein and subjected to SDS-PAGE.  The RipA-TC fusion protein was 
detected and quantified by relative mean fluorescence with wild type F. tularensis LVS 
lacking any TC fusion protein serving as a control to determine background fluorescence.  To 
determine the limit of detection of LVS Φ(ripA’-TC) and LVS pKK Φ(ripA’-TC) (Table 6.1), 
labeled whole cell lysates (6000 ng to 60 ng total protein) were separated using SDS-PAGE 
and in - gel fluorescence measured.  Three nonspecific biarsenical fluorescein binding 
proteins were detected between 22 kDa and 30 kDa in size in wild type F. tularensis LVS; 
however, these were easily distinguishable from RipA-TC which migrated at approximately 
18 kDa (Fig. 6.3c).  RipA-TC expressed from multi-copy plasmid was detectable in 60ng of 
whole cell lysates while single copy was detected in 600 ng (Fig. 6.3c).  The concentration of 
RipA-TC (multi-copy) was approximately 6.5 fold greater than RipA-TC (single copy). 
Thus, the use of the RipA-TC fusion in conjunction with biarsenical labeling provided a 
sensitive and reproducible method to detect and quantify RipA in Francisella.  
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Expression of ripA is pH sensitive.  In separate studies designed to determine the function 
of RipA we found that ∆ripA mutants were sensitive to increasing pH (data not shown).  We 
therefore used Φ(ripA’-lacZ) strains to examine the effects of pH on ripA expression.    β-
galactosidase levels from mid exponential phase F. tularensis LVS Φ(ripA’-lacZ) reporter 
strains grown in Chamberlains defined media at pH 5.5 and pH 7.5 were measured.  The 
LVS pKK Φ(ripA’-lacZ)1 reporter strain expressed 125 ± 3 and 223 ± 2 Miller units at pH 
5.5 and 7.5, respectively (Fig. 6.4a) representing a 1.8 fold difference ( P < 0.001).    The 
LVS Φ(ripA’-lacZ)2 reporter strain expressed 2618 ± 121 and 3419 ± 71 Miller units at pH 
5.5 and 7.5, respectively (Fig. 6.4b) representing a 1.3 fold difference (P = 0.0016).    
 RT-PCR and FlAsH™ labeling of RipA-TC were used as complementary assays to 
evaluate the pH effects on ripA transcription and protein concentration revealed by the 
Φ(ripA’-lacZ) expression results.  RT-PCR of ripA was conducted in replicates of four 
independent cultures and normalized using tul4 expression (Lauriano et al., 2004).  Primers 
internal to ripA and tul4 were designed with matched melting temperatures and amplicon 
sizes.  Total RNA was collected from F. tularensis LVS to compare ripA transcript levels at 
mid exponential growth in Chamberlains Defined media at pH 5.5 and pH 7.5.  cDNA was 
generated from the RNA samples using random primers in a reverse transcriptase reaction.  
Samples lacking reverse transcriptase negative were used to monitor DNA contamination.  
Quantitation of ripA expression was achieved by densitometry of gene-specific products 
isolated by agarose electrophoresis.  Mean normalized expression of ripA ± standard 
deviation at pH 5.5 was 1.527 ± 0.1656 and 2.448 ± 0.2934 at pH 7.5 (Fig. 6.4c) representing 
a 1.6 fold expression differential (P = 0.0033).  This result was consistent with the 1.3 fold 
difference in expression exhibited by the Φ(ripA’-lacZ)2 transcriptional fusion strain. 
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  The concentration of RipA protein present at pH 5.5 and pH 7.5 were measured by 
FlAsH™ labeling RipA-TC in LVS Φ(ripA’-TC)  whole cell lysates (Table 6.1).   Six µg of 
total protein was incubated with TC specific FlAsH™ reagents, separated by SDS-PAGE and 
subjected to in-gel fluorescence.  Mean intensity of RipA-TC ± standard deviation of four 
independent samples at pH 5.5 was 1.083x107 ±  6.340x105 arbitrary units as compared to 
1.551x107 ± 8.734 x 105 arbitrary units at pH 7.5 (Fig. 6.4d), representing a 1.43 fold change 
in expression (P = 0.00031) as compared to the 1.8 fold difference expressed by the Φ(ripA’-
lacZ)1 translational fusion.  
  
F. tularensis LVS ripA expression is suppressed during intracellular growth.  In a 
previous study we found that an F. tularensis LVS ∆ripA mutant entered host cells and 
escaped from the phagosome, but failed to replicate upon release to the cytoplasm (Fuller et 
al., 2008).  Since ripA expression is required for late, but not early stages of host cell 
interaction, we hypothesized that ripA may be differentially regulated during intracellular 
growth.  To test this hypothesis, we measured β-galactosidase produced by F. tularensis 
Φ(ripA’-lacZ)2 at different stages of intracellular growth in J774A.1 macrophage-like cells.  
Expression of iglA, a gene located on the pathogenicity island, is induced upon entry into 
host cells (de Bruin et al., 2007). We therefore constructed a strain expressing an Φ(iglA’-
lacZ) transcriptional fusion (Table 6.1) for use as a control in these experiments.  Host cell 
entry was synchronized by centrifugation of reporter strains onto chilled J774A.1 monolayers 
as described (Craven et al., 2008) and LacZ activity was measured in the inocula, and at 1, 6, 
and 24 hours post inoculation using a modified β-galactosidase assay based on the rate and 
amount of chlorophenol red-ß-D-galactopyranoside (CPRG ) conversion per CFU. 
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 The mean activity (± standard deviation) of β-galactosidase produced by LVS 
Φ(ripA’-lacZ)2 at 1 , 6, and 24 hours was 155.9 (± 12.96), 193.5 (±  23.99), and 80.6 (± 
17.83) units, respectively (Fig. 6.5a).  The activity of the inoculum was 199.7 (± 13.32) units.  
Each data point was significantly different from all others (P < 0.05).  The most significant 
change in intracellular ripA expression was at 24 hours post inoculation as compared to the 
inoculum.  By this time, Φ(ripA’-lacZ)2 expression was approximately two fold lower than 
the expression at all previous time points. 
The mean (± standard deviation) β-galactosidase activity of LVS Φ(iglA’-lacZ) at 1, 
6, and 24 hours was 97.8 (± 9.59), 199.4(±  26.24), and 112.0 (± 24.21) (Fig. 6.5b).  The 
activity of the inoculum was 135.0 (± 9.59).  The 6 hours activity was significantly higher 
than both the 1 hour and 24 hours time points (P < 0.01).  This result is in accordance with 
the published data on intracellular IglA expression (de Bruin et al., 2007).  Both Φ(ripA’-
lacZ)2 and Φ(iglA’-lacZ) were marginally, but significantly (P < 0.05), down at 1 hour post 
inoculation as compared to the inoculums.    
      
The transcriptional regulators mglA and sspA decrease Φ(ripA’-lacZ)2 expression.  
MglA and SspA are transcriptional regulators that associate with DNA and RNA-polymerase 
and modulate the expression of a number of stress response and virulence associated genes in 
F. tularensis (Brotcke et al., 2006; Charity et al., 2007; Guina et al., 2007; Lauriano et al., 
2004).  In a recent study comparing protein expression profiles of wild type and mglA mutant 
strains, the concentration of IglA was decreased and RipA increased in an mglA mutant 
compared to wild type (Guina et al., 2007).  We investigated further the relationship between 
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the regulators MglA and SspA, and RipA expression using the Φ(ripA’-lacZ)2 and Φ(iglA’-
lacZ) transcriptional fusions in ∆mglA and ∆sspA mutants (Table 6.1). 
 β-galactosidase assays were conducted on mid exponential phase reporter strains 
grown in Chamberlains defined media.  The mean expression of ripA was nearly two-fold 
higher in the ∆mglA (4091 ± 75) and ∆sspA (4602 ± 52) strains as compared to wild type 
(2549 ± 128) (Fig. 6.5a).  Wild type levels of expression were restored by the wild type 
alleles in the complemented mutant strains (Fig. 6.5a).  The differences of ripA expression in 
the mutant backgrounds were all significantly different from wild type (P < 0.01).   
The mglA and sspA deletions had the opposite effect on iglA expression.  The mean 
expression (± standard deviation) of LVS Φ(iglA’-lacZ) was 2757 (+ 98) Miller units, but 
only 80 (+ 2.2) and 67 (+ 0.9) Miller units in ∆mglA and ∆sspA strains, respectively (Fig 
6.6b).  The differences of iglA expression in the mutant backgrounds were all significantly 
different from wild type (P < 0.01), and near wild type levels of expression were restored by 
complementation with mglA and sspA in trans (Fig. 6.6b).  Together, these results confirm 
that mglA and sspA expression positively influence iglA expression, and conversely 
demonstrate that these two regulators negatively influence ripA expression. 
 
DISCUSSION 
As a facultative intracellular pathogen F. tularensis is able to survive and replicate 
within several different types of eukaryotic cells as well as in a number of extracellular 
environments (Abd et al., 2003; Bosio & Dow, 2005; Craven et al., 2008; Forestal et al., 
2007; Hall et al., 2006; Kobayasi, 1960; Thorpe & Marcus, 1964).  Organisms similarly 
capable of adapting to multiple environments such as Salmonella typhimurium (Chen et al., 
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1996), Legionella pneumophila (Bruggemann et al., 2006), and Listeria moncytogenes 
(Chatterjee et al., 2006; Moors et al., 1999) exhibit differential gene expression in response 
to entering or exiting host cells and even as they transition between intra-vacuolar and 
cytoplasmic niches.  These studies have helped identify bacterial products that function 
specifically in adaptation to, and manipulation of the host cell environment.   
   Studies on intracellular gene expression by Francisella species revealed a number 
of genes including iglC (Golovliov et al., 1997), iglA (de Bruin et al., 2007) and mglA (Baron 
& Nano, 1999), that are induced upon entry and growth in macrophages.  IglC protein 
concentrations increase between 6 hours and 24 hours post host cell invasion (Golovliov et 
al., 1997).  Similarly IglA protein concentrations increase between 8 hours and 12 hours post 
invasion as measured by Western blot (de Bruin et al., 2007), and in this study we found that 
iglA expression was induced during intracellular growth, but not immediately after host cell 
invasion. 
 MglA is a transcriptional regulator (Baron & Nano, 1998; Charity et al., 2007).  
Transcription of the mglA gene is induced in macrophages as early as 1 to 4 hours post 
invasion (Baron & Nano, 1999).  Results from microarray and proteomic (Brotcke et al., 
2006; Charity et al., 2007; Guina et al., 2007; Lauriano et al., 2004) analyses demonstrate 
that IglC and IglA expression are regulated by MglA.  After entry into the host cell, 
Francisella is transiently associated with a membrane bound phagosome, but within 2 hours 
post invasion greater than 90% of internal bacteria are free in the cytoplasm (Checroun et al., 
2006; Craven et al., 2008; Golovliov et al., 2003). Coupled with the kinetics of gene 
expression changes, there is a strong correlation between MglA regulated genes and 
adaptation to the cytoplasmic environment.    
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   The ripA gene was not identified as being regulated by MglA or SspA in 
transcriptional profiling studies of mglA and sspA mutant strains by microarray (Charity et 
al., 2007).   However, in complementary proteomic studies RipA (FTN_0157) is present in 
two fold higher amounts in an mglA mutant strain as compared to wild type F. novicida in 
mid exponential phase bacteria cultured in rich media (Guina et al., 2007).  This result 
suggested that MglA has a repressive effect, directly or indirectly, on RipA expression.  We 
tested this hypothesis using Φ(ripA’-lacZ) reporters and found that ripA expression was 
increased significantly in both ∆mglA and ∆sspA mutants.  Thus, results using the Φ(ripA’-
lacZ) reporters correlated with proteomics analysis of MglA regulation and not with 
published microarray – based results.  This may be due at least in part to the relative 
magnitude of the MglA and SspA effects on ripA expression.   
We found that F. tularensis ripA and  iglA gene expression changes during the first 24 
hours of growth in the intramacrophage environment progressing from vacuolar, to early 
cytoplasmic, and then late cytoplasmic stages of infection.  MglA, which is involved in the 
regulation of a number of genes that function in intracellular growth, had opposing effects on 
iglA and ripA expression exerting positive and negative effects, respectively. On the surface 
this appears to present a paradox with respect to ripA expression patterns and the requirement 
of ripA for intracellular growth and survival. However, it is important to note that under no 
condition or circumstance tested was ripA completely repressed.  Genes required for 
Francisella virulence may be either promoted or suppressed by MglA.  This suggests that the 
intracellular regulation of MglA causes a temporal compartmentalization of gene expression 
with different patterns of up or down regulation during the different phases of the Francisella 
intracellular lifecycle.   Further work on the transcriptomes and proteomes during these 
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phases of the F. tularensis intracellular lifestyle may give insight into the programmed 
response of gene expression that makes F. tularensis such a successful pathogen in the host 
intracellular environment.   
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TABLES AND FIGURES 
 
Table 6.1. Bacterial strains and plasmids. 
Strains or Plasmid Description Source or Reference
Bacteria   
Francisella tularensis   
LVS F. tularensis live vaccine strain CDC, Atlanta, GA 
LVS ripA::Tn5 Tn5 ripA transposon mutant (Fuller et al., 2008) 
LVSΦ(ripA’-lacZ)1 BSK Φ(ripA’-lacZ)1 cat cointegrate This work 
LVS Φ(ripA’-lacZ)2 BSK Φ(ripA’-lacZ)2 aphA1cointegrate This work 
LVS Φ(iglA’-lacZ) BSK Φ(iglA’-lacZ)1 aphA1cointegrate This work 
LVS Φ(ripA’-TC) Replacement of ripA with Φ(ripA’-TC) This work 
LVS ∆mglA Inframe deletion of mglA This work 
LVS ∆mglA Φ(ripA’-lacZ)2 BSK Φ(ripA’-lacZ)2 aphA1cointegrate This work 
LVS ∆mglA Φ(iglA’-lacZ) BSK Φ(iglA’-lacZ)1 aphA1cointegrate This work 
LVS ∆sspA Inframe deletion of sspA This work 
LVS ∆sspA Φ(ripA’-lacZ)2 BSK Φ(ripA’-lacZ)2 aphA1cointegrate This work 
LVS ∆sspA Φ(iglA’-lacZ) BSK Φ(iglA’-lacZ)1 aphA1cointegrate This work 
LVS ∆mglA ∆sspA Inframe deletion of sspA and mglA This work 
LVS ∆mglA ∆sspA Φ(ripA’-lacZ)2 BSK Φ(ripA’-lacZ)2 aphA1cointegrate This work 
LVS ∆mglA ∆sspA Φ(iglA’-lacZ) BSK Φ(iglA’-lacZ)1 aphA1cointegrate This work 
Plasmids   
pBSK bla lacZ pBluescript cloning vector Stratagene 
pBSK lacZ aphA1 bla AmpR, Francisella KmR, lacZ reporter This work 
pBSK lacZ cat bla AmpR, Francisella CmR, lacZ reporter This work 
pBSK Φ(ripA’-lacZ)2 aphA1 bla Francisella KmR, Transcriptional fusion This work 
pBSK Φ(ripA’-lacZ)1 cat Francisella CmR, Translational fusion This work 
pBSK Φ(iglA’-lacZ)2 aphA1 Francisella KmR, Transcriptional fusion This work 
pMP590 KmR, sacB Francisella suicide vector (LoVullo et al., 2006) 
pMP590 ∆mglA mglA allelic exchange vector This work 
pMP590 ∆sspA sspA allelic exchange vector This work 
pMP590 Φ(ripA’-TC) Φ(ripA’-TC) allelic exchange vector This work 
pMP633 HygR, E. coli–F. tularensis shuttle vector (LoVullo et al., 2006) 
pMP633 mglA+ mglA+ allele with native promoter This work 
pMP633 sspA+ sspA+ allele with native promoter This work 
pKK MCS KmR, E. coli–F. tularensis shuttle vector (Fuller et al., 2008) 
pKK MCS Φ(ripA’-lacZ)1 KmR,translational fusion of ripA and lacZ This work 
pKK MCS Φ(ripA’-lacZ)1a KmR,Φ(ripA’-lacZ)1, -10 mutation This work 
pKK MCS Φ(ripA’-lacZ)1b KmR,Φ(ripA’-lacZ)1, RBS mutation This work 
pKK MCS Φ(ripA’-lacZ)1c KmR,Φ(ripA’-lacZ)1, lacZ frameshift This work 
pKK MCS Φ(ripA’-lacZ)2 KmR,transcriptional fusion This work 
pKK MCS Φ(ripA’-TC) Φ(ripA’-TC), CT tetracysteine tag fusion This work 
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Figure 6.1.  (a) Graphical representation of the ripA region. Primers utilized for RT-PCR are 
marked with arrows while the region complementary to the RNA probe used in the Northern 
analysis is demarcated by a solid line.  (b)  RT-PCR analysis of the expression of genes 
FTL_1912 (F14-R14), FTL_1913 (F13-R13), and ripA (F14-R14) shown in the upper image.  
Analysis for transcripts bridging FTL_1912 to FTL_1913 (F12-R13) and FTL_1913 to ripA 
(F13-R14) shown in lower image.  PCR of cDNA demarcated by a (+) and reverse 
transcriptase negative reactions to assess DNA contamination marked as (-).  (c) Northern 
analysis to determine the transcript size of ripA containing RNA.  Roche digoxigenin labeled 
RNA ladder is present in the left most lane followed by total RNA from F. tularensis LVS 
(wt) and F. tularensis LVS ripA:: Tn5.  This analysis used a ripA complementary 
digoxigenin labeled RNA probe demonstrating the presence of monocistonic ripA transcript 
in LVS and the absence of the transcript in F. tularensis LVS ripA::Tn5. 
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Figure 6.2. (a) Multiple sequence alignment of translational and transcriptional Φ(ripA’-
lacZ) fusions.  Predicted -10 and RBS sequences are boxed with introduced mutations in 
each highlighted.  (b)  β-galactosidase activity of single and multi-copy translational and 
transcriptional F. tularensis LVS Φ(ripA’-lacZ) reporter strains displayed as mean Miller 
units.  Error bars represent standard deviation of three independent samples.  (c) β-
galactosidase activity of F. tularensis LVS multi-copy translational Φ(ripA’-lacZ)1 promoter 
mutations displayed as mean Miller units.  Error bars represent standard deviation of three 
independent samples.   
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Figure 6.3.  (a)  Graphical depiction of F. tularensis LVS ripA locus showing the location of 
SOE PCR primers used to insert the C terminal TC tag.  (b) Nucleotide and amino acid 
sequence of the C terminal TC tag showing the overlapping sequence of the SOE PCR 
primers.  (c) In gel fluorescence of RipA-TC (black arrow) from dilution series of F. 
tularensis LVS (multi-copy) pKK Φ(ripA’-TC) and F. tularensis LVS (single copy) Φ(ripA’-
TC) using 6000 ng to 60 ng total protein of whole cell lysates.  F. tularensis LVS lysates (wt) 
used as a non TC tagged control displaying three non specific bands (gray arrows) at a higher 
molecular weight than RipA-TC. 
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Figure 6.4.  Effect of pH on F. tularensis LVS ripA expression.  All experiments were 
performed using mid exponential phase bacteria cultured in Chamberlains defined media at 
pH 5.5 or pH 7.5.  Data are presented as mean values with error bars representing one SD.  
(a) β-galactosidase activity of F. tularensis LVS pKK Φ(ripA’-lacZ)1 at pH 5.5 and pH 7.5.  
Difference in expression levels were significant (P < 0.01). (b) β-galactosidase activity of F. 
tularensis LVS Φ(ripA’-lacZ)2 at pH 5.5 and pH 7.5. Difference in expression levels were 
significant (P < 0.01). (c) F. tularensis LVS ripA RNA concentrations displayed as tul4 
normalized mean trace (Int mm) on four independent RT-PCR reactions using purified total 
RNA samples of mid exponential F. tularensis LVS cultured at pH 5.5 and pH 7.5.  
Difference in expression levels were significant (P < 0.01). (d)  RipA-TC concentration in 
whole cell lysates of mid exponential phase F. tularensis LVS Φ(ripA’-TC) cultured at pH 
5.5 and pH 7.5.  Concentrations were measured using densitometry of the specific in-gel 
fluorescence of FlAsH™ labeled RipA-TC. Four independent samples were used to calculate 
mean expression.  Difference in expression was significant (P < 0.01). 
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Figure 6.5.  Intracellular expression of LVS Φ(ripA’-lacZ)2 (a) and LVS Φ(iglA’-lacZ) (b) 
in J774A.1 mouse macrophage like cells infected at an MOI of 100.  All assays were 
performed on four independent samples and reported as mean activity ± standard deviation.  
Activities were calculated from four samples taken before application of the inoculums.  
Mean β-galactosidase activity is normalized by time of development and CFU per well 
minus the activity from the control samples.  All differences in expression were significant (P 
< 0.05) with the exception of comparisons between Φ(ripA’-lacZ)2 inoculum to 6h, and 
Φ(iglA’-lacZ) 1h to 24h. 
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Figure 6.6.  MglA and SspA effects on ripA and iglA expression.  Mid exponential phase 
cultures of the indicated transcriptional lacZ reporter strains cultured in Chamberlains 
defined media were assayed for β-galactosidase activity in replicates of three and reported as 
mean Miller units ± standard deviation. (a) F. tularensis LVS Φ(ripA’-lacZ)2 expression in 
wild type (wt), ∆mglA, ∆sspA, and ∆mglA∆sspA backgrounds.  In trans complementation 
(pmglA and psspA) was accomplished using wild type alleles and native promoters cloned 
into pMP633.  F. tularensis LVS pMP633 was used as the vector only control (vector).  (b) 
F. tularensis LVS Φ(iglA’-lacZ) expression in wild type (wt), ∆mglA, ∆sspA, and 
∆mglA∆sspA backgrounds. 
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ABSTRACT 
 
 Expression of the Francisella virulence factor RipA changes through the course of 
intracellular growth.  We screened a transposon mutant library to identify potential regulators 
of ripA.  Insertions in FTL_0439 and FTL_0073 which are predicted to encode two putative 
envelope proteins of unknown function resulted in a 3.95 fold increase and 0.63 fold decrease 
in ripA expression respectively.  Insertions in two known regulatory loci, hupB and nusA, 
resulted in 0.68 and 0.17 fold decreases in ripA expression respectively.  HU form B is 
encoded by hupB and is a DNA binding protein, whereas NusA regulates termination and 
anti-termination by Rho.  The nusA::Tn5 mutant was not complemented by the wild type 
allele.  However, expression of nusA in the wild type background resulted in decreased ripA 
expression.  We concluded that the change in ripA expression was due to polar effects on the 
downstream infB locus and possible autoregulation by NusA on nusA-infB expression.  
∆hupB and ∆FTL_0073 mutants were constructed and analyzed for their effects on ripA 
expression.  The ∆hupB mutation resulted in a 0.40 fold decrease in ripA expression that was 
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partially restored by the wild type allele in trans.  The ∆FTL_0073 mutation resulted in a 
2.45 fold increase in ripA expression that was restored by the wild type allele in trans. 
 
INTRODUCTION 
Research on the regulation of virulence factors in Francisella tularensis has focused 
almost exclusively on the transcriptional factors MglA and SspA (Barker & Klose, 2007; 
Baron & Nano, 1998; Charity et al., 2007; Guina et al., 2007; Lauriano et al., 2004).  MglA 
and SspA bind cooperatively to RNA polymerase to positively regulate the transcription of 
many F. tularensis genes required for intracellular replication (Charity et al., 2007).  MglA is 
necessary for intracellular replication and is induced after cell invasion (Baron & Nano, 
1999).  RipA is a cytoplasmic membrane protein in F. tularensis that is required for 
intracellular replication and virulence in a mouse model of tularemia (Fuller et al., 2008a).  
RipA expression is repressed after cell invasion (Chapter 6).  This seeming paradox of 
intracellular repression of a protein required for intracellular replication is mitigated by the 
fact that RipA expression is only lowered, not completely absent at this stage of infection 
(Chapter 6). A remaining question is how MglA, described as a positive regulator of 
transcription, acts to repress gene expression.  We hypothesize that MglA acts indirectly 
through other loci to negatively impact ripA expression.  To test this hypothesis, we 
constructed and screened a transposon mutant library for mutations that effected ripA 
expression. 
 
MATERIALS AND METHODS 
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Bacterial strains and Cell culture.  Escherichia coli TOP10 cells were used for propagating 
clones.  E. coli cultures were grown in Luria’s broth at 37 °C with shaking.  Francisella 
tularensis Live Vaccine Strain (LVS) was obtained from the Centers for Disease Control and 
Prevention, Atlanta, Ga. F. tularensis LVS was propagated on chocolate agar (25g/l BHI, 
50µg/ml hemoglobin, 15g/l agar) supplemented with 1% (v/v) IsoVitaleX (Becton-Dickson), 
complete BHI broth (35g/l BHI, 50µg/ml hemin, 1% (v/v) IsoVitalex), or Chamberlains 
Defined Media (Chamberlain, 1965).  All bacterial strains cultured on chocolate agar were 
grown at 37°C.  Broth cultures were incubated in a shaking water bath at 37 ºC. 
 
Plasmids and Molecular Techniques.  Cloning of F. tularensis LVS DNA was 
accomplished as described previously (Fuller et al., 2008a).  Sequence integrity was 
confirmed by DNA sequencing and comparison to the F. tularensis LVS genome 
(NC_007880).  The Francisella shuttle vector pKK MCS (Fuller et al., 2008a) was used for 
trans complementation experiments.  Kanamycin selection was maintained at 20 µg/ml for E. 
coli TOP10, and 10 µg/ml for F. tularensis LVS.   
 
Transposon mutagenesis and colony selection.  The Francisella Tn5 kanR linear 
transposon was removed from the pMOD-2 backbone (Epicentre) by restriction digest with 
PvuII.  The transposon was purified by agarose gel electrophoresis in the absence of ethidium 
bromide, since ethidium bromide reduces the efficiency of later transposition reactions.  
Linear transposon was mixed with transpose by the manufacturor’s protocols to form DNA-
protein transposome complexes (Epicentre).    The transposome was introduced into F. 
tularensis LVS Φ(ripA’-lacZ)1 (Fuller et al., 2008b) by electrotransformation using a Bio-
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Rad Gene Pulsar set at 2.0 kV, 25 µF, and 200 . Immediately following 
electrotransformation the cells were suspended in 1 ml of BHI broth, incubated for 4 h at 
37°C, and then plated on chocolate agar containing 10 µg of kanamycin/ml and 50 µg/ml X-
gal.  Colonies were chosen for screening based on altered blue/white phenotype from the 
parent reporter strain. 
 
Galactosidase assays. The activities of reporter strains were analyzed by quantitative β-
galactosidase assay as described (Fuller et al., 2008b; Miller, 1972).  Reporter strains were 
cultured overnight in Chamberlains defined media and diluted 1:10 before growth to mid 
exponential phase (OD600 0.2 to 0.8) (Fuller et al., 2008b).  Activity was calculated as 
follows: 
Miller Units = 1000 * OD420  * ∆T-1 * CBR-1 * OD600-1 
 Statistical analysis was calculated as mean Miller units and standard deviation in 
replicates of three independent samples and significance determined using an unpaired two 
tailed t test with unequal variance. 
 
Transposon insertion location. Transposon insertion sites were determined by two-stage 
semi-degenerate PCR and DNA sequencing (Jacobs et al., 2003) and compared to the F. 
tularensis LVS genome to determine insertion location and orientation. 
 
Statistical analysis.  The predicted number of F. tularensis LVS reading frames containing a 
transposon insertion was calculated using a neutral-base pair model (Jacobs et al., 2003).  In 
this model, every base-pair is assumed to be equally likely to contain a transposon insertion.  
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The probability of an open reading frame containing an insertion (pj) is based upon the open 
reading frame size and chromosome size (1,895,994 bp).  Coverage was calculated based 
upon the number of transposon insertions (n = 16,000) and the number of annotated reading 
frames (k = 1,967) with the addition of an extra open reading frame consisting of non-coding 
DNA.  For a neutral-base pair model the expected number of open reading frames hit is. 
 
 
 
Mutagenesis and Allelic Exchange.  Deletion constructs were made by splice overlap 
extension (SOE) PCR as described (Fuller et al., 2008a; Horton et al., 1989) using primers 
designed to delete the hupB and FTL_0073 loci.  The deletion constructs were ligated into 
pMP590 to make suicide vectors for allelic exchange.  Allelic exchange was conducted as 
described (LoVullo et al., 2006).  Native loci with predicted promoters were cloned into pKK 
MCS for in trans complementation experiments (Fuller et al., 2008a). 
 
RESULTS AND DISCUSSION 
Construction of an improved Francisella transposon.  Transposon mutagenesis of 
Francisella tularensis is a viable means to create a library of mutants that can be screened for 
informative phenotypes (Kawula et al., 2004).   Mutagenesis of F. tularensis with existing 
transposons resulted in insufficient coverage of the genome and insertion bias.  However, 
Gallagher et. al. improved upon this by using a Francisella promoter to drive an antibiotic 
resistance gene on a transposon.  Using this transposon they isolated mutations in 84% of the 
predicted open reading frames of F. novicida (Gallagher et al., 2007).  To construct an 
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improved Tn5 based transposon for use in Francisella we synthesized a Francisella codon 
optimized aphA1 allele expressed by the Francisella groEL promoter and cloned it into the 
Epicentre pMOD-2 <MCS> EZ-Tn5 ™ transposon construction vector.  The resulting 
transposon was purified as described and mixed with purified transposase enzyme creating a 
transposome.  The transposon complexed with transposase is inactive in solution with 
limiting magnesium.  Following electroporation into Francisella the increased intracellular 
magnesium concentration activates the transposase enzyme (Kawula et al., 2004) initiating 
insertion of the transposon into the chromosome.  The highest efficiency of transformation 
was achieved using mid-exponential phase F. tularensis cultured in BHI broth.  Greater than 
104 kanamycin resistant mutants were generated with each electrotransformation with no 
insertional bias (data not shown).      
 
Screen for ripA regulators. Investigation of Francisella gene regulation has focused on the 
positive transcriptional regulator MglA (Charity et al., 2007).  MglA has a repressive role 
with a limited number of genes including ripA (Guina et al., 2007).  Based on the hypothesis 
that other genes operate in conjunction with MglA to negatively impact ripA expression we 
screened for genes that when interrupted by Tn5 insertion impacted ripA expression.  We 
used β-galactosidase activity of a F. tularensis LVS Φ(ripA’-lacZ)1 reporter strain to analyze 
ripA expression.  This strain was chosen because of the low basal level of β-galactosidase 
activity expressed, because F. tularensis is sensitive to high concentrations of the X-gal 
cleavage product (Baron & Nano, 1999).  This strain grew with no apparent difference from 
wild type on Chocolate agar plates containing 50 µg ml-1 X-gal.  Strains with native Φ(ripA’-
lacZ)1 expression (~20 Miller units) formed light blue colonies.  Changes in Φ(ripA’-lacZ)1 
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expression were identified by alterations in colony color when grown in Chocolate agar 
containing X-gal. 
 The Φ(ripA’-lacZ) strain was transformed with transposome and plated on Chocolate 
agar containing kanamycin to select for insertions and X-gal to screen for Φ(ripA’-lacZ) 
expression variations.  1.6 x 104 transposon mutants from two independent 
electrotransformations were screened on X-gal Chocolate agar for altered Φ(ripA’-lacZ) 
expression based on color different from the parent reporter strain.  Control 
electrotransformations with no transposome mix resulted in a spontaneous kanamycin 
resistance at a frequency of less than 1 in 1011 (no resistant colonies were detected in five 
independent electrotransformations).  Using a neutral-base pair model (Jacobs et al., 2003), 
1917 of the annotated 1967 loci in the genome should be covered in the library; although 
insertions in only non-essential genes will be recovered in the screen.   137 mutants exhibited 
altered Φ(ripA’-lacZ)  expression.  Each strain was subjected to quantitative β-galactosidase 
assay using mid exponential phase bacteria in Chamberlains defined media and compared to 
the parent reporter strain.  Twenty strains failed to grow in Chamberlains defined media.  
Chamberlains defined media is a minimal media and these mutants were most likely 
auxotrophs.  Mutants displaying activity greater than three standard deviations from the mean 
wild type Φ(ripA’-lacZ) activity (99% confidence interval) were identified by DNA 
sequencing (Jacobs et al., 2003). 
Of these 43 mutants, 21 had transposon insertions in the lacZ gene and  22 had 
insertions in 14 unique loci (Table 7.1).  Twelve exhibited decreased and 10 increased 
Φ(ripA’-lacZ) activity relative to wild type.  Multiple transposon insertions were isolated in 
three loci, FTL_0439 (induced, seven insertions), FTL_0073 (repressed, two insertions), and 
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FTL_1790 (induced, two insertions).  FTL_0439 and FTL_0073 are designated as envelope 
proteins of unknown function, while FTL_1790 is described as a transport and binding 
protein of unknown specificity by the TIGR Comprehensive Microbial Resource 
(http://cmr.jcvi.org/cgi-bin/CMR/CmrHomePage.cgi).  Two possible known regulatory 
proteins were identified in the screen that repressed Φ(ripA’-lacZ) expression, FTL_0895 
(hupB) and FTL_1810 (nusA).  FTL_0895 encodes HU form B which is a chromosome 
associated DNA binding protein that can impact  global gene regulation (Balandina et al., 
2001), stationary phase survival (Claret & Rouviere-Yaniv, 1997), DNA repair (Kow et al., 
2007), and DNA replication in E. coli (Jaffe et al., 1997).  HU form B is currently the only 
annotated histone-like protein in the Francisella genome.  FTL_1810 encodes a homolog to 
NusA.  NusA regulates gene expression in E. coli via termination and anti-termination 
activity of Rho (Greenblatt & Li, 1981; Shankar et al., 2007).  
Seven independent transposon insertions in FTL_0439 resulted in increased Φ(ripA’-
lacZ) expression (Figure 7.1).  FTL_0439 is a hypothetical envelope protein of unknown 
function.  FTL_0439 is a fusion of the 5’ end of FTT0918 with the 3’ terminus of FTT0919 
created by the deletion of the intervening sequence in F. tularensis LVS (Figure 7.1).  
FTT0918 and FTT0919 are important in the virulence of F. tularensis Schu4 in a mouse 
model of tularemia (Twine et al., 2005).  Further characterization of FTL_0439 was not 
pursued in this study due to the mutation of the native allele in the LVS strain.  Further work 
in the virulent F. tularensis Schu4 strain is needed to clarify the roles of FTT0918 and 
FTT0919 in ripA expression.  FTL_1810 and FTL_0895 were chosen for further 
investigation because of a possible role in transcriptional regulation and FTL_0073 because 
of its identification in other published screens for Francisella virulence factors.   
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Insertional inactivation and NusA overexpression repress Φ(ripA’-lacZ) activity.  
FTL_1810 nusA was investigated in depth because of its possible role as a transcriptional 
regulator and the strongly repressed expression of Φ(ripA’-lacZ) in the nusA::Tn5 strain. The 
nusA gene is essential in E. coli (Nakamura & Uchida, 1983) and was determined to be 
essential in Francisella by analysis of a saturating transposon mutagenesis screen in F. 
novicida (Gallagher et al., 2007).  The nusA::Tn5 mutant isolated in this study had an 
insertion in the 3’ end of the gene.  NusA is predicted to be 490aa in length.  The transposon 
insertion results in a truncation of NusA(441-490).  In E. coli, the C terminal domain (431-
490), of NusA plays a role in protein-protein interactions as well as RNA binding to create a 
functional anti-termination complex with Rho (Eisenmann et al., 2005).  While this might not 
be the case in Francisella, the high degree of similarity between NusA in E. coli and F. 
tularensis makes this a valid hypothesis.  To assess the role of nusA in Φ(ripA’-lacZ) 
expression, the wild type allele was cloned and placed under control of the groEL promoter 
in the F. tularensis shuttle vector pKK214 (pnusA).  Expression of Φ(ripA’-lacZ) was 
assessed in the nusA+, nusA::Tn5, nusA::Tn5 pnusA, and nusA+ pnusA backgrounds by assay 
for β-galactosidase activity in mid exponential phase bacteria cultured in Chamberlains 
defined media (Figure 7.2).  The wild type allele did not restore expression of Φ(ripA’-lacZ) 
to wild type levels in the nusA::Tn5 background, and in fact, repressed expression of 
Φ(ripA’-lacZ) in a nusA+ background.  The failure to complement the mutation may have 
been due to polar effects on the downstream FTL_1809 infB locus; and in fact, nusA and infB 
constitute an operon in E. coli (Cenatiempo et al., 1987).  Translation initiation factor 2 (IF-
2) is encoded by infB.  IF-2 plays a role in the regulation of translation initiation in E. coli 
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(Cole et al., 1987).  However, this did not explain the repression we observed in the wild 
type background.  NusA has been found to be autoregulatory in E. coli and overexpression 
resulted in the downregulation of the nusA-infB operon (Cenatiempo et al., 1987).  This 
could result in lowered expression of infB in both the nusA::Tn5 strain and the pnusA strain.  
The infB locus was determined to be essential in F. novicida and no transposon insertions 
have currently been described in this locus (Gallagher et al., 2007).     
 
F. tularensis ∆hupB and ∆FTL_0073 impacts ripA expression.  Transposon insertions into 
FTL_0073 and FTL_0895 (hupB) both resulted in decreased expression of Φ(ripA’-lacZ).  
Deletion strains were created via allelic exchange to further assess the role of these loci in 
ripA expression.  Slice overlap extension PCR was used to create inframe deletion constructs 
of FTL_0073 (first two codons fused to the last six codons) and FTL_0895 (first four codons 
to the last four codons).   The integrity of flanking DNA in deletion constructs was confirmed 
by DNA sequencing.  Constructs were cloned into the F. tularensis suicide vector pMP590 
and allelic exchange achieved as described (Fuller et al., 2008a; LoVullo et al., 2006).  pBSK 
Φ(ripA’-lacZ)1 cat (Chapter 6) was integrated into F. tularensis LVS ∆FTL0073 and ∆hupB 
as a single copy reporter to compare expression to the wild type reporter strain.   The native 
FTL_0073 and hupB loci were cloned with their predicted native promoters and subcloned 
into the pKK MCS Francisella shuttle vector for trans complementation experiments (Fuller 
et al., 2008a).  
  Φ(ripA’-lacZ)1 activity was measured in wild type F. tularensis LVS, F. tularensis 
LVS ∆hupB or ∆FTL_0073, and F. tularensis LVS ∆hupB pKK hupB+ or F. tularensis LVS 
∆FTL_0073 pKK FTL_0073+ strains.   Φ(ripA’-lacZ)1 activity was as follows for the 
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analysis of the ∆hupB: wild type, 26.7 (± 0.04) Miller units; ∆hupB, 10.7 (± 0.6) Miller units; 
and  ∆hupB pKK hupB+, 17.2 (± 1.3) Miller units.  Φ(ripA’-lacZ)1 activity was as follows 
for the analysis of the ∆FTL_0073: wild type, 32.0 (± 5.2) Miller units; ∆FTL_0073, 78.4 (± 
2.9) Miller units; and  ∆FTL_0073 pKK FTL_0073+, 25.6 (± 1.1) Miller units (Figure 7.3).  
All results are significantly different from each other by ANOVA analysis (P < 0.05).  Thus, 
∆hupB had a negative influence on Φ(ripA’-lacZ)1 expression and ∆FTL_0073 had a 
positive influence on ripA expression.  The wild type alleles in trans resulted in partial 
restoration of wild type expression. The change in expression of Φ(ripA’-lacZ)1 in the 
∆FTL_0073 strain and the FTL_0073::Tn5 strain were the opposite.  Polar effects and the 
expression of a truncated protein in the transposon insertion could result in the observed 
differences.  We concluded that the results obtained with the ∆FTL_0073 strain were 
accurate because the changes in ripA expression were restored to wild type levels by the 
native allele.  Although the differences observed in the transposon mutant may lead to future 
avenues of investigation.    
   The FTL_0073 locus was identified as important in lung pathogenesis in a Signature 
tagged mutagenesis screen for Francisella virulence factors (Su et al., 2007).  FTL_0073 
encodes a potential envelope protein of unknown function.  Since its function is unknown, 
the route by which it impacts ripA expression is not easily definable.  Mutations in envelope 
proteins may lead to varied effects in permeability, transport, membrane potential, or 
membrane composition.  Characterization of F. tularensis LVS ∆FTL_0073 may shed light 
on the function of FTL_0073 in the envelope and hence how it impacts ripA expression. 
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TABLES AND FIGURES 
 
Table 7.1.  F. tularensis LVS Tn5 mutants that impact ripA expression.  F. tularensis 
LVS loci identified as impacting Φ(ripA’-lacZ) expression based upon transposon 
mutagenesis.  Expression falling outside a 99% confidence interval of the wild type Φ(ripA’-
lacZ) expression was used as a criteria from selection.  All differences in expression listed 
were significant (P < 0.01) using an unpaired student’s t test from that parent reporter strain.  
Fold change is calculated as the ratio of mutant expression to native expression 
(MUTn5/MUwt).  Positive or negative MglA regulation is based upon proteomics and 
microarray data in F. novicida mglA. 
 
locus Putative identification fold change
TIGR  
Cellular Role Category 
MglA 
regulated
FTL_1810  nusA 0.17 Transcription yesa 
FTL_1059 hypothetical protein 0.34 Hypothetical proteins noa 
tRNA-Val2 tRNA-Val2 0.43 tRNA noa 
FTL_0329  CDP-alcohol phosphatidyltransferase 0.53 Fatty acid and phospholipid metabolism yes
a 
FTL_1666  DNA Pol I 0.57 DNA metabolism yesa 
FTL_0073d hypothetical protein 0.63 Cell envelope noa 
tRNA-Arg1 tRNA-Arg1 0.64 tRNA noa 
FTL_0895 HU Form B (hupB) 0.68 DNA metabolism yesa 
FTL_0690 Acyl-CoA synthetase  (long-chain-fatty-acid--CoA ligase) 0.69 
Fatty acid and phospholipid 
metabolism no
a 
FTL_0699 ribosomal large subunit  pseudouridine synthase D 0.70 Protein synthesis yes
a 
FTL_1306 hypothetical protein 0.82 Hypothetical proteins yesa 
FTL_0597  NAD dependent epimerase (wcaG) 1.37 Energy metabolism yesa 
FTL_1790d MFS tranporter (ampG) 1.78 Transport and binding proteins yesb 
FTL_0439c hypothetical protein 3.95 Cell envelope noa 
 
a (Guina et al., 2007) 
 
b (Charity et al., 2007) 
 
c seven Tn5 insertions 
 
d two Tn5 insertions 
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Figure 7.1.  Organization of FTL_0439, FTT0918, and FTT0919. (A) Graphical 
representation of the Tn5 insertions in F. tularensis LVS FTL_0439.  Numerical designation 
of each insertion designated above the locus.  FTL_0439 is a gene fusion of the 5’ of 
FTT0918 and the 3’ of FTT0919.  (B) The organization of FTT0918 and FTT0919 in F. 
tularensis Schu4.  The regions of FTL_0439 homologous to FTT0918 and FTT0919 are 
demarcated in green.     
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Figure 7.2. Impact of nusA on Φ(ripA’lacZ)1 activity.  Activity of the F. tularensis LVS 
Φ(ripA’lacZ)1 reporter in wild type (nusA+), nusA::Tn5, nusA::Tn5 pnusA+, and nusA+ 
pnusA+ backgrounds.  pnusA+ is the wild type nusA allele expressed from the Francisella 
groEL promoter in the Francisella shuttle vector pKK214.  Reporter activity is significantly 
repressed relative to wild type expression in all cases (P < 0.001). 
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Figure 7.3.  Impact of ∆hupB and ∆FTL_0073 on Φ(ripA’lacZ)1 activity.  (A) Activity of 
the F. tularensis LVS Φ(ripA’lacZ)1 reporter in wild type (hupB+), ∆hupB, ∆hupB phupB 
backgrounds.  phupB is the native hupB allele and promoter in the Francisella shuttle vector 
pKK MCS.  Reporter expression is significantly (P < 0.01) reduced by ∆hupB and partially 
restored to wild type expression by the wild type allele in trans. (B) Activity of the F. 
tularensis LVS Φ(ripA’lacZ)1 reporter in wild type (FTL_0073+), ∆FTL_0073, ∆FTL_0073 
pFTL_0073 backgrounds.  pFTL_0073 is the native FTL_0073 allele and promoter in the 
Francisella shuttle vector pKK MCS. Reporter expression is significantly (P < 0.001) 
increased by ∆FTL_0073 and restored to wild type expression by the wild type allele in 
trans.
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ABSTRACT 
RipA is a cytoplasmic membrane protein required for virulence in Francisella 
tularensis, but its function is not currently known.  We used co-immunoprecipitation to 
identify proteins that interact with RipA to gain insight on the functions of this protein.  RipA 
co-precipitated with the transcriptional regulator IclR (FTL_1364) and the 
glycosyltransferases FTL_0265 and FTL_0604.  IclR localized to the cytoplasm and the 
cytoplasmic membrane fraction in wild type and ∆ripA strains suggesting that IclR-RipA 
protein interactions do not impact IclR localization.  FTL_0265 localized to the cytoplasmic 
membrane fractions of both wild type and ∆ripA strains.  The localization of RipA, IclR, and 
FTL_0265 to the cytoplasmic membrane strengthens the hypothesis that they interact. 
  
INTRODUCTION 
 RipA is a Francisella tularensis virulence factor required for intracellular replication 
and for virulence in a mouse model of tularemia (Fuller et al., 2008).  There are a small 
group of conserved hypothetical membrane proteins in diverse bacterial species with 
similarity to RipA.  None of these proteins have a known function.  Assessment of the impact 
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of RipA on phenotypes related to virulence such as intracellular replication and trafficking 
have so far been descriptive and do not directly address the function of RipA.  Most proteins 
do not function in isolation; rather they interact with other proteins to fulfill their function.  
Identifying proteins that interact with RipA that have a known function may shed light on the 
function of this protein. 
 
MATERIALS AND METHODS 
Bacterial strains and Cell culture.  Escherichia coli TOP10 cells were used for cloning.  E. 
coli cultures were grown in Luria’s broth at 37 °C with shaking.  Francisella tularensis Live 
Vaccine Strain (LVS) was obtained from the Centers for Disease Control and Prevention, 
Atlanta, Ga. F. tularensis LVS was propagated on chocolate agar (25g/l BHI, 50µg/ml 
hemoglobin, 15g/l agarose) supplemented with 1% (v/v) IsoVitaleX (Becton-Dickson), 
complete BHI broth (35g/l BHI, 50µg/ml hemin, 1% (v/v) IsoVitalex), or Chamberlains 
Defined Media (Chamberlain, 1965).  All bacterial strains cultured on chocolate agar were 
grown at 37°C.  Broth cultures were incubated in a shaking water bath at 37 ºC. 
 
Fusion of C terminal epitopes.  Gene fusions to C terminal epitope tags were constructed by 
splice overlap extension PCR (Chapter 6).  Overlapping primers were designed that fused 
either HA (Chen et al., 1993; Kolodziej & Young, 1991) or V5 (Dunn et al., 1999; Grabar & 
Cain, 2004) epitope tags to the C terminus of the coding sequence.  Glycine residues were 
added as a linking sequence between the tag and the C terminus (Figure 8.1).  Sequence 
integrity was confirmed by DNA sequencing.  The 5’ flanking sequence of Φ(ripA’-HA), 
Φ(FTL_1364’-V5), and Φ(FTL_0265’-V5) contained the predicted promoter sequences 
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allowing constructs to be cloned into either the Francisella shuttle vector pKK MCS (Fuller 
et al., 2008) for expression or pMP590 for allelic exchange.  Allelic exchange was done as 
described (LoVullo et al., 2006). 
 
Co-immunoprecipitation assays. RipA-HA was immunoprecipitated from mid-exponential 
phase F. tularensis LVS whole cell lysates.  Mid exponential phase broth cultures grown in 
BHI were pelleted by centrifugation.  Bacterial pellets were lysed in non-denaturing lysis 
buffer (1% (v/v) NP40, 20 mM Tris pH 7.5, 150 mM NaCl, 1 mM MgCl2) for 1 hour on ice.  
Lysates were clarified in a microcentrifuge at 16,000 xg for 15 minutes.  Antibody agarose, 
anti-HA agarose or anti-V5 agarose (Sigma), was washed once in lysis buffer and clarified 
lysates added to agarose beads.  Immunoprecipitations were incubated overnight with 
shaking at 4 °C.  Beads were washed three times in either low salt wash buffer (1% (v/v) 
NP40, 20 mM Tris pH 7.5, 150 mM NaCl, 1 mM MgCl2) or high salt wash buffer (1% (v/v) 
NP40, 20 mM Tris pH 7.5, 300 mM NaCl, 1 mM MgCl2) followed by two washes in 
microcentrifuge spin columns with the same buffer.  Low pH glycine elution (0.2% (v/v) 
NP40, 0.1 M Glycine pH 2.5) using two volumes equal to the amount of antibody agarose 
used was done and pooled.  The pH of the eluate was neutralized with 1 M Tris pH 9.5 and 
eluates separated using SDS-PAGE followed by either Coomasie straining or Western blot.  
Coomasie stained specific co-precipitating proteins were identified using MALDI MS/MS at 
the UNC-Duke Michael Hooker Proteomics Center.     
 
SDS-PAGE and Western analysis.  Western blot analysis of immunoprecipitated proteins 
was as described (Fuller et al., 2008). Non-specific binding to the membrane was blocked 
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with 7% (w/v) non-fat milk (0.05% (v/v) Tween 20, Dulbeco’s phosphate buffered saline 
(PBS)).  Antibody dilutions (1:10,000 mouse monoclonal anti-HA clone HA-7 or 1:1000 
mouse monoclonal anti-V5 clone V5-10, Sigma) were in 0.5% (w/v) BSA (0.05% (v/v) 
Tween 20, PBS). 
 
Membrane fractionation. Membranes were fractionationed as described previously by 
ultracentrifugation and Sarkosyl extraction (Fuller et al., 2008).  Mid exponential phase 
bacteria were lysed by bead beating for 20 minutes.  The lysates were clarified at max speed 
in a microcentrifuge for 5 minutes and crude membranes pelleted by ultracentrifugation for 1 
hour at 100,000 x g.   The cytoplasmic membrane fraction was enriched for by extraction 
with 0.2% sarkosyl and the outer membrane fraction re-pelleted by ultracentrifugation. 
 
Construction of chromosomal mutant alleles. Allelic exchange protocols were as 
described (LoVullo et al., 2006).  pMP590 suicide vectors containing mutant versions of the 
targeted alleles were integrated using Kanamycin selection (10 µg/ml) and resolved by 
counterselection with 10% sucrose on chocolate agar plates.  PCR with primers specific to 
either the HA tag (5’-CACCAGCATAATCTGGAACATCATAAGGATAGCC-3’) or V5 
tag (5’-AAACCAATACCAAACCCACTACTAGGACTAGATTCTAC-3’) were used to 
form an amplicon with chromosomal specific primers to screen for retention of the fusion 
allele.  Expression was confirmed by Western blot with HA or V5 specific antibodies.  
 
RESULTS AND DISCUSSION 
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MS/MS Identification of RipA co-precipitating proteins.  F. tularensis RipA is 
homologous to a limited number of conserved hypothetical membrane proteins of unknown 
function in diverse bacterial species.  Identifying protein-protein interactions may help 
elucidate unknown protein functions (Hishigaki et al., 2001).  Co-immunoprecipitation with 
specific antibodies is a well documented method to accomplish this (Elion, 2007). Rabbit 
anti-RipA antiserum to recombinant RipA bound numerous Francisella proteins and thus 
was of limited use for immunoprecipitations (Fuller et al., 2008). Therefore, we constructed 
C terminal HA epitope tagged RipA fusion protein so that monoclonal antibodies to HA 
could be used in the immunoprecipitation assays.   
The amino acid sequence of the HA epitope was reverse translated to a codon 
optimized sequence (Figure 8.1) based on the Francisella codon usage tables.  This sequence 
was inserted 5’ to the native ripA stop codon by splice overlap PCR.  The native DNA 
sequence 5’ and 3’ to the HA tag was included in the construct to allow incorporation in the 
Francisella chromosome via allelic exchange as described (Fuller et al., 2008; LoVullo et al., 
2006).  Cointegrates were selected by growth on kanamycin and plasmid resolution identified 
by sucrose counterselection.  Retention of the fusion allele was determined by PCR 
amplification using a primer specific the epitope tag sequence and a primer specific to the 
native chromosomal sequence.  Validation of the fusion protein expression was accomplished 
by Western blot using monoclonal mouse anti-HA antibodies. 
 Mid exponential phase F. tularensis LVS Φ(ripA’-HA) were lysed with non-
denaturing NP40 lysis buffer and immunoprecipitated with anti-HA agarose.  Samples were 
separated by SDS-PAGE and stained by Coomasie blue to identify specific co-precipitating 
proteins relative to the control precipitation with RipA-HA negative whole cell lysate.  Co-
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precipitating proteins were identified by MALDI MS/MS and Mascot database search by the 
UNC-Duke Michael Hooker Proteomics Center.  Three proteins were identified that were 
specific and did not precipitate in the negative controls.  These proteins were identified as 
FTL_1364, FTL_0265, and FTL_0604.   Two of these proteins (FTL_1364 and FTL_0265) 
retained interaction with RipA-HA after higher stringency high salt washes.  FTL_1364 was 
identified as a homolog to the IclR superfamily of transcriptional regulators.   
 
RipA and IclR coprecipitate.  To evaluate interactions between RipA and FTL_0265 or 
IclR, C terminal V5 epitope tagged constructs of FTL_0265 and IclR (Figure 8.1) were 
constructed utilizing SOE PCR.  Fusion proteins were introduced into F. tularensis via allelic 
exchange as described above and expression of V5 fusion proteins was confirmed by 
Western blot with anti-V5 monoclonal antibodies (clone V5-10, Sigma).  
 RipA-HA and IclR-V5 were immunoprecipitated using anti-HA (HA-7) or anti-V5 
agarose (V5-10) after non-denaturing lysis of mid exponential phase broth cultures using 
NP40 low salt lysis buffer.  Immunoprecipitates were analyzed by Western blot using 
monoclonal anti-HA or anti-V5 antibodies (Figure 8.2).  Both RipA-HA and IclR-V5 co-
precipitated the opposing partner (Figure 8.2).  RipA-HA and IclR-V5 were not pulled down 
by nonspecific antibody agarose validating the interaction (Figure 8.2). 
   
IclR and FTL_0265 localize to the Cytoplasmic membrane.  The possibility that IclR, a 
putative transcriptional regulator, interacted with RipA, an integral cytoplasmic membrane 
protein raises the question of where IclR is localized in F. tularensis.  Bioinformatics 
predictions of the subcellular localization of IclR based on the predicted amino acid sequence 
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were inconclusive.  To investigate this question experimentally, we analyzed subcellular 
fractions for the presence of IclR-V5 by Western blot.  Cytosolic, cytoplasmic membrane, 
and outer membrane fractions were isolated as described previously (Fuller et al., 2008).  
The resulting cytosolic, cytoplasmic membrane and outer membrane fractions were 
normalized to an equivalent number of bacteria and analyzed by Western blot using anti-V5 
antibodies.  IclR-V5 was present in the cytoplasmic and the cytoplasmic membrane fractions 
in similar amounts (Figure 8.3).  RipA was used as a marker for the purity of the cytoplasmic 
membrane fraction.  Previous studies have demonstrated that RipA is localized to the 
cytoplasmic membrane fraction (Fuller et al., 2008)(Figure 8.3). 
 To see if RipA impacted the localization of IclR or FTL_0265, membrane fractions 
were analyzed for IclR-V5 and FTL_0265-V5 localization.  Crude membrane fractions were 
isolated from the cytosolic fractions by ultracentrifugation.  Samples were loaded with 
equivalent amounts of total protein and analyzed by Western blot with anti-V5 antibodies.  
No difference in IclR-V5 localization or FTL_0265-V5 was noted between the ripA+ to 
∆ripA backgrounds (Figure 8.4).  Based on these results we conclude that RipA and IclR or 
FTL_0265 interact in the cytoplasmic membrane in a fashion that does not impact the 
subcellular localization of IclR or FTL_0265.  This interaction may impact IclR 
transcriptional regulation and future work in this area will explore the possibility. 
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FIGURES 
 
Figure 8.1.  HA (A) and V5 (B) epitope tag sequences inserted by splice overlap extension 
PCR between last coding sequence and stop codons in designated loci.  Glycine linkers have 
been added to the C and N terminus of epitopes. (C) Cartoon of RipA with the 
transmembrane domains (TM), HA epitope (HA), the C terminus (CT), and N terminus (NT) 
demarcated. (D) Cartoon of IclR with the Helix-Turn-Helix (HTH) DNA binding domain, 
IclR substrate binding domain (IclR), V5 epitope (V5), the C terminus (CT), and N terminus 
(NT) demarcated. 
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Figure 8.2.  RipA-HA and IclR-V5 co-precipitate. Western blot of immuno-precipitated 
proteins.  Presence of C terminal V5 and HA fusions RipA-HA and FTL_1364-V5 (IclR-V5) 
designated with “+” and absence as “-“.  Antibody-agarose used in immuno-precipitation 
listed under IP (α-HA or α-V5).  Antibody used as primary in Western blot listed at the 
bottom of the image.  Immuno-precipitation of RipA-HA co-precipitates FTL_1364-V5 
(center lane, right panel). Immuno-precipitation of FTL_1364-V5 co-precipitates RipA-HA 
(center lane, left panel).  Positive control for precipitation of the targeted fusion protein in the 
left lane of each panel (probe Western with the same antibody used in the precipitation).  
Antibody agarose does not non-specifically precipitate FTL_1364-V5 or RipA-HA (note 
absence of bands in right lane of each panel). 
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Figure 8.3.  Subcellular localization of IclR. FTL_1364 (IclR) localizes to the cytosolic 
(Cyt.) and cytoplasmic membrane (Cyt. M.) subcellular fractions of F. tularensis LVS 
Φ(ripA’-HA) Φ(FTL_1364’-V5) and does not localize to the outer membrane fraction (OM).  
Western blot of subcellular fractions utilizing anti-HA and anti-V5 antibodies specific for 
RipA-HA and FTL_1364-V5 fusion proteins.  Samples normalized to load equivalent 
numbers of CFU per lane.  Crude membrane fraction isolated by ultracentrifugation and 
cytoplasmic membrane fraction enriched by Sarkosyl extraction.   
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Figure 8.4.  Impact of RipA of IclR subcellular localization.  FTL_1364 (IclR) and 
FTL_0265 are predicted to interact with RipA based upon immunoprecipitation.  However, 
the subcellular localization of FTL_1364 and FTL_0265 were not impacted in ∆ripA 
background.  FTL_1364 localized in both the cytosolic and crude membrane fractions.  
FTL_0265 localized in the crude membrane fraction only.  Western blots were conducted 
using anti-V5 antibodies specific to FTL_1364-V5 and FTL_0265-V5 fusions proteins.  
Gene fusions are C terminal and have replaced the wild type chromosomal allele.  Samples 
are normalized to be equivalent in total protein loaded (10 µg total protein).  Crude 
membrane fractions (Membrane) were isolated by ultracentrifugation and cytosolic fractions 
(Cytosol). 
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Chapter 9 
 
Conclusions 
 
 
F. tularensis was recognized as a highly virulent pathogen in the early 1900’s.  
Outbreaks of “Deer-fly fever” in Tulare County California after the San Francisco earthquake 
in 1906 led to the isolation of F. tularensis in 1912.  Early on, F. tularensis was described as 
a fastidious intracellular pathogen and intracellular replication by this pathogen was noted to 
be important for F. tularensis virulence.  While intracellular replication has been well 
described, the processes and mechanisms that form the basis for the pathogenesis and 
virulence remain largely unknown.  A lack of genetic tools for F. tularensis is a major 
limitation.  We have developed genetic tools for use in F. tularensis and used them to 
identify and characterize the virulence factor RipA.  RipA is required for virulence and 
intracellular replication. 
 
Replication in the cytosol requires RipA.  Intracellular pathogens evade some host immune 
responses by colonization of the intracellular niche; however, host immunity also includes 
intracellular mechanisms. Low pH, antimicrobial peptides, and nutrient limitation 
synergistically make the phagosomal environment very hostile for most bacteria.  
Intracellular bacteria must resist, alter, or escape the phagosomal environment to survive.  
Francisella escapes from the phagosome early after invasion and replicates in the cytosol 
before re-entering a vacuole with autophagosomal characteristics late in its intracellular life 
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cycle (Checroun et al., 2006; Golovliov et al., 2003; Lindgren et al., 2004). F. tularensis 
LVS ∆ripA escapes from the phagosome, but fails to replicate in the cytosol.  Electron 
micrographs of infected macrophages demonstrated that F. tularensis LVS ∆ripA was free in 
the cytoplasm at similar time points post invasion as wild type. However, unlike wild type, 
the mutant ∆ripA bacteria in the cytosol did not increase in density by 24 hours post 
inoculation.  Some of the other Francisella mutations that result in failure to replicate in the 
cytoplasm are auxotrophs (Pechous et al., 2006; Qin & Mann, 2006).  However, F. tularensis 
LVS ∆ripA replicates in minimal media with the same doubling time and to the same 
maximum density as wild type.  This leads to the conclusion that failure of ∆ripA strains to 
replicate was not due to nutrient limitation. 
F. tularensis re-enters Francisella containing vacuoles in a process that is dependent 
upon replication (Checroun et al., 2006).   F. tularensis LVS ∆ripA re-enters vacuoles in a 
manner different from wild type.  Individual F. tularensis LVS ∆ripA are found in 
autophagosomal like vacuoles at 24 hours post inoculation.  The lack of replication of the 
mutant contrasts with the described requirement for replication before re-entry into vacuoles 
for the wild type bacteria (Checroun et al., 2006).  This suggests that either re-entry is 
mediated in a different fashion or that the triggering of the processes is different in the ∆ripA 
mutant.  Another interpretation is that reentry is dependent of protein synthesis and not 
replication.  Checroun et. al. used chloramphenicol to block vacuole re-entry (Checroun et 
al., 2006).  Future work blocking bacterial replication with a DNA synthesis inhibitor instead 
of a protein synthesis inhibitor may be able to differentiate theses hypotheses.  
Autophagy is a process that can be triggered by the inflammatory response.  
Francisella modulates the host inflammatory response although this has not been linked to 
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re-entry into a vacuole.  We hypothesize that modulation of the inflammatory response is 
different in the ∆ripA mutant leading to increased autophagy of the bacteria.  Further work on 
inflammation and autophagy with the ∆ripA mutant would help clarify this issue. 
 
 
RipA is modulated during intracellular growth and by the Francisella regulator of 
virulence MglA.  Virulence factor regulation is a significant area of research in 
pathogenesis.  Many genes that are necessary for growth in the intracellular niche, but not 
under laboratory conditions are regulated by facultative intracellular pathogens.  In 
Salmonella, for example, SifA differentially regulates virulence factors and is upregulated 
under intracellular conditions (Buchmeier et al., 1997; Spory et al., 2002).  Legionella 
presents programmed transcriptional responses that change between the replicative and 
transmisive phases of its life cycle (Bruggemann et al., 2006).  The Francisella 
transcriptional regulator MglA positively regulates some genes required for virulence (Baron 
& Nano, 1998; Charity et al., 2007; de Bruin et al., 2007) and itself is upregulated in the 
intracellular environment (Baron & Nano, 1999).  Shotgun proteomics studies in a F. 
novicida mglA- background revealed that RipA is repressed by MglA; however, microarray 
analysis of ∆mglA strains did not reveal any differences in ripA transcription.  We clarified 
these contradictory findings through the use of Φ(ripA’-lacZ) reporters to analyze ripA 
expression in the intracellular niche and in a ∆mglA background (Chapter 6). 
 Φ(ripA’-lacZ) reporter expression was increased in a ∆mglA background.  Expression 
was returned to wild type levels by the introduction of the wild type mglA allele in trans.  
MglA exerts a negative influence on RipA expression.  Since MglA predominantly has a 
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positive effect on gene regulation it logically follows that other genes work in conjunction 
with MglA to exert a negative effect on gene expression. 
We identified NusA as a possible regulator of RipA expression in a transposon 
screen.  Overexpression of NusA resulted in suppression of Φ(ripA’-lacZ) expression, and 
NusA expression was greater than 20 fold changed in the MglA shotgun proteomics analysis.  
Although these findings relating RipA expression to NusA and MglA are significant, they do 
not thoroughly explain the mechanisms of RipA regulation.  NusA is also repressed, not 
induced by MglA.  We were not able to complement the nusA::Tn5 phenotype with the wild 
type allele.  Likely, other genes either downstream of nusA in the nusA operon or in other 
transcripts play a significant role in repression of gene expression by MglA.   Since mglA 
was found to be increased after cell invasion, we measured ripA expression in the 
intracellular niche as well.  Early (1 hour PI), early cytoplasmic (6 hours PI), and late 
cytoplasmic (24 hours PI) stages were evaluated.  RipA was suppressed at the late 
cytoplasmic time point, possibly through an intermediary such as NusA that would act 
concert with MglA. Analysis of iglA, a gene induced by MglA, gene expression showed an 
induction during early cytoplasmic growth that was reduced by late cytoplasmic growth.  We 
hypothesize that this programmed gene expression in the intracellular niche serves a role in 
adaptation to the cellular niche and maintenance of the intracellular lifecycle.  Further work 
on the genes up-regulated during each stage of the Francisella lifecycle may give clarity to 
the genes necessary for adaptation and successful propagation of F. tularensis. .   
 
RipA interacts with the transcriptional regulator IclR.  Phenotype analysis showed that 
RipA is necessary for intracellular replication and virulence in a mouse model of tularemia, 
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but insight into what function RipA plays in Francisella is currently elusive.  RipA protein-
protein interactions were analyzed to try to clarify this issue.  We found that RipA co-
precipitates with IclR (FTL_1364).   IclR is a common transcriptional regulator in gram 
negative bacterial species.  It is characterized by the IclR domain superfamily which consists 
of a helix-turn-helix DNA binding domain and a substrate binding domain in characterized 
IclR superfamily members.  IclR regulates diverse systems and binds to a wide variety of 
small molecule effectors in the bacteria where it has been studied.  Based on the hypothesis 
that RipA may modulate IclR transcriptional regulation through sequestration to the bacteria 
membrane, we assessed the subcellular localization of IclR.  RipA did not appear to impact 
IclR localization; however, an interesting finding was that IclR itself localizes to the 
cytoplasmic membrane.  Thus IclR may form a membrane complex with RipA or possibly as 
transient association with RipA.  Such as transient association could function to modify IclR 
or act as a cofactor in IclR transcriptional regulation.  How this impacts IclR mediated 
transcriptional regulation and what genes are regulated by IclR are currently under 
investigation.   
 In summary, RipA is a factor necessary for virulence in a mouse model of tularemia 
that modifies F. tularensis replication and trafficking after escape from the phagosome.  
RipA may interact with the transcriptional regulator IclR.  How this interaction may impact 
IclR gene regulation and virulence phenotypes remains to be determined.  The Francisella 
regulator of virulence MglA represses RipA expression. However, the biologic significance 
of the changes in RipA expression is unknown.  What is clear is that MglA regulated genes 
show patterns of induction and repression during the intracellular lifecycle.  Clarification of 
programmed gene response during different phases the intracellular lifecycle would give 
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insight into the importance of different loci during these stages and the intracellular 
environment during that stage.  Also, research on the modulation of inflammatory cytokines 
by wild type and ∆ripA Francisella strains may help clarify the mechanisms underlying 
relocalization into Francisella containing vacuoles.  Taken together these future studies will 
lead to a cohesive story on the place of RipA in Francisella pathogenesis.   
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Appendix A 
An immunoaffinity tandem mass spectrometry (iMALDI) assay for detection of 
Francisella tularensis 
Jian Jiang, Carol E. Parker, James R. Fuller, Thomas H. Kawula, and Christoph H. Borchers 
 
ABSTRACT  
 Francisella tularensis (F. tularensis) has been designated by the CDC as 1 of the 10 
organisms most likely to be engineered for bioterrorism. Symptoms of tularemia in humans 
are nonspecific, thus making the disease difficult to diagnose. If not quickly diagnosed and 
treated, the disease has a high mortality rate – thus methods for early and specific diagnosis 
are of critical importance.  
This immunoaffinity MALDI MS/MS (iMALDI) assay provides unambiguous detection of 
F. tularensis peptides at attomole levels from peptide solutions, and at low CFU levels from 
bacteria. The addition of stable-labeled versions of the peptide as internal standards allows 
absolute quantitation of F. tularensis peptides with a linear dynamic range spanning two 
orders of magnitude. The ability of mass spectrometry to obtain amino acid sequence data on 
affinity-captured peptides provides absolute specificity and avoids “false positives” from the 
non-specific binding. The F. tularensis iMALDI assay has been applied to different samples, 
such as nasal swabs.  
This novel quantitative diagnostic F. tularensis iMALDI assay allows the safe, sensitive, 
and specific detection of F. tularensis. The assay can be easily adapted to other target 
peptides and therefore has broad application potential in clinical diagnosis of other pathogens 
and diseases.  
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INTRODUCTION 
Tularemia is caused by Francisella tularensis (F. tularensis), a small, non-motile, aerobic 
Gram-negative cocco-bacillus. Although normally causing a relatively rare tick-borne disease 
in humans, F. tularensis has the potential to be engineered for bioterrorism. The bacteria can 
penetrate unbroken skin, can survive and multiply within macrophages, and can then spread 
to various organs through the blood [1]. Ten bacteria injected subcutaneously [2], 10–50 on 
contact with unbroken skin [3], 10–50 given by aerosol [4,5],or10
2
–10
8 
bacteria by ingestion 
[3] are sufficient to cause infection. Humans who have direct physical contact with infected 
animals or insects, or have inhaled aerosolized bacteria, have a good chance of becoming 
infected. Untreated, the mortality rate can be 30% [6].  
Initial non-specific flu-like symptoms usually appear 3 days after exposure [7], and general 
laboratory tests (CRP, LDH, alkaline phosphatase, leukocytes, etc.) are insufficient for 
diagnosis. Because early antibiotic therapy (with streptomycin or gentamicin) can greatly 
reduce the lethality rate [8], immediate diagnosis of an infection with F. tularensis is critical. 
Because of the virulence of F. tularensis, the severity of the disease, the rapidity of 
progression from initial onset to seriousness or death, and the high mortality rate, several 
agencies [9] have been concerned about the weaponization of  
F. tularensis, especially the use of aerosolized bacteria by terrorists as an airborne pathogen 
[10–12]. F. tularensis has been designated as one of the organisms most likely to be engi-
neered for bioterrorism [13], and one of the six “category A bioterrorism organisms” 
[1,11,14,15].  
Bacteriological methods can be used for detecting F. tularensis [16], but culturing the 
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organism is difficult [2,4,10,17], time-consuming (sometimes taking several days), and is 
potentially hazardous to laboratory personnel [18]. Moreover, several studies have shown 
[19] that the sensitivities and specificities of these methods are low (note: “specificity” means 
that there are no “false positives” – i.e., the test gives a positive result only for the target 
organism).  
Since culturing F. tularensis is difficult, serological tests such as the bacterial 
microagglutination (MA) test, have been used to diagnose tularemia, but this takes 1 week 
for measurable levels of antibodies to develop, and an additional week for sufficient antibody 
levels for a reliable test [10,20–23]. Antibodies against F. tularensis may cross-react with 
other organisms such as Brucella, Proteus OX19, and Yersinia spp. [10], which reduces the 
specificity and could lead to false positives. More recently, another type of serological test, 
an enzyme-linked immunosorbent assay (ELISA), achieved a detection limit of 10
3 
bacteria 
mL
−1 
in PBS and 10
4 
bacteria mL
−1 
in human serum [24]. However, when samples are 
contaminated with other microorganisms[25], accurate diagnosis with ELISA or culturing 
methods is very difficult due to their low specificities.  
PCR is a molecular method for detection of F. tularensis that usually takes several hours 
per reaction. A handheld PCR assay could detect F. tularensis in 3 h, and achieved the 
analytical sensitivity of 100 bacteria mL
−1 
PBS or 10
3
–10
4 
bacteria mL
−1 
serum [26]. 
However, PCR may give false positives from contamination with other DNA, which lowers 
its specificity. Moreover, simultaneous assaying for multiple species or virulence factors by 
PCR is difficult [27].  
In this paper, we describe a peptide-based immunoaffinity MALDI mass spectrometry 
(iMALDI) assay for detection of F. tularensis, which circumvents many of the problems 
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associated with traditional detection methods. It is based on capture of the F. tularensis IglC 
aa49–61 peptide. This F. tularensis peptide assay is capable of fast, safe, sensitive, and 
specific detection of F. tularensis in PBS solution. It can be used for absolute quantitation of 
target peptides and, therefore, for absolute quantitation of their parent proteins. We also 
demonstrate the applicability of iMALDI to the detection of F. tularensi in clinical samples, 
such as human plasma and nasal swabs. 
 
EXPERIMENTAL 
In iMALDI (Fig. A.1) [28,29], anti-peptide antibodies are first produced and immobilized on 
affinity beads. Next, the proteome of interest is proteolytically digested. Isotopically-labeled 
epitope-containing peptides, called “heavy” peptides, are added into the digest as internal 
standards for quantitation. The digest, containing both the labeled “heavy” peptides and the 
unlabeled native (“light”) peptides, is incubated with the antibody beads and both types of 
peptides are adsorbed. After immunoadsorption, the antibody beads are arranged in a 
microarray/spot format on the MALDI-target plate. MALDI matrix solution is then added, 
which enables the elution of the affinity-bound peptides from the immobilized antibodies 
permitting MALDI analysis of the peptides. The relative abundances of the molecular ion 
signals corresponding to the original “light” and “heavy” peptides are used for quantification. 
Absolute specificity can be achieved by mass spectrometric sequencing of the epitope-
containing peptide, using MALDI–MS/MS.  
2.1. Target protein  
The 23 kDa protein, IglC, from F. tularensis bacteria is encoded by iglC, whose sequence 
has no significant homology to any other gene present in the GenBank database [29]. Live 
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Vaccine Strain (LVS) bacteria, at a concentration of 2.25 × 10
9 
CFU (colony forming units) 
mL
−1 
in 70% ethanol, were used. The total protein concentration of the bacteria sample was 
700 ng mL
−1 
as determined with an ELX800 Universal Microplate Reader.  
2.2. Nasal swab samples  
Mice were inoculated intranasally with 1 × 10
5 
LVS. Two days post inoculation, a small, 
moist, alginate swab was used to rub across the nostrils of the mice. The swab was then 
swirled in a tube containing 100 µL PBS. Next, 100 µL of 95% ethanol was added to the 
sample to ensure inactivation.  
2.3. Tryptic digestion  
Digestion of human plasma (UNC blood bank) was carried out in 25 mM ammonium 
bicarbonate (Sigma) at 37 
o
C overnight. A ∼ 1:10 enzyme:substrate ratio of trypsin 
(sequencing-grade modified trypsin, Promega) to protein was used. The digested human 
plasma was spiked with F. tularensis peptides or a bacterial digest to mimic clinical samples. 
Before digestion, the nasal swab solution was diluted with ammonium bicarbonate until the 
final concentration of ethanol was 38%, which is compatible with tryptic digestion.  
2.4. Antibody production and immobilization of antibodies on beads  
Four F. tularensis IglC tryptic peptides, which are absolutely unique to, and thus diagnostic 
of F. tularensis, were selected for their high sensitivity in the MALDI–MS mode (Fig. A.2 
and Table A.1). These four peptides were synthesized by Sigma-Genosys. Antibodies were 
raised against each peptide, and tested by ELISA to determine the detection sensitivi-
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ties/efficiencies. The peptide that showed the highest binding efficiency was selected for use 
in the Francisella peptide assay, and the corresponding antibody was purified by Sigma-
Genosys.  
The anti-peptide antibody was then immobilized on CNBractivated sepharose beads 
(Amersham Pharmacia) according to the manufacturer’s instructions [30]. Briefly, by react-
ing with the primary amine groups on the antibody, the sepharose beads covalently linked to 
the antibody. Excess binding sites on the beads were blocked by incubation with an amine-
containing buffer, (in this case, Tris). The process was completed by a series of washes at 
alternating pH.  
2.5. Immunoadsorption protocol  
An aliquot of settled antibody-bead slurry (1–5 µL) was added to a compact reaction column 
(USB) and washed 4–5 times with 400 µL of 0.1 × PBS. A bacterial digest or synthetic F. 
tularensis IglC peptide [CNIVAIEGGEDVTK, calculated MW = 1446.71 (note: the N-
terminal cysteine, C, is not part of the native sequence, but was added to facilitate antibody 
production)] was dissolved in water/buffer and diluted to a series of concentrations, e.g. 25 
ng µL−1,5 ng µL−1, 0.5 ng µL−1, etc. A 20 µL aliquot of each solution was incubated 
separately with a small amount (1–5 µL) of antibody beads to immuno-adsorb the epitope-
containing peptide. Peptide solutions or a bacterial digest spiked into a plasma digest mixture 
was used to mimic clinical samples. Three negative control experiments were performed by 
incubating (a) unconjugated agarose beads with PBS; (b) unconjugated agarose beads with 
synthetic peptide or bacteria digest sample; and (c) antibody beads with PBS, respectively.  
After incubation for 2–4 h at room temperature with end-to-end rotation on a “Labquake” 
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rotator (Lab Industries), the beads were washed six times with 400 µL of freshly made 50 
mM ammonium bicarbonate. When high levels of nonspecific binding were expected in 
complex samples such as plasma, the beads were washed three times with 400 mM of NaCl 
(Sigma) followed by three times with 50 mM ammonium bicarbonate. Then the beads were 
re-suspended in a small volume of 50 mM ammonium bicarbonate (1–5 µL) and an aliquot of 
the beads (0.5 µL) was spotted directly onto the MALDI target as described in Section 3.  
2.6. Isotopic labeling for absolute quantitation  
The F. tularensis IglC aa49–61 peptide 
49
NIVAIEGGEDVTK
61 
(calculated MW = 1343.69) 
containing an isotopically-labeled valine at position 59 (underlined) (the “heavy” peptide) 
was synthesized at the UNC Peptide Synthesis Facility, using a 
13
C-labeled fmoc valine 
purchased from Isotec/Sigma–Aldrich according to the fmoc approach described in details 
elsewhere [31]. The increase in mass from the unlabeled (“light”) F. tularensis IglC aa49–61 
peptide was 6 Da.  
2.7. Absolute quantitation  
The “heavy” peptide, dissolved in water (HPLC grade, Pierce) was used as an internal 
standard. Heavy peptide was spiked into a F. tularensis bacterial digest in various amounts, 
immuno-adsorbed on anti-F. tularensis IglC peptide antibody beads, and analyzed by 
MALDI–MS of the beads on the MALDI target.  
2.8. Mass spectrometric analysis  
MALDI–MS experiments were performed on Bruker Dal-tonics’ (Billerica, MA) Reflex III 
and Ultraflex MALDI-TOFs, using Bruker’s Anchor-chip MALDI-target plates (400 or 600 
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µm/384 spot format). MS/MS analyses were carried out on an Applied Biosystems Voyager 
4700 (Framingham, MA) MALDI-TOF/TOF. The matrix used for all experiments was re-
crystallized (from hot methanol) α-cyano-4-hydroxycinnamic acid (HCCA) (Sigma). A 
saturated solution of HCCA in 50:49.9:0.1 acetonitrile (Caledon Laboratories):water (HPLC 
grade, Pierce):trifluoroacetic acid (Pierce) was used. A small volume (1–5 µL) of ammonium 
bicarbonate (ABC) solution (50 mM) was added for easy placement of the beads on the 
MALDI target. Following placement of the antibody beads on the target, 0.3–0.5 µL of 
HCCA matrix was added, and the spot was allowed to dry at room temperature.  
 
RESULTS AND DISCUSSION 
The iMALDI technique belongs to a general category of techniques which couples affinity 
capture with direct mass spectrometric analysis of target proteins (Fig. A.1) [32–48]. In 
iMALDI, anti-peptide antibodies are immobilized on sepharose beads for affinity capture, 
rather than on the surface of a plate, thus eliminating the need for special surface chemistry. 
Additional advantages of using affinity beads are less-stringent sample storage requirements 
after antibody immobilization, fewer complications resulting from denaturation of the 
capture antibody in solution, and the ability to incubate several types of beads with small 
volumes of tryptic-digested biological fluid instead of “soaking” the entire target. Because 
peptides are more stable and less susceptible to denaturation, the iMALDI should be more 
reproducible from sample to sample than the techniques based on anti-protein antibodies, and 
sample storage requirement should not be as stringent.  
Unlike conventional affinity capture/elution/MALDI techniques [33,34], the “stable 
isotope standards with capture by anti-peptide antibodies” (SISCAPA) approach [35], or on-
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target elution followed by removal of affinity beads as was done by Schriemer and Li [49], in 
iMALDI the affinity beads are placed directly on the MALDI target and analyzed without 
prior elution of the bound analytes [32–48], which greatly reduces the sample loss and 
therefore increases the detection sensitivity. In iMALDI, after immunoadsorption, the 
antibody beads are arranged in a microarray/spot format on the MALDI target plate. Addition 
of MALDI matrix solution releases the affinity-bound peptides from the immobilized 
antibodies permitting MALDI analysis of the peptides. Multiple samples can be analyzed 
simultaneously by mass spectrometry as an array of different anti-peptide antibody beads on 
a MALDI target. Furthermore, since complete inactivation of the bacteria can be achieved by 
enzymatically digesting the lysate at the time of sample collection, the iMALDI technique 
carries low risk to laboratory personnel. 
3.1. Sensitivity  
3.1.1. Detection of F. tularensis bacteria in PBS solution  
By direct MALDI–MS analysis of the beads, the detection limit for the synthetic F. 
tularensis IglC peptide (cysteine was added for antibody production) was determined to be in 
the low attomole range (14 amol) in buffer (HPLC-grade water or PBS). Without enrichment 
by iMALDI, in MALDI–MS analysis, the detection sensitivity of the peptide in buffer was in 
the low femtomole range (17 fmol) (Fig. A.3).In the enrichment process, the peptides are 
bound to antibody beads, which greatly reduce losses due to adsorption by tubes and tips. 
Moreover, when spotted on the target plate, even after elution by the matrix solution, the 
peptides do not spread out all over the spot area. Instead, they tend to aggregate at “hot 
spots”, and when the laser is focused at these “hot spots”, greatly increased detection 
sensitivities can be obtained.  
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The F. tularensis iMALDI assay, based on the anti-F. tularensis IglC aa49–61 antibody, 
can also detect the target F. tularensis peptide from a bacterial digest. The target F. tularensis 
peptide was determined in a bacterial digest equivalent to 80 bacteria. The bacteria were 
digested and incubated with a small aliquot (1–5 µL) of anti-aa49–61 NIVAIEGGEDVTK 
antibody beads. One tenth of the antibody beads were spotted on the MALDI target plate and 
analyzed directly. Although there were signals from some unknown impurities or non-
specifically bound peptides from, for example, the bacterial digest, the target peptide was still 
detectable by its mass. The singly charged, epitope-containing tryptic peptide (aa49–61 
NIVAIEGGEDVTK) from the IglC protein was observed at m/z = 1344.7 (Fig. 
A.4).Therefore, the detection limit for bacteria in PBS solution is determined to be 8 CFU 
bacteria on target by using 50% of the antibody beads incubated with 50 µL of a bacterial 
solution in PBS, at a concentration of 320 CFU mL
−1
,which is as low as the most sensitive 
detection systems yet developed [50,51].It should be noted that 8 CFU does not represent the 
lowest possible detection limit in real applications, but is an estimate of the lowest possible 
detection limit of our method, as the tryptic digestion of the protein equivalent of 8 CFU 
might be difficult.  
3.1.2. Detection of F. tularensis bacteria in blood  
The following detection limits were determined for the synthetic F. tularensis IglC and F. 
tularensis bacteria spiked into blood samples (plasma): 69 amol of the F. tularensis IglC syn-
thetic peptide and 800 CFU of bacteria (Fig. A.5)on target by using 50% of the antibody 
beads incubated with 125 µL of spiked plasma, at a concentration of 1 fmol mL−1 IglC aa49–
61 peptide and 1280 CFU mL
−1 
bacteria, respectively. Although this method is not as 
sensitive for the detection of F. tularensis bacteria in blood as it is for the detection of 
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bacteria in PBS solution, the detection limit is still comparable to most ELISA methods 
[24,52]. However, our technology has the advantage of greater safety because we are 
detecting bacterial peptides after the bacteria have been inactivated by lysis and proteolysis. 
In addition, our technology has higher specificity, since tandem mass spectrometry is a 
molecular approach with sequencing capabilities to provide absolute identification of the 
target molecule.  
Due to the high virulence of bioterrorism pathogens, high sensitivity is one of the most 
important requirements in order to avoid “false negative” results. The sensitivity in plasma 
(800 CFU) is lower than in PBS solution (ca. 10 CFU bacteria), maybe due to incomplete 
digestion and to high levels of nonspecific binding of other plasma proteins which can 
suppress the ion signal from the target peptide. Optimized sample preparation protocols may 
alleviate this problem. In particular, a major advantage of this MS/MS-based technique is 
that the proteins which are the source of these non-specifically bound peptides can be 
identified from the MS/MS spectra of their peptides, and depletion protocols can be 
specifically designed to remove these proteins prior to digestion and affinity capture of the 
target peptides [53]. Improved sample preparation protocols and improvements in mass 
spectrometric detection technology, should lead to routine detection sensitivities of ∼ 10–100 
amol of peptide.  
3.1.3. Detection of F. tularensis bacteria in nasal swab samples  
The current technique is also usable for nasal swab analyses. Nasal swabs are widely used in 
clinical tests, and are a simple and useful method for collecting a wide range of respiratory 
viruses. The collection of a nasal swab is easy and painless, and it can easily be performed in 
remote locations [54]. In the mouse nasal swab samples collected 2 days after inoculation, a 
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very low level of target peptide (m/z = 1344.7) was detected (Fig. A.6a).The absence of the 
signal for this peptide in the uninfected mouse samples supports these results (Fig. A.6b). 
MS/MS was not performed on the ion at m/z = 1344.7 because the ion abundance was below 
the instrument threshold for MS/MS acquisition. No bacteria were observed in a culture of 
the nasal swab solution from the infected animal (which later developed tularemia), thus 
demonstrating that iMALDI could detect F. tularensis at levels too low for successful 
culturing of the bacteria.  
3.2. Specificity  
By “specificity” of the assay, we mean that the target peptide is unique to the organism (as 
determined by a BLAST search of the peptide sequence). Thus, the detection of this peptide, 
at the appropriate MW and with the correct sequence is a positive indication of the presence 
of F. tularensis. The iMALDI can provide this specificity by combining two molecular 
characteristics of the epitope-containing peptides: (i) the molecular weight, typically 
measured by MALDI–MS within an error of ≤100 ppm and (ii) the amino acid sequence, 
determined by performing MS/MS on the same sample. 
We have demonstrated that this iMALDI technology is able to accurately determine the 
molecular weight of an immunoaffinity-enriched F. tularensis peptide from a proteolytic 
digest of F. tularensis bacteria in PBS solution and blood. The molecular weight 
determination was accurate to within 60 ppm. Sequence information on the affinity-bound 
peptide was also obtained by MALDI–MS/MS (Fig. A.7a). MS/MS analysis produces high-
abundance sequence-specific ions, resulting in an almost complete amino acid sequence of 
the peptide. These sequence-specific ions allow confident assignment of the target peptide 
(Fig. A.7b).Using the existing NCBInr database (2006.02.16), searching with only MS data, 
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we retrieved 74,528 hits out of more than three million entries; in contrast, searching with 
combined MS and MS/MS data, resulted in only one hit. This demonstrates the specificity of 
this iMALDI technique for detecting F. tularensis. Here, we used polyclonal antibodies 
because of their ready availability. Polyclonal antibodies often contain more than a single 
epitope within a particular stretch of amino acids, and therefore, are able to capture even 
modified peptides since they are likely to contain an unmodified stretch of amino acids. This 
makes this detection method tolerant of small sequence variations. On the other hand, the use 
of polyclonal antibodies might lead to cross-reactivity with peptides from other species. This 
could decrease specificity and/or the detection limit of our method. This issue could be 
resolved by using a several monoclonal antibodies, or perhaps even both types of antibodies, 
for the final clinical version of this technique.  
3.3. Quantitation  
Mass spectrometry is well suited for peptide/protein quantitation. MS can perform relative 
quantitation using reference peptides from two different samples that have been differentially 
labeled with stable isotopes, or absolute quantitation if a known amount of a stable-isotope 
labeled peptide has been added as an internal standard.  
To determine the absolute concentration of a given peptide in a sample, and, therefore, the 
absolute concentration of the original protein, as is done in isotope dilution-mass spectrom-
etry (ID-MS) [55], synthetic stable-isotopically labeled “heavy” peptide is used as an internal 
standard. These heavy peptides are identical in amino acid sequence to the native epitope 
containing “light” peptides from the protein in the sample, but are higher in mass. They are 
added to the proteolytically digested protein sample prior to incubation with the immobilized 
anti-peptide antibody. Following incubation, MALDI–MS analysis of the antibody beads 
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shows doublets of ion signals from the “light” and “heavy” peptides. The relative abundances 
of the molecular ion signals corresponding to the “light” and “heavy” peptides are used to 
quantify the amount of the “light” peptide and therefore its parent protein in the original 
sample.  
For quantifying F. tularensis IglC protein, the F. tularensis IglC aa49–61 peptide 
49
NIVAIEGGEDVTK
61 
was synthesized with an isotopically labeled valine at position 59 
(underscored). This “heavy” peptide (H) is identical in amino acid sequence to the native 
epitope-containing “light” peptide (L), but is 6 Da higher in mass(m/z = 1350.7) due to six 
13
C’s in place of 6 
12
C’s. In these experiments, the heavy peptide was added in various 
amounts (100 fmol–5 pmol) to a proteolytic digestion of F. tularensis bacteria in PBS 
solution, and was immuno-adsorbed using the anti-F. tularensis IglC aa49–61 antibody 
immobilized on affinity beads (Fig. A.8a–d).Analysis of an aliquot of these beads spotted 
directly on the MALDI target reveals monoisotopic protonated molecular ions from the two 
peptides, separated by 6 Da. (Fig. A.8e) shows a linear correlation (R
2 
= 0.9988) between the 
ratio of the two peptides (H/L) and the amount of H spiked in as internal standard over near 
two orders of magnitude (from 100 fmol to 5 pmol). The nearly perfect linear correlation 
demonstrates the stability of iMALDI for the absolute quantitation of F. tularensis peptides 
using an internal standard.  
Compared to the traditional culturing method and microagglutination test [2,4,10,17,20–
23], iMALDI is more rapid, sensitive and specific. The peptide sequencing capability of 
tandem mass spectrometry in iMALDI provides higher molecular specificity than ELISA. 
The sensitivity of iMALDI is comparable to the most sensitive PCR method [26], but may 
not be as rapid when the digestion and incubation time is considered. However, the digestion 
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time of iMALDI can be greatly reduced by using immobilized trypsin [56], and the 
incubation time can be reduced by using an antibody with high affinity. Moreover, compared 
to other methods, iMALDI has higher safety, better absolute quantitation capabilities, and 
improved high-throughput analysis capability which significantly reduce the cost per sample. 
One major disadvantage of iMALDI is that its overall quality highly depends on the affinity 
and specificity of the antibody. However, this problem should be able to be solved by using 
different strategies of antibody optimization, or alternative affinity-capture materials such as 
aptamers [57,58].  
CONCLUSIONS 
We have shown that the combination of two mass spectrometric approaches (MALDI–MS 
and MALDI–MS/MS), inherent in our iMALDI approach, can unambiguously identify 
affinity-bound peptides, and therefore, permits specific detection of F. tularensis bacteria. 
The F. tularensis iMALDI can detect F. tularensis bacteria in PBS solution at a sensitivity of 
better than 10 CFU of bacteria. Since both the molecular weight and the sequence of the 
bacterial peptide is determined at high accuracy, the high sensitivity of this technique means 
a low rate of “false negatives”, and the high specificity means a low rate of “false positives”. 
In addition, the iMALDI F. tularensis peptide assay is adequate for accurate and absolute 
quantitation of the target protein concentration. With the addition of robotic liquid handling 
systems, it would be an even safer technique, as well as being capable of high-throughput 
analyses. This would make iMALDI an extremely valuable tool for the early detection of F. 
tularensis and other bioterrorist agents.  
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TABLES AND FIGURES 
 
 
Fig. A.1 – Analytical scheme of the iMALDI assay. Epitope-containing peptides, 
49
NIVAIEGGEDVTK
61
, synthesized using isotopically labeled amino acid V, are added to 
the proteolytic digest of F. tularensis bacteria and are subsequently incubated with the anti-
aa49–61 (F. tularensis IglC) antibody beads to immuno-adsorb both isotopically labeled and 
unlabeled peptides. After immunoadsorption of the differentially labeled peptides, the 
antibody beads are arranged in a microarray/spot format on the MALDI-target plate. MALDI 
matrix solution added to the affinity-bound peptides elutes the peptides from the immobilized 
antibodies, permitting MALDI analysis of the peptides. The relative abundances of the 
molecular ion signals corresponding to “heavy” (isotopically labeled) and “light” (unlabeled) 
peptides are used to quantify the amount of this protein in the original sample. Absolute 
specificity can be achieved by mass spectrometric sequencing of the epitope-containing 
peptide, using MALDI–MS/MS. 
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Fig. A.2 – Selection of F. tularensis IglC peptides for raising antibodies to be used for the F. 
tularensis iMALDI assay. MALDI–MS of proteolytic F. tularensis IglC peptides obtained by 
in-solution digestion of IglC with trypsin. Four “true” (C-terminal cleavage of K or R 
residues) tryptic peptides of IglC were selected for antibody production based on the high 
sensitivity in the MALDI–MS. 
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Table A.1 - Affinity determination of the four anti-(F. tularensis IglC) peptide antibodies 
against their epiptope peptide by ELISA (the cysteine residue marked with asterisk has been 
added to the native sequence because of ease of conjugation with the carrier protein) 
F. tularensis IglC peptides used for 
antibody production 
Anti-(F. tularensis IglC) peptide 
Antibodies 
ELISA response 
(titer) 
153AFSISIESPTELMGVS167 [(F. tularensis IglC) aa153-167] 1/50,000 
8QQVTSGETHIHVR29 [(F. tularensis IglC) aa8-19] 1/3,000 
48C*NIVAIEGGEDVTK61 [(F. tularensis IglC) aa48-61] 1/500,000 
62ADSATAAASVIR73 [(F. tularensis IglC) aa62-73] 1/10,000 
The cysteine residue marked with asterisk has been added to the native sequence because of ease of conjugation 
with the carrier protein. 
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Fig. A.3 – Detection sensitivity of synthetic F. tularensis IglC peptides in solution and using 
the F. tularensis iMALDI assay. MALDI–MS spectrum of synthetic F. tularensis IglC 
peptide CNIVAIEGGEDVTK (a) in solution: (a-1) 100 fmol; (a-2) 1 fmol; (a-3) 10 amol. (b) 
Affinity-bound to anti-aa48-61 (F. tularensis IglC) antibody beads: (b-1) 138 fmol; (b-2) 
1.38 fmol; (b-3) 13.8 amol. 
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Fig. A.4 – Detection of F. tularensis bacteria in PBS solution using the F. tularensis 
iMALDI assay. MALDI–MS spectrum of peptides obtained after proteolysis of F. tularensis 
bacteria in PBS solution, affinity-bound to anti-aa49–61 (F. tularensis IglC) antibody beads. 
The singly charged epitope-containing tryptic peptide (aa49–61 F. tularensis IglC protein) is 
observed at m/z = 1344.7 (see inset). The spectrum represents the amount of IglC peptide 
equivalent to 8 CFU for F. tularensis bacteria.  
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Fig. A.5 – Detection of F. tularensis bacteria in plasma samples using the F. tularensis 
iMALDI assay. MALDI–MS spectrum of peptides obtained from proteolyzed F. tularensis 
bacteria spiked in plasma digest, affinity-bound to anti-aa49–61 (F. tularensis IglC) antibody 
beads. The singly charged epitope-containing tryptic peptide (aa49–61 F. tularensis IglC 
protein) is observed at m/z = 1344.7 (see inset). The spectrum represents the amount of IglC 
peptide equivalent to 800 CFU for F. tularensis bacteria.  
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Fig. A.6 – Detection of F. tularensis bacteria in nasal swab samples using the F. tularensis 
iMALDI assay. (a) MALDI–MS spectrum of peptides affinity-bound to anti-aa49–61 (F. 
tularensis IglC) antibody beads, obtained after proteolysis of mouse nasal swab extracts 
collected 2 days after the mice were inoculated with F. tularensis. The singly charged, 
epitope-containing, tryptic peptide, NIVAIEGGEDVTK, corresponding to aa49–61 of the F. 
tularensis IglC protein, was observed at m/z = 1344.7 (see inset). (b) MALDI–MS spectrum 
of anti-aa49–61 (F. tularensis IglC) antibody beads obtained after proteolysis of nasal swab 
extracts collected from uninfected mice on the same day. 
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Fig. A.7 – Highly specific detection of F. tularensis bacteria in PBS solution by mass 
spectrometric sequencing of the immunoaffinity-enriched F. tularensis IglC aa49–61 peptide, 
using the F. tularensis iMALDI assay. (a) MALDI–MS/MS spectrum of the peptide at m/z = 
1344.7 affinity-bound to anti-aa49–61(F. tularensis IglC) antibody beads, obtained after 
proteolysis of F. tularensis bacteria in PBS solution. All of the abundant ions can be assigned 
to sequence-specific y-and b-ions of the F. tularensis IglC peptide aa49–61, resulting in 
unambiguous identification of the immunoaffinity-enriched peptide. (b) This table shows the 
mass accuracies of the fragment ions, demonstrating that the assignment of these ion signals 
is correct. This therefore demonstrates that, using our F. tularensis iMALDI assay, F. 
tularensis bacteria can be detected with high specificity and correspondingly low “false 
positive” rates. 
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Fig. A.8 – Quantitation of F. tularensis bacteria using the F. tularensis iMALDI assay. 
Absolute quantitation of the IglC peptide NIVAIEGGEDVTK (aa48–61) (L, light peptide, 
m/z = 1344.7) in a bacterial sample. F. tularensis bacteria were digested and incubated with 
different amounts of heavy peptides (H, m/z = 1350.7) as internal standards: (a) 0.1 pmol, (b) 
0.5 pmol, (c) 1 pmol, (d) 5 pmol, (e) Plot of the observed ratios of monoisotopic abundances 
of H and L in the MALDI–MS spectra (a–d) versus the absolute amount of H added. Note, 
only a 10% aliquot has been used for the analysis. 
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